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 Although first discovered in viruses, previous studies have identified programmed 
-1 ribosomal frameshifting (-1 PRF) signals in eukaryotic genomic sequences, and 
suggested a role in mRNA stability.  This work improves and extends the computational 
methods used to search for potential -1 PRF signals.  It continues to examine four yeast 
-1 PRF signals and show that they promote significant mRNA destabilization through the 
nonsense mediated (NMD) and no-go (NGD) decay pathways.  Yeast EST2 mRNA is 
highly unstable and contains up to five -1 PRF signals.  Ablation of the -1 PRF signals or 
of NMD stabilizes this mRNA.  These same computational methods identified an 
operational programmed -1 ribosomal frameshift   (-1 PRF) signal in the human mRNA 
encoding CCR5.  A -1 PRF event on the CCR5 mRNA directs translating ribosomes to a 
premature termination codon, destabilizing it through the nonsense-mediated mRNA 
decay (NMD) pathway.  CCR5-mediated -1 PRF is stimulated by at least two miRNAs, 
one of which is shown to directly interact with the CCR5 -1 PRF signal. Structural 
analyses reveal a complex and dynamic mRNA structure in the -1 PRF signal, 
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Cells regulate gene expression via diverse mechanisms.  From mRNA 
transcription to protein degradation, many regulatory systems affect the timing, 
localization, and rate of each reaction.  Gene expression is primarily concerned with the 
abundance and translational activity of mRNA; therefore expression is increased when a 
message is transcribed more rapidly, stabilized by the cell, or more available to actively 
translating ribosomes.  Increased mRNA degradation, decreased transcription, 
translational silencing, and the storage of mRNA are the hallmarks of decreased 
expression.  Post-transcriptional regulation of gene expression is a growing field of 
inquiry; it has primarily concentrated on cis-acting elements in the 5’ and 3’ untranslated 
regions (UTRs) of mRNAs, and the trans-acting factors with which they interact.  Protein 
coding regions have not been as closely examined for effects on post-transcriptional 
control; however multiple cis-acting mRNA elements have been found which cause 
elongating ribosomes to recode the mRNA sequence [for review see [1], Appendix 12].  
These include, but are not limited to, sequences responsible for +1 and -1 programmed 
ribosomal frameshifting, termination suppression, stop-start elements, selenocysteine 
incorporation in all kingdoms of life, and pyrolysine incorporation in archaea[2].  More 
recently, programmed recoding has taken on a whole new dimension, as artificial tRNA 
synthetases and codon:anticodon pairs provide the means to literally re-encode the 
genome [introduced in [3]  and reviewed in [4]]. 
At its heart, this work is an attempt to tie together a group of disparate 
observations; each with its own background, literature, and state of the art.  The primary 
determinants of highly transcribed, functional, and stable mRNAs are well established[5].  
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In specific instances the opposite is also true; some destabilizing elements have been 
well characterized.  Similarly, the viral determinants of -1 PRF have been described in 
numerous instances[6].  The mechanisms of -1 PRF are still debated, but center around 
specific stages during translation elongation[7].  Even the contentious fields of NMD[8] 
and ncRNA research[9] are coalescing around relatively well defined hypotheses.  The 
questions remain:  how do these mechanisms interact?   How do we find specific 
examples which demonstrate the interplay between mRNA structure, translational 
fidelity, and mRNA stability?  Finally, what future avenues of research do these 
observations suggest?  No computational nor laboratory methodologies provide the 
answers, but existing tools provide glimpses and opportunities to search for and analyze 
strong candidates.  In the following sections, I will provide the background of these post-
transcriptional processes and the computational methodologies involved. 
This thesis focuses upon -1 programmed ribosomal frameshifting (PRF); which is 
a recoding mechanism historically associated with viruses[10]a and 
retrotransposons[11,12]b.  A PRF signal stochastically redirects translating ribosomes 
into an alternate reading frame.  A cursory glance at Appendix 12 shows that, with the 
notable exception of Thermus thermophilus’ extraordinary poly-U slippage event, -1 PRF 
follows a generally consistent pattern of a stimulatory element immediately downstream 
of a group of weakly pairing bases.  On the other hand, +1 PRF, ribosomal shunting, and 
suppression events intermingle proximal RNA secondary structures, distant RNA 
structures, mixtures of rare 0 frame and “hungry” +1 frame codons, and even alternate 
tRNA species.  This work therefore limits its scope to canonical -1 PRF as initially 
described in the Rous sarcoma virus[10].  In this context, a -1 PRF signal leads to 
                                               
a Jacks and Varmus introduce the first -1 programmed ribosomal frameshifting signal in this 
paper. 
b Craigen et al. describe +1 PRF in the expression of bacterial release factor 2.  In the same year, 
Farabaugh published a speculative paper suggesting +1 PRF in the Ty1 retrotransposon, which 
was later proved in Clare et al. by sequencing cDNA from the Ty1 mRNA. 
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expression of the Gag-pol polyprotein from two overlapping ORFs.  Thus, a viral -1 PRF 
signal allows ribosomes to bypass the 0-frame stop codon and continue synthesis of a 
C-terminal extended fusion protein[13]c.  Though PRF was first described in viruses, we 
now have evidence that organisms in all three kingdoms of life employ PRF[14–16]d, 
opening the possibility for a conserved mechanism affecting the expression of actively 
translated mRNAs[17].  
This peculiar post-transcriptional regulation system ties together the 
mRNA/ribosome interactions which occur in viral -1 PRF (for review, see [18]), with the 
surveillance mechanisms against aberrant, truncated messages (for reviews, see 
[8,19,20]).  While the requirements of PRF are well understood in viruses and a specific 
set of transcripts, the potential of PRF outside these contexts has not been fulfilled.  For 
example, while splicing dependent Nonsense Mediated Decay (NMD) substrates have 
been well characterized[21]e, there remain many more transcripts which are known to be 
up-regulated when NMD is knocked out and cannot be fully explained[22]f.  One final 
observation lays the foundation for this work: more than 95% of predicted genomic -1 
PRF signals are followed not by a C-terminal extension, but by a -1 frame stop 
codon[23,24]; as summarized in Figure 1 for the ORFs of the Homo sapiens genome, 
which is consistent with observations of most other genomes observed (Figure 54).  
Taken together, these disparate observations engender the hypothesis that active 
translation of -1 PRF signal containing mRNAs negatively regulates these messages via 
NMD and/or No-Go Decay (NGD).  This hypothesis assumes that it is possible to find 
                                               
c This paper provides some early examples of PRF in viruses, notably in Table 2. 
d Cobucci-Ponzano observed the frameshift products of the archael α-l fucosidase via Mass 
Spectrometry (MALDIMS) in their first publications, and later provided more examples in the 
following review.  In Brierley’s 2004 paper, they switch the focus from viral PRF to bacterial and 
eukaryotes. 
e ~2,000 of 5,693 mRNAs were found with alternative splicing isoforms which lead to PTCs in the 
coding exons of RefSeq. 
f Microarray experiments with Saccharomyces cerevisiae NMD knockout strains found a set of 




and evaluate novel decay substrates in sequence databases, and that this form of post-
transcriptional regulation is regulated by trans-acting factors.  Work performed in the 
mammalian context adds the observation that non-coding RNAs (ncRNA) provide 
transcript specific regulation of -1 PRF substrates. 
 
Figure 1: The distribution of -1 PRF signal in Homo sapiens. 
Left:  A histogram of the number of potential -1 PRF signals with respect to relative ORF position 
in Homo sapiens.  Middle:  The percent of the total which is predicted to translate the -1 reading 
frame by 30 or more codons.  Of note is the marked decrease of the total from 90-100% and 
simultaneous increase in the percentage which extend by 30 or more codons (left vs. middle).  
Right: The distribution of length of -1 PRF signal encoded peptides in Homo sapiens.  More 
examples may be found in Figure 54. 
The mRNA Life Cycle 
Messenger RNA expression is tightly controlled from transcription until 
degradation.  RNA polymerase II (Pol) recruitment to DNA and activation is controlled by 
binding; these may recruit or block Pol II as well as stimulate or inhibit transcription 
elongation[25].  Maturation of nascent transcripts via m7G addition, splicing, and 
polyadenylation protect these new messages from decay, while the UTRs harbor 
powerful signals which recruit or block mRNA decay.  One example which proved useful 
in this work includes AU rich elements in the 3’ UTR[26]; these promote mRNA 
decay[27]g.  Trans-acting factors are important in other instances; in one particularly 
powerful example, loss of 3’ UTR was shown to activate proto-oncogenes partially 
                                               
g The highlight of this paper is the early time-course assay of β-globin RNA. 
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because these mRNAs no longer contained binding sites for miRNAs which kept them 
under control[28].  Indeed, in the case of the yeast HO endonuclease, two separate PUF 
proteins have been found to simultaneously bind the 3’ UTR such that full repression 
occurs only when both are bound[29].  On the other hand, the amino acid starvation 
response is mediated partially through the relocalization of mRNAs out of processing 
bodies (P bodies) mediated by the 3’ UTR and other miRNA binding sites[30]h.  
 Mature, properly formed, and localized messages remain at risk from attack by 
ncRNAs; including micro-RNAs (miRNA) (reviewed in [31]) and short interfering RNAs 
(siRNA) (reviewed in [32]).  These quickly recruit the cell’s silencing machinery in a 
sequence specific manner, leading to rapid endonucleolytic cleavage, decapping, 
deadenylation, and exonucleolytic decay.  Messages which maintain the balance of 
these transcriptional control elements are translated and subject to a separate set of 
post-transcriptional regulatory mechanisms.  In order to address these mechanisms, it is 
first necessary to address translation as it progresses from initiation, through elongation, 
termination, and eventually recycling. 
Translation Subversion 
The actively translating ribosome coordinates an exquisitely complex series of 
individual activities to complete the cycle of initiation, elongation, and termination 
(Figure 2).  Once the translational reading frame is established during initiation, this 
reading frame must be maintained throughout elongation.  During each cycle, the ternary 
complex (in eukaryotes comprising eEF1A, the tRNA, and GTP) delivers a new 
elongator tRNA to the decoding center of the small ribosomal subunit.  If the amino-acyl 
tRNA anticodon is complementary to the mRNA codon, they form a helix stabilized by  
                                               
h Bhattacharyya et al. used polysome fraction alaysis and immunofluorescence microscopy to 
demonstrate that the CAT-1 3’ UTR determines its translational status and localization.  It goes 




Figure 2: The translation cycle. 
The current model of the prokaryotic translation cycle includes initiation, elongation, termination, 
and recycling.  The initiation factors bring together the large and small ribosomal subunits (50S 
and 30S respectively in bacteria) with the initiator tRNA located in the small subunit P site on the 
mRNA start codon.  Elongation factors (bacterial EFG and EF-Tu) continue to bring new tRNAs to 
the ribosome and promote translocation through the elongation cycle in a GTP dependent 
manner.  When the elongating ribosome reaches a stop codon, release factors are incorporated 
instead of aminoacyl tRNA, thus freeing the newly synthesized polypeptide.  Finally, ribosomal 
recycling separates the subunits, removes the peptidyl tRNA and mRNA, and leaves the system 
ready for another round of initiation.  This figure is from Marshall et al.[33]. 
interactions among the small subunit (SSU) rRNA and SSU protein S12[34]i.  In turn this 
causes eEF1A to hydrolyze GTP and release the tRNA; it is this process which allows 
                                               




the aminoacylated 3’ end to move from the periphery of the large subunit into the A-site 
of the peptidyl transfer center (PTC) via the accommodation corridor. 
Peptidyl transfer catalysis occurs in the PTC via positioning of the incoming tRNA 
and an active (requiring energy from GTP hydrolysis) transesterification reaction 
performed by the ribosome (Figure 3, reviewed in [35]).  During this reaction, the 3’ end 
of the deacylated tRNA moves into the E-site of the large subunit.  Simultaneously, the 
A-site tRNA, which just received the peptide, moves into the P-site; the anticodon loops 
of both tRNAs remain in the small subunit P and A sites respectively, creating the hybrid 
state of the ribosome.  The entire ribosome rotates from the “classical” to “rotated” 
state[36]j during this step.  Translocation follows and defines the next step in reading 
frame maintenance.   Translocation begins when eEF2 is recruited to the ribosome, 
leading to GTP hydrolysis, which provides the energy required to separate the tRNAs 
from the mRNA, and the energy to move the anticodon loops from the P and A sites to 
the E and P sites respectively[37]k.  Upon completion, this leaves the A site empty and 
ready for the next ternary complex.  Recent methodologies, including X-ray 
crystallography, cryo-EM, and single molecule FRET experiments, have elucidated the 
structural features of the ribosome which ensure that the tRNAs remain correctly 
positioned, and ensure that translocation is limited to three nucleotides[38]l.  
Furthermore, actively expressed eukaryotic mRNAs maintain an assembly of 
factors including: the m7G cap and polyA tail circularized by polyA binding protein 
(PABP); initiation factors 4G and 4E (eIF4G, eIF4E) (Figure 4, reviewed in [39]); and the 
                                               
j Figure 1 of this paper has a nice way of demonstrating the rotation of the ribosome, while Figure 
2 shows the extent of tRNA bending from the P/P to the P/E state. 
k Filterbinding assays were performed which suggest that tightly coupled ribosomes harbor 3 
tRNAs / ribosome (Figure 3C), thus beginning the hypothesis of the E-site and a long-term 
disagreement with Wintermeyer. 




splicing complex (reviewed in [40]).  These mRNAs must maintain the processivity of 
translating ribosomes to stave off the surveillance complex, lest they be rapidly 
 
Figure 3: Peptide bond formation in the ribosome. 
A new peptide bond is formed when the α-amino group of aminoacyl-tRNA(red) attacks the 
carbonyl carbon (shown by the black arrow on the left) of the peptidyl-tRNA in the P-site (blue).  
This leaves a one amino acid longer peptidyl-tRNA in the A site and a deacylated tRNA in the P 
site.  This figure is from Beringer & Rodnina[35]. 
degraded via the nonsense mediated decay (NMD) [41,42], non-stop decay(NSD)[43,44] 
or no-go decay (NGD)[45] pathways.  
Subverting Initiation 
Given this interplay of individually complex systems, it is no surprise that every 
phase of translation is subverted by so many viral and cellular systems.  Internal 
Ribosome Entry Sites (IRESes) mimic the initiation complex via many methods, such 
that the entire spectrum of initiation factors may or may not be required for translation of 
these RNAs (reviewed in [46]).  The CrPV IRES requires none of the endogenous 
initiation factors, while the polio virus IRES uses all of the endogenous machinery except 
eIF4e (Figure 5).  Viral and endogenous elements derail elongating ribosomes to 
diverse ends.  Two methods are primarily employed in this context: disrupting the 
kinetics of elongation and molecular mimicry.  A programmed ribosomal frameshift event 
is an excellent example of what happens when the normal dynamic of elongation is 





Figure 4: Visualizing circular mRNA by atomic-force microscopy. 
Microscopy performed by A. Sachs shows complexes formed on capped, polyadenylated mRNAs 
in the presence of eIF4G, poly(A)-binding protein, and eIF4E.  This figure is from Mendez & 
Richter[39]. 
in Figure 9)  or by juxtaposing a very rare codon with a common codon in the +1 reading 
frame[47].   
Restarting Elongation 
The bacterial use of transfer-messenger RNA (tmRNA) to free stalled 
ribosomes[48,49] and the TCV ribosome binding element[50] illustrate two ways in which 
molecular mimics of the translational players promote elongation.  tmRNA performs this 
function by simply combining the separate elements of an initiator tRNA and short 
mRNA into a single molecule.  This accommodates into stalled ribosomes and causes 
elongation over its short message and normal termination.  Similarly, the TCV binding 
element mimics a tRNA in order to recruit the ribosomal large subunit as well as 





Figure 5: The spectrum of IRES factor requirements. 
These examples show the spectrum of factors required for IRES translation.  This study noted the 
trend that as viral RNA becomes more structured it requires fewer cellular factors for successful 
translation.  This figure is from Filbin 2009[51]. 
Modifying Termination 
Termination is subverted in multiple ways, leading to suppression and allowing 
viruses to encode multiple peptides from a single mRNA.  The influenza B stop-start 
signal, though still not fully understood[52]m, produces both the M1 and BM2 proteins 
while managing to escape NSD.  The termination suppression activity demonstrated by 
the murine leukemia retrovirus is better understood[53].  It uses a strong pseudoknot 
                                               
m This paper has the unusual distinction of using a tri-cistronic reporter containing two 
fluorescence genes followed by firefly luciferase, each ORF separated by the start-stop element. 
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RNA structure to force ribosomes to pause, this allows its reverse transcriptase to bind 
polymerase[54]n. 
Examples in the Genomic Context 
These few examples illustrate some of the methods employed by viruses to 
disturb normal translational equilibria.  Examples employing these methods are also 
being found in the genomic context with increasing frequency.  The most well 
documented method described to date is the cellular IRES; first described in the 
immunoglobulin heavy chain-binding protein mRNA[55], the cellular IRES has since 
been implicated in many contexts including the transcription factor c-myc, which is 
expressed when cap-dependent translation is otherwise compromised[56]o.  Overlapping 
ORFs which lead to translation reinitiation are common in multi-cistronic bacterial 
messages[57]; but are not generally found in eukaryotes with one glaring exception: 
upstream open reading frames (uORFs).  The most famous example comes from yeast, 
where the ribosomes of starving cells translate through the uORFs preceeding GCN4, 
thus translating this powerful activator of many biosynthetic pathways (Reviewed in [58]).  
While metazoans do not have GCN4 to turn on our stress pathways, the uORFs before 
ATF4 demonstrate the same mechanism[59].  uORFs are important not only because 
they are implicated in an important non-canonical translation system, but also because 
uORF containing messages are strong substrates for nonsense mediated decay. 
This work expands on the hypothesis that there is a linkage between -1 PRF and 
Nonsense Mediated Decay.  Programmed ribosomal frameshifting (PRF) occurs when a 
cis-acting signal in an mRNA directs translating ribosomes into an alternate reading 
                                               
n This paper provides a classic example of the mutagenesis strategy: “Mutate the 5’ side of a 
stem, mutate the 3’ side of a stem, mutate both.” 
o This is notable not only for the immunodepletion of eIF4GI as a stimulator of IRES driven 
translation, but also because it introduced the XIAP IRES, which goes on to test for an IRES 
element in the mammalian dual luciferase reporter system. 
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frame at a much higher rate than the normal 0.06%[60]p or  0.005% frameshift events 
per message transit[61]q.  PRF is most commonly observed to shift ribosomes by one 
base either in the 3’ (+1 PRF) or 5’ direction (-1 PRF) (comparisons in [62]), but may 
also include much larger shifts or ribosomal shunting events.  Ribosomal shunting is 
another means to translate sequences which would normally remain quiescent; instead 
of coding for an overlapping ORF, the shunting target lies far downstream and is often 
triggered when normal, cap dependent translation is impaired.  Adenovirus provides the 
primary example of this mechanism:  its shunting signal uses similarity to 18S rRNA to 
trigger translation over 220 nucleotides downstream[63]. 
Programmed -1 ribosomal frameshifting was first observed in the Rous-sarcoma 
virus; in this viral context, a single mRNA transcript encodes two peptides and expresses 
them at a specific ratio via -1 PRF.  The majority of the translated product consists of the 
shorter, unshifted gag structural protein.  When -1 PRF occurs, translating ribosomes 
bypass the zero-frame stop codon, resulting in translation of the Gag-pol fusion product 
(Figure 6).  Subsequently, it was found that some plus stranded RNA viruses, dsRNA 
viruses, and retroviruses also use -1 PRF.  For example, the dsRNA L-A yeast Totivirus 
was shown to produce of its major coat protein and RNA-dependent RNA polymerase 
using this method[64].  It was further shown that maintenance of the M1 satellite virus of 
L-A requires a specific frameshifting rate[65]r, demonstrating a distinct phenotype 
dependent on ribosomal frameshifting.  Multiple phylogenetically conserved cellular 
mechanisms have first been identified in viruses, this may also be true for -1 PRF. 
                                               
p This value is presumed to be high because it was measured with β-galactosidase activity. 
q Though we cite this value often, the logic of this calculation is problematic in the context of 
programmed -1 ribosomal frameshifting because it is based on observations made with tRNA 
suppressor mutants. 




Figure 6: The organization and results of viral -1 PRF. 
Diagrams of three -1 PRF containing viral genomes show the overlapping open reading frames 
and the resulting peptides which are synthesized if translation stays in the 0 reading frame (gag) 
or shifts into the -1 reading frame (Gag-pol fusion). 
To date, a few -1 PRF signals of viral origin have serendipitously been found in 
metazoan genomes, including the mouse Edr[66] and the human paraneoplastic Ma3 
genes[67]. 
Models of -1 Programmed Ribosomal Frameshifting 
The role of -1 PRF outside the viral context was not clear, but the mechanisms 
have been thoroughly debated.  A -1 PRF signal consists of several conserved 
elements: a “slippery heptamer”, followed by a significantly stable downstream mRNA 
secondary structure, separated by a spacer (Figure 7).  The “slippery heptamer” 
consists of N NNW WWH (spaces delineate reading frame, N, W, H follow IUPAC 
conventions: N is any three identical bases, W is any three identical weak bases, and H 































causes elongating ribosomes to pause while the tRNAs are positioned over the slippery 
site.  The nature of the slippery site allows the aminoacyl and peptidyl-tRNAs to form a 
relatively stable mini-helix with the mRNA -1 frame bases[10].  The constituent bases of 
the slippery site are also important for the rate of -1 PRF, and further have different 
effects depending on the translational system expressing the sequence[68].  The mRNA 
secondary structure provides an energetic barrier to translating ribosomes and positions  
 
Figure 7: The elements of a -1 PRF signal. 
A functional -1 PRF signal occurs when an actively translating ribosome is forced to pause at a 
strong mRNA secondary structure, usually an H-type pseudoknot.  The ribosome A and P sites 
are situated over the NNW and WWH nucleotides of the slippery site due to an appropriately 
sized (6 bases in this drawing) spacer. 
them over the slippery heptamer.  H-type mRNA pseudoknots are the most common 
stimulatory structure, but other structures, including proteins bound to stem-loops[69], 
variously sized stem-loops[70], and RNA triplexes[71] promote efficient frameshifting. 
The 'simultaneous slippage' model[72] of -1 PRF states that translating 
ribosomes pause on the downstream structure while the peptidyl-tRNA and aminoacyl-
tRNA are situated over the 'NNW' and 'WWH' bases of the slippery heptamer (Figure 8).  
In the time it takes the ribosomal helicase to resolve the downstream mRNA, the A and 
P site codons break their 0-frame hydrogen bonds and subsequently re-form them in the 
-1 frame, pairing with 'NNN' and 'WWW.'  Finally, elongation resumes normally in the -1 
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frame.  This model provides neither details of the timing nor the position of the ribosome 
at the time of the frameshift event. 
 
Figure 8: A Model Mechanism of -1 PRF. 
Illustration of the ribosomal A and P sites during a -1 Programmed Ribosomal Frameshifting 
event.  First, the ribosome (light blue) is forced to pause before the mRNA secondary structure 
(right knot) while its P site tRNA is situated in the classical conformation over a glycine codon and 
an newly accommodating asparagine tRNA is in the A/P conformation.  The physical strain 
caused on the spacer by the ribosome attempting, but failing to translocate eventually causes the 
tRNAs to re-pair over the GGG and AAA codons.  Finally the ribosomal helicase unwinds the 
downstream structure and elongation proceeds in the -1 reading frame.  The figure is from Plant 
et al.[73] 
Later models have stepped in to fill in these details, in each case the actual 
slippage event is coupled to GTP hydrolysis during elongation.  The “integrated 
model”[62] hypothesized that the shift occurs after the ternary complex delivers the aa-
tRNA to the A-site, but before peptidyl-transfer and therefore translocation by eEF2.  
This model was later refined in an attempt to explain the role of the downstream 
secondary structure[73].  In this model, the downstream element resists the movement 
of the mRNA during translocation, thus causing tension along the mRNA in the entrance 
tunnel and therefore partially blocking accommodation of the incoming aa-tRNA during 
eEF1A hydrolysis.  This tension is released when the A and P site tRNAs break from the 
mRNA, allowing the mRNA to shift one base.  In this model, the aa-tRNA serves as a 
lever and the LSU as a fulcrum to shift the mRNA before peptidyl transfer and 
translocation[74].  A separate model hypothesized that the -1 PRF event occurs during 
translocation.  In this case eEF2 mediated GTP hydrolysis breaks the tRNA/mRNA helix, 
but the downstream mRNA secondary structure frustrates the movement of the 
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ribosome, leading to an incomplete translocation of two nucleotides[75]s.  Interestingly, 
this model does not specify during which round of translation the incomplete 
translocation will occur.  In one scenario, the NNW WWH nucleotides are in the E and P 
sites but are forced to slip by the downstream element, leading the incoming tRNA to be 
in the -1 frame in the A site of the ribosome before peptidyl transfer.  The frameshift 
event may also occur during the following translocation, thus the mRNA shifts by only 
two nucleotides as the tRNAs transition from classical P/P and A/A to P/E and A/P 
states. 
 Each of these models has the support of experimental evidence, thus -1 PRF 
does not follow a single mechanism, but may best be explained as a series of kinetic 
partitioning events (for examples, see [76,77]) over the course of the elongation cycle 
such that each type of frameshift event results in a separate off-pathway product.  The 
“kinetic model” of -1 PRF[7] unified these models and illustrated the relative contribution 
during each step of elongation (Figure 9). 
Nonsense Mediated Decay 
 The logical link which makes it possible to hypothesize that -1 PRF affects mRNA 
abundance comes from comparing the fate of translating ribosomes after translating a 
viral -1 PRF signal compared to a putative genomic signal.  This distinction was 
suggested in Figure 1, but may be more explicitly shown by plotting the -1 frame 
extension in codons over the length of genomic mRNA (Figure 10).  While viral -1 PRF 
signals significantly extend an open reading frame, genomic -1 PRF signals are 
predicted to truncate the reading frame.  From this perspective, a functional -1 PRF 
signal in the genomic context acts as a stochastic premature termination codon[78], 
                                               
s Mutagenesis was performed on the three bases before the slippery heptamer and caused 




Figure 9: Kinetic Partitions which lead to -1 PRF. 
Two elongation cycles are diagrammed showing the on-product 0-frame translation and three 
separate pathways which result in the ribosome reading in the -1 frame.  Thus the aminoacyl-
tRNA mechanically wedges into the A-site during the first translocation event (Pathway I); tension 
of the mRNA caused by the mRNA secondary structure is relieved by slippage during the second 
accommodation event (Pathway II); or the second elongation cycle is frustrated by the mRNA 
secondary structure (Pathway III).  This figure is from Liao et al[7].  
and therefore as a substrate for nonsense mediated decay. 
NMD: Increasing Complexity 
 Diverse mechanisms exist to ensure the fidelity of gene expression; nonsense 
mediated decay (NMD) occurs post-transcriptionally and is among the most thoroughly 
debated.  The name harkens to the observation in yeast that nonsense codons in the 
ura3 ORF reduce the mRNA’s half-life[79]t and steady-state levels by as much as 5 fold.  
Nonsense codons in mRNAs are not unique to eukarya, but bacteria couple transcription 
and translation and do not remodel messages as extensively as eukaryotes.  Thus 
                                               




Figure 10: Genomic -1 PRF signals do not significantly extend the ORF. 
The distribution of length of each -1 frame extension following a slippery heptamer in Homo 
sapiens is plotted with respect to relative ORF position.  Each dot is colored according to the 
identity of the first 3 bases of the slip site (red: AAA, green: UUU, blue: GGG, black: CCC).  
Approximately 0.07% extend more than 30 codons past the 0 frame stop codon. 
bacterial NMD is currently thought to begin when internal cleavage sites are exposed by 
prematurely terminating ribosomes; these unprotected sites are endonucleolytically 
cleaved[80] by RNase E in E. coli, leaving the mRNA a target for rapid decay. 
In eukarya, there are many more proteins involved (Table 3) in NMD, and still more 
models arguing the details; but it is encouraging to note that the general idea that 
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successfully translating ribosomes protect messenger ribonucleoproteins (mRNPs) from 
degradation[81]u is shared with the bacterial model (Figure 11). 
 
Figure 11: Translating ribosomes protect mRNPs from NMD. 
This model summarizes the elements which promote and inhibit nonsense mediated decay.  Thus 
if Upf1 is able to mark mRNAs as having long 3’ UTRs, or the exon junction complex is not 
remodeled efficiently, then the mRNP is a strong candidate for decay.  Conversely, the poly-A 
binding protein complex and ribosomal readthrough protect the mRNP from decay.   This figure is 
from Hogg and Goff [81]. 
The primary sources of disagreement among the eukaryotic models of NMD 
reside with the importance and function of exon junction complex in NMD; the role of 
nuclear export in NMD; and the cap binding complex.  Therefore, if NMD is to be the 
                                               
u Assayed by inserting Murine Leukemia Virus Pseudoknot mutants into the 3’ UTR of a 
constitutively expressed β-globin construct.  Mutants which allow efficient readthrough 




foundation of a model of post-transcriptional regulation, it is imperative to first 
understand NMD in the context of Saccharomyces cerevisiae. 
NMD:  Current Model in Saccharomyces cerevisiae 
 The complete yeast genome[82] marked a shift in the understanding of the 
complexity of eukaryotic organisms.  As of April 2011v, 6,607 open reading frames 
(ORFs) have been identified across the 16 chromosomes, mitochondria, and the 
endogenous 2-micron plasmid.  The initial report of intron containing genes in yeast 
identified 228 introns[83], a number which has since grown to 282 (4.3% of the genome).  
Amazingly though, nearly 25% of the Saccharomyces cerevisiae transcriptome is 
generated from messages containing introns, including 9,168 mRNA molecules per hour 
per cell (73% of the ribosomal protein mRNAs)[84].  Furthermore, the intron containing 
ribosomal protein mRNAs comprise 90% of all intron containing transcripts in yeast.  In 
contrast, when microarray experiments were performed using cells deficient in the NMD 
machinery, 746 transcripts out of 7,839 (9.5%) were upregulated, including 545 out of 
6,086 protein coding ORFs (9.0%)[85] assayed.  When these transcripts were 
categorized, it was noted that genes involved in protein synthesis were 
underrepresented in the population of NMD regulated transcripts (1.7%).  From these 
observations (summarized in Table 1), it is unlikely that nonsense mediated decay in 
Saccharomyces cerevisiae is mediated primarily by the exon junction complex.  When 
He et al. examined the chromosomal positions of each transcript, 36% of all up-
regulated in NMD deficient cells were positioned within 20 kb of telomere ends; while 
only 8% of the transcripts farther away were similarly up-regulated.  This peculiar spatial 
arrangement of NMD regulated transcripts led to the observation that strains deficient in 
                                               
v The 6,607 ORFs currently assayed at: 
http://www.yeastgenome.org/cache/genomeSnapshot.html were not all available to Ares et al. nor 
He et al.; therefore these are three separate but comparable datasets. 
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NMD express genes normally silenced in telomeric regions[86], at least when tested 
using a telomere localized URA3 and 5-FOA reporter system. 






















Other proteins without introns 5,922 95.70% 24,226 64.06% 
Total 6,188  37,817  
Table 1: Classifying intron containing genes in Saccharomyces cerevisiae  
Ares et al. catalogued the number of mRNAs transcribed by Saccharomyces cerevisiae per hour 
and observed that a majority of the intron containing messages are from ribosomal proteins.   
Thus 1.5% of the genome is comprised of ribosomal proteins while 24% of the transcriptome is 
ribosomal protein RNA. 
Class in NMD∆ cells [85]  Increased Percentage of 
genome Increased 
Decreased 
Annotated Genomic ORFs 545 8.81% 6 
Mitochondrial, plasmid, unannotated ORFS 150 2.42% 5 
Small RNA, tRNA, rRNA 51 0.82% 8 
Total 746 12.06% 19 
Table 2: Observed RNA abundances for different classes of ORFs 
He et al. catalogued the ORFs which display increased expression in NMD deficient cells by 
micro-array.  If all NMD is due to splicing, then the number of genes expected to be increased in 
an NMD deficient strain should be much lower than the observed  8.81% of the entire genome, 
but closer to 2.17% (bold in Table 1). 
This marks one of the first instances in which NMD is cast in a role not only as a 
protector against deleterious transcripts, but also as a regulator of cellular homeostasis.  
These roles are in turn defined by the underlying mechanism of NMD.  The remaining 
models of NMD attempt to describe how yeast distinguish normal termination from 
premature: the “surveillance complex”[87], and “faux-3’ UTR"[88]w models.  Though the 
latter is now accepted as predominant mechanism in yeast, the surveillance complex 
model remains important because it is the direct antecedent of the currently prevalent 
model of NMD in metazoans, the pioneer round hypothesis[89,90]. 
                                               
w This was first demonstrated with some excellent PABP tethering experiments. 
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The surveillance complex model was posited when it was observed that Hrp1p 
interacts with Upf1p as well as a substrate for NMD[91]x.  A poorly defined downstream 
sequence element (DSE) located 3’ of a PTC leads to rapid degradation via NMD; when 
the DSE was removed these transcripts were no longer degraded.  Furthermore, the 
hrp1-3 allele increased the half-life of NMD substrates by factors of 5-10.  Therefore 
Hrp1p was identified as a recruiter of the surveillance complexy; it binds weakly to the 
DSE upstream of the stop codon and is easily removed by actively translating 
ribosomes.  When ribosomes terminate before the DSE, then Hrp1p is free to bind the 
mRNA and recruit Upf1p, leading to rapid degradation (Figure 12). 
 
Figure 12: The surveillance complex model in yeast. 
A. mRNA binding proteins (including Hrp1p) interact freely with the message inside the nucleus 
but are removed by translocating ribosomes in the cytoplasm.  B. If ribosomes terminate 
prematurely; Hrp1p is free to recruit the surveillance complex, leading to rapid decapping, 
deadenylation, and decay.  This figure is from Czaplinski et al.[8]. 
The primary strength of this model lies in its implicit coupling of active translation 
to the degradation of NMD substrate mRNAs.  Translating ribosomes prevent the 
binding of Hrp1p to the DSE and subsequent degradation.  Thus the weakness of the 
model, the poorly defined DSE (TGYYGATGYYYYY), is used to demonstrate that some 
messages house many separate DSEs[92]; but this model cannot explain rapidly 
degraded NMD substrates which do not contain this motif.  The faux 3’ UTR model fills in 
this logical gap. 
                                               
x This paper serves as a cautionary tale against overinterpreting EMSA data. 
y Hrp1p is generally identified as part of cleavage factor I.  In this role it is responsible for cleaving 
and polyadenylation of pre-mRNAs. 
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 This model does not focus on active elongation as a protector of mRNPs, but 
notes the position of terminating ribosomes in the context of a normal stop codon versus 
premature termination.  Toeprint analyses demonstrated that terminating ribosomes do 
not protect the mRNA 17 bases downstream of a normal stop codon; but do protect the 
same position when a stop codon is recognized as aberrant (Figure 13).  Similarly, the 
+6 position was deprotected in a time dependent manner in the case of premature 
termination; but adding a m7G cap analog attenuated these effects, as did performing 
the experiment in Upf1p deficient cells. 
 
Figure 13: Toeprints of normal and premature termination. 
Significant differences were observed when cycloheximide (CHX) was used to stop translation in 
the context of normal versus premature termination.  In this case, the +17 position is protected 
from transcription elongation by the presence of an abnormally terminating ribosome (lane 7), but 
not when m7G cap analog is supplied (lane 8).  This figure is from Amrani et al. [88]. 
These observations lead to the conclusion that the DSE was not in fact a salient 
feature of the mRNA which explicitly recruits a surveillance complex, but another sign 
that the context of termination and the mRNP is aberrant.  Under this model, NMD is a 
function of the interplay between: the m7G cap, the initiation factors eIF4G and eIF4E, 
 24 
 
poly-A binding protein (PABP), and the poly-A tail of the mRNP; these in concert with the 
continued successful transition of ribosomes from termination to reinitiation serve to 
ward off the Upf proteins and rapid degradation.  These elements are shared with the 
components involved in the 3’ UTR length surveillance model of NMD[81]. 
 A termination event must be recognized as aberrant in order for the faux 3’ UTR 
model to function (Figure 14).  Normal termination occurs when the elongating ribosome 
encounters a UAA/UAG/UGA codon in the appropriate context.  Class I Release Factors 
(RF) (eRF1 is Sup45p in yeast) recognize these stop codons in the A site and stimulate 
release of the polypeptide chain from the P site tRNA.  Class II RFs (eRF3 is Sup35p in 
yeast) use GTP to stimulate the class I RF; in addition the N-terminal portion of Sup35p 
interacts with PABP, stimulating mRNA decay[93].  One assumption of the faux 3’ UTR 
model is that premature termination affects this interaction.  From the opposite 
perspective, the faux UTR model suggests that the proteins bound to the 3’ UTR are 
important for the stability of the message, specifically the proximity of PABP to the site of 
termination.  To test this implication of the faux UTR hypothesis, Amrani et al. used a 
construct containing the MS2 coat protein binding site with a PTC  used to bind a portion 
of Pabp1[88].  This ‘tethering’ of Pabp1 to the otherwise strong substrate for NMD 
stabilized the message significantly.  Taking one step further, eRF3 was tethered in a 
similar fashion and also stabilized NMD substrates (PGK1 with a PTC); but when eRF1 
was used no effect was observed.  These observations lead to the conclusion that 
termination is normally a process of eRF3 binding near Pabp1, activation by eRF1, and 
efficient ribosomal decoupling.  In contrast, premature termination is inefficient and, 
without Pabp1, leaves time for the Upf proteins to bind and promote decay.  The details 
of this process are not fully understood, but are suggested by the structures of the Upf 
proteins, their interactions with the decapping proteins Dcp1p and Dcp2p, the 5’ 




Figure 14: The Faux 3' UTR Model of NMD. 
The context of termination is the primary determinant of suitability for NMD in the faux 3’ UTR 
model.  This figure is from Brogna et al.[94] 
The Upf proteins 
The primary actors of NMD are Upf1pz, Upf2p, and Upf3p; they are required for 
function and partially conserved among eukaryotic species.  The complete panoply of 
NMD associated factors is difficult to define (Table 1).  Upf1p is the judge of aberrant 
termination; it subsequently interacts with Upf2p and Upf3p to trigger mRNA 
degradation.  This judicial activity is partially demonstrated by Staufen-Mediated Decay 
(SMD).  In this mechanism staufen recruits Upf1p downstream of a termination codon 
and leads to rapid mRNA degradation[95].  These activities are mediated by two 
conserved domains in Upf1p (Figure 15); the Upf2p interacting N-terminal domain and a 
C-terminal helicase region which interacts directly with mRNA.  In addition, this region 
contains 7 superfamily 1 RNA/DNA helicase domains[96].  
Crystal structures of the mammalian UPF1 (RENT1) helicase domain bound to 
ssRNA and AMPPNP[97] provide hints regarding how UPF1 may unwind mRNA 
                                               





Figure 15: The domains and interactions of UPF1. 
A.  The order and relative positions of the human and yeast Upf1p domains.  This image is from 
Applequist et al.[96]  B.  Depiction of Upf1p interactions with release factors and Upf2p.  This 
image is from Ivanov et al.[98] 
powered by ATP.  Cryo-EM structures (along with SAXS and crystal structures) of UPF1 
with UPF2[99] provide an image of the C-terminus of UPF2 bound to the UPF1 CH-
domain.  In mammalian systems this feeds a model of NMD whereby UPF1 and UPF3 
transiently join eRF1 and eRF3 (the SURF complex).  The EJC in turn meets the SURF 
complex mediated by UPF2.  Once all the components are in place, SMG1 
phosphorylates the C-terminal SQ motifs of UPF1.  This in turn leads to rapid 
degradation, at least partially through SMG6’s endonuclease activity and partially by 
SMG7’s ability to promote destabilization via DCP2 and XRN1.  In addition, 








Thus UPF1 stands at the center of a strongly redundant network of interactions which 
serve to rapidly detect and remove NMD substrates. 
UPF2 is usually considered an adaptor protein, bringing either UPF3 or the 
SURF complex to UPF1.  Recent work[100] has illustrated how UPF2 affects the 
ATPase and mRNA unwinding abilities of UPF1.  This model condenses the 7 helicase 
regions of UPF1 into 2 RecA domains and the N-terminal Zn finger into a CH domain.  
Crystal structures with various ATP analogues and UPF2 showed that the CH domain 
inhibits the ATPase activity of UPF1 and binds UPF2.  The two RecA domains of UPF1 
in these structures each have an additional domain (termed 1C and 1B which are an α-
helix and β-barrel respectively) that affects nucleic acid binding to the RecA domains.  
When UPF2 was bound to UPF1 in these crystal structures, the CH domain moved to a 
position almost diametrically opposed to the unbound state (Figure 16).  This surprising 
shift of a relatively large 1500 Å2 surface area was initially thought to be an artifact, but 
eventually shown to be facilitated by a flexible linker.  When the CH domain is bound by 
UPF2, they drive a shift of the CH domain to the other side of 1B, allowing it to relax and 
increasing RNA unwinding activity.  Therefore, UPF2 is not only an adaptor protein as 
previously thought, but has a strong role in activating UPF1. 
UPF3 is both structurally simpler and evolutionarily more complex than the other 
two primary members of the NMD system.  In yeast it contains 387 amino acids, which 
are shuttled between the nucleus and cytoplasm by importin-α in order to maintain fully 
active NMD[101].  However a duplication event during the evolution of higher organisms 
resulted in two paralogous isoforms, UPF3A and UPF3B.  The interactions between 
UPF3 and the other NMD factors are further complicated because UPF3A and UPF3B 




Figure 16: Long distance movement of UPF1 CH domain upon UPF2 binding 
Crystal structures of UPF1 (red with lime 1b domain, yellow 1c domain, and purple CH domain) 
complexed with UPF2 fragments (blue) suggest that the CH domain travels over 1,500 Å2.  In 
addition, the RecA domains (bottom left) switch from a contracted to relaxed conformation while 
the 1B and 1C domains remain relatively stable.  This image was generated from PyMol using 
PDB accessions 2WJV and 2GJK, descriptions from Chakrabarti et al[100], and the pdb parser 
from Leshin et al.[102]. 
a transcription independent manner[103].  The full purpose of UPF3A/B in mammalian 
NMD is not known, but it has been shown to shuttle between the nucleus and cytoplasm 
along with SMG5 and SMG7. The SMG (suppressor with morphogenetic effects on 
genitalia) proteins were identified in Caenorhabditis elegans because mutants 
suppressed specific nonsense containing alleles, some rearrangements, and aberrant 3’ 
UTR containing genes[104].  Later work showed that these are the same players as the 
yeast Upf proteins with the addition of a phosphorylation control system via SMG1 
(kinase activation of UPF1), SMG5-7 (phosphatase inactivation of UPF1). 
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RENT1/UPF1 Target of SMG1 phosphorylation.  Disrupts translation termination. 
UPF2 Interacts with UPF1 and UPF3.  Promotes UPF1 phosphorylation. 
UPF3X (UPF3B) Initial interaction with NMD target, attracts UPF2. 
UPF3 (UPF3A) Early interaction with NMD target, attracts UPF2.  Immunoprecipitates with Y14, RNPS1, eIF4AIII. 
SMG1 Kinase of UPF1. 
SMG5 Dephosphorylates UPF1, requires SMG7 to function. 
SMG6 Dephosphorylates UPF1, interacts with Y14. 
SMG7 Dephosphorylates UPF1, Recruits SMG5 to decay foci for 5’ to 3’ decay via DCP2 and XRN1. 
SMGL1 / hNAG Unknown, but required for NMD. 





(CBC80/CBC20) Binds mRNA m
7G cap upon nuclear export. 
eIF4E / eIF4G Tethers PABP to m7G cap after nuclear export. 
PABP Poly-A binding protein, links m7G cap to poly-A tail after nuclear export. 
eRF1 / eRF3 Peptide release factors, competing with Upf proteins for ribosomes. 
Y14, Magoh Core of the exon junction complex. 
DCP1 / DCP2 The decapping complex. 
XRN1 / RAT1 5’ to 3’ exonuclease, cytoplasmic and nuclear respectively. 
PNRC2 Links UPF1 to DCP1. 
DHH1 and PAT1 Remove mRNAs from active translation and increase decapping rate. 




Rrp41, Rrp46, Mtr3 Create a portion of the hexameric ring, each has an RNAse PH domain. 
Rrp42, Rrp43, Rrp45 Also serve to create hexameric ring, their PH domains are inactive. 
Rrp4, Rrp40 Create the S1 ‘pore’ structure to guide incoming RNA. 
Csl4 Also has a S1 domain. 
Rrp44 RNase R domain containing component (RNase II). 
Rrp6 Similar to RNase T/D, only found in nuclear exosome. 
Rrp47 Putative RNA binding protein, only found in nuclear exosome. 
Ski7 GTPase, only found in cytoplasm. 
Table 3: A partial listing of proteins involved in Homo sapiens NMD 
The full catalogue of proteins involved in NMD includes these, the components of the exon 
junction complex, the ribosome, initiation complex, the complexes involved in elongation, RNAi, 
and factors involved in remodeling the mRNA.  With that in mind, these are some of the most 
immediately involved.  Exosome components are transcribed from Houseley et al.[105]. 
Other Factors 
Y14 and Magoh are cytoplasmic shuttling proteins which bind mRNAs in a 
position specific manner with respect to the exon junction complex[106].  Together they 
make an extremely stable heterodimer[107] which is hypothesized to form a clamp 
 30 
 
around the mRNA and  binding platform for the formation of the rest of the EJC.  If this 
clamp is not removed from an actively translated mRNA, then it becomes a substrate for 
NMD.  
 Important Nucleases  
The factors which encourage NMD are still being identified and examined, but the 
proteins which actually perform the degradation of the mRNA are well established.  The 
degradation of a translationally competent mRNA occurs in two stages: the stabilizing 7-
methyl-guanosine cap and poly-A tail are removed via the decapping complex and 
deadenylase respectively.  First (in yeast), the poly-A tail is shortened via a complex of 
Ccr4p and Pop2p.    Once this is complete, decapping occurs via Dcp1p and Dcp2p.  
This process is in turn affected by a series of trans-acting factors including:  Dhh1p, 
Pat1p/Mrt1p, the Lsm complex, Vsp16p, Edc1p, and Edc2p.[108]  Interestingly however, 
Dhh1p is not required for NMD in yeast while it does interact with the yeast deadenylase; 
thus functionally linking deadenylation and decapping.  A denuded mRNA is an excellent 
substrate for 5’ to 3’ decay via Xrn1p and 3’ to 5’ decay via the ski complex and 
exosome (Figure 17).  These same complexes are required for the decay of mRNAs 
which have been targeted for RNAi[109] and serve to degrade mRNAs in the same 
fashion as occur during NGD (Figure 18).  In these contexts, decapping and 
deadenylation do not  occur, but the mRNA is endonucleolytically cleaved; leaving the 5’ 
fragment available for degradation from the 3’ end via the exosome and the 3’ fragment 





Figure 17: Crystal Structure of the Archael Exosome 
The exosome from Arcaheoglobus fulgidus[110].  RNA is guided to the centrally located, 
catalytically active PH domains by the (orange) S1 and (red) KH domains.  The archael exosome 
shows the RNAse domains on alternating (blue) Rrp41 and (green) Rrp42 while the RNA binding 
domains are located on the Rrp4 subunits.  Yellow regions are identical to the PNPase of the 
bacterium Streptomyces antibioticus[111].   This figure is from Houseley et al.[105]. 
 
Figure 18: Methods of mRNA decay. 
The various interactions of endo and exo-nucleolytic decay which lead to mRNA degradation.  
The figure is from Parker and Song.[112] 
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If -1 PRF has a regulatory role in shifting the equilibrium of this enormously 
complex degradation machinery, then it too must be regulated.  Ideally, a regulatory 
framework for -1 PRF should be sequence specific and able to be rapidly engaged by 
the cell.  The burgeoning field of RNAi provides excellent candidates to fulfill these 
criteria. 
Small RNAs and Genome Regulation 
Small non-coding RNAs are assuming an increasingly important role in post-
transcriptional regulation.  These classes of molecules are predicted to control 
approximately 1/3 of all protein coding genes in mammals and plants and participate in 
the regulation of every cellular process thus far examined[113,114].  Most characterized 
miRNAs control gene expression by modulating translation and mRNA stability in the 
cytoplasm.  In Arabidopsis, miRNAs have been shown to directly affect methylation on 
the chromosomes[115], setting the precedent for other uses of miRNA.  Since then, hsa-
miR-122 has been shown to directly interact with the Hepatitis C virus (HCV) in liver 
cells[116], while networks of interactions between cellular miRNAs (specifically hsa-miR-
29a) with HIV-1[117] and viral miRNAs with cellular messages[118,119] have been 
identified in human cells. 
Given the multifarious interactions between small RNAs and both endogenous 
and exogenous mRNAs, it is not a difficult transition to hypothesize that similar 
interactions may occur between miRNAs and the regions of mRNA which include -1 PRF 
signals.  In order to make these hypotheses, one first must have a general 




Figure 19: miRNA Biogenesis 
miRNA biogenesis often begins with Pol II transcription of large intron containing sequence, 
followed by multiple rounds of processing.  Drosha and Pasha cleave the stem-loop intronic 
sequence away, followed by Dicer to remove the loop sequence, leaving a miRNA duplex, and 
finally an active argonaute bound miRNA.  This figure is from Bushati and Cohen.[114] 
Most miRNAs are transcribed by RNA polymerase II and are comprised of a 
stem-loop which contains one or more primary miRNA (pri-miRNA) sequences.  These 
stem-loop sequences range from 100-10,000+ nucleotides and are found primarily (in 
mammals at least) in intron containing sequences[120].  Processing of these stem-loops 
occurs in the nucleus by the ‘Microprocessor,’ which is a multi-protein complex which 
contains Drosha (an RNase III) and Pasha (which provides dsRNA binding capability).  
These cleave the end of the stem-loop, leaving a pre-miRNA which has 2-3 bases of 
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overhang on one side and the RNA loop on the other.  This is exported into the 
cytoplasm where it is bound by the dsRNA binding protein, TRBP, and again cut by 
Dicer, another RNase III.  The remaining duplex contains a miRNA bound to miRNA* 
(also 5p vs 3p).  Finally, this is split apart and loaded on the RNA-induced silencing 
complex (RISC).  Usually the miRNA strand has less base pairing on the 5’ side; thus it 
is possible to preferentially load the miRNA strand and discard the miRNA*. 
Once the RISC complex is loaded with miRNA, it scans for RNA targets by base-
pairing interactions.  If (near) perfect hybridization occurs, the mRNA target is cleaved by 
Argonaute (Ago2p) and rapidly degraded.  However, imperfect complementarity still 
results in translation repression.  In animals this relationship is particularly skewed, such 
that to date only one mRNA has been reported to be directly cleaved via miRNA[121].  
Instead, most animal miRNAs pair imperfectly and lead to translational repression and 
eventual degradation by deadenylation and decapping[122]. 
The mechanisms through which animal miRNAs repress target mRNAs are not 
completely understood.  Work performed using the dual luciferase reporter system 
containing multiple copies of the CXCR4 miRNA binding site in multiple contexts showed 
that miRNA mediated repression requires capped, polyadenylated messages.  Thus, 
when miRNA was applied to cells the CrPV IRES upstream of a luciferase reporter, it 
had no effect; but when either 5’ cap or 3’ tail were added back the miRNA had 
moderate effect on expression[123].  Completely conflicting evidence suggests, 
however, that mRNA repression occurs during elongation, and that repression requires 
active translation by polysomes.  In this case, adding miRNA to the CrPV IRES was able 
to completely repress expression, and adding miRNA to actively translated messages 
led ribosomes to dissociate from the target mRNA[124].  In both cases, the final result is 
clear:  miRNA binding to the message results in strong translational repression. 
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The scope and process of miRNA repression have been studied primarily by 
mutating known target sites, looking for evolutionarily conserved miRNA target sites, and 
by modifying miRNA expression[125].  These analyses have come to the consensus that 
target identification occurs primarily through a heptameric 5’ “seed” region of perfect 
complementarity.  When mismatches occur in the seed, compensatory bases further 
downstream provide additional specificity.   However, when individual miRNAs have 
been depleted using RNAi or miRNA mutants, the catalog of affected RNAs includes not 
only the predicted targets but also multiple RNAs which contained unanticipated binding 
sites.  Furthermore, depleting cells of a specific miRNA led not only to an increase in the 
expected mRNAs, but also decreased expression of other, unexpected messages[126]. 
Computational Searches for mRNA Structure 
Computational Pipelines to Filter Data 
The technique of combining previous computational methods into more 
descriptive tools has been used in many contexts; one of the most eloquent examples is 
PSI-BLAST[127], a pipeline of BLAST output informing each subsequent database 
search.  Another advantage of implementing a pipeline for performing large-scale 
searches lies in the potential to optimize each individual step and/or perform steps in 
parallel.  Recent improvements to HMMER3[128] provide not only an excellent example 
of this concept at work, but also significant improvements over PSI-BLAST in terms of 
statistical significance and sensitivity.  In a similar fashion, excellent work has been 
performed using RNAMotif[129] in order to implement computational pipelines searching 
for self-cleaving ribozymes[130,131], generic ribozymes[132], or even localization 
signals in mRNA[133].  The following catalogue of algorithms and implementations 
provides a view of some of the choices available for the proposed computational pipeline 
used in this work and is summarized in Table 4. 
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Grammar Searches in Large Datasets (RNAMotif) 
The aspects of RNAMotif which make it such a powerful and widely used tool 
include its pattern language which is able to distinguish each type of base pair (16 types 
of canonical and non-canonical) in any arbitrary configuration.  In addition, it is able to 
score aspects of the motif including GC content, number of mismatches, or number of 
bases paired, among others.  Finally, it is able to use experimentally determined 
thermodynamic parameters[134] in order to approximate the thermodynamic stability of 
each specific sequence motif it finds.  Combined, these attributes make RNAMotif an 
extensible, multi-purpose tool when searching for potential mRNA secondary structures. 
Predictive vs. Statistically Informed Searches 
 The current implementation of the predicted ribosomal frameshift database 
(PRFdb) uses RNAMotif to find candidate sequences which have the potential to form H-
type pseudoknots.  RNAMotif, though powerful, is ill-suited to normalizing its output to 
find an approximation of the most stable secondary structure for a given sequence 
window; nor is it intended to take into account evolutionarily conserved mRNA 
structures.  While the venerable mfold[135] suite accomplishes the former, it has no 
means to search for pseudoknotted sequences. Over time, usage of mfold has migrated 
towards the Vienna RNA folding applications[136].  This exhaustive suite of tools 
includes facilities to fold pre-aligned sequences de-novo predictions (excluding 
pseudoknots), RNA duplex and hybridization calculations, and RNA folding kinetics 
simulation.  One missing piece in this suite of tools is the ability to search RNA 
databases to find similar or homologous sequences; infeRNAl[137] nicely fills this niche 





















CMFinder O(n3) No Yes Heuristic No 
HotKnots O(n4) Yes No Heuristic Yes 
ilm O(n4) Yes No Heuristic Yes 
infeRNAl O(n7) No Yes Optimal Yes 
mFold O(n3) No No Optimal Yes 
NUPACK O(n5) Yes No Heuristic No 
pknots O(n7) Yes No Optimal No 
pknots-
RG 
O(n4) Yes No Heuristic No 
PFinder O(n3) No Yes Heuristic Yes 
rnamotif O(n2) Yes No Heuristic Yes 
TT2NE O(n6) Yes No Heuristic No 
Vienna 
RNA 
O(n3) No No Optimal No 
Table 4:  Summary of some common RNA prediction algorithms 
The most important aspects of a program to be used in a predictive pipeline for sequences 
containing strong secondary structures include:  running time, ability to predict pseudoknots, what 
type of heuristic it uses (if it uses one), whether or not it provides sub-optimal structures, or uses 
statistical or evolutionary information, and its input/output requirements.  Though it is not 
specifically a predictor of structure, the scoring functions of rnamotif make it a useful addition to 
this repertoire.  
thus dissimilar sequences which fold into similar structures may be used to identify and 
align other sequences from a provided database.  Like RNAMotif, these techniques 
depend initially upon a context-free grammar which describes the base pairing 
possibilities at each position, but they then add likelihood estimates for each observed 
base pair (for examples, see pages 233-269 of [138]).  While extremely sensitive, these 
techniques are complex and can be computationally intensive (thus Tornado runs > 
O(n3) with respect to time, even when using the simplest model[139]).  Finally, though 
stochastic context free grammars (SCFGs) can be used to distinguish ambiguous 
characters, the nested structure of an RNA pseudoknot is unavailable to current 
implementations, including Pfold[140] and CMFinder[141]. 
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As the primary purpose of the PRFdb is to identify mRNA sequences which are 
able to fold into pseudoknots, the limitation to only search for stem-loops is 
unacceptable.  This leaves the simpler minimum free energy (MFE) strategies as the 
most likely tool.  Searching in this manner is NP-complete[142], imposing a limit on 
searchable length of sequence.  The classic dynamic programming algorithm solution to 
this problem was implemented in O(n6.8) time by pknots[143]; primarily because this 
implementation iterates through the entire search space for stem-loops and simple 
pseudoknots.  At the time of its implementation, thermodynamic information was 
unavailable for some aspects (dangling bases in multi-loop structures, for example) of 
the nested stems found in pseudoknots and so these were estimated or filled in with 
contemporary values[144].  It is worth noting that the other programs discussed here use 
more current and complete values[134].  The iterative loop matching algorithm[145] and 
NUPACK[146] seek to improve the computational complexity of this problem by 
implementing heuristics to decrease the search space of the dynamic programming 
matrix.  In the first case this is accomplished by initially collecting short optimal 
secondary structures, subsequently building them up until they attempt to include the 
entire sequence of interest; and then using the unpaired bases to perform another round 
of the same process, finally repeating as required for each class of seconday structures 
(pseudoknot, kissing loop, or stem-loop for examples).  Therefore the worst case 
scenario for this algorithm is >= O(n4) (the n3 of a normal secondary structure prediction 
multiplied by another approximate n for the iterative aspect).  HotKnots employs loop 
matching to achieve a similar simplification, but then applies another heuristic to 
determine if each matching loop (hotspot) is promising.  This causes HotKnots to 
examine a slightly smaller subset of the available search space and perform at O(n4) 
time.  On the other hand, HotKnots uses a more complete free-energy model which may 
also be easily replaced with other models (including the covariance models used by 
 39 
 
Tornado above) in order to add a statistical or phylogenetic aspect to the scoring 
function.  TT2NE is a more recent addition to this list of heuristics[147], performing a 
depth-first search of the available space.  It then applies a branch-and-bound procedure 
(as had been suggested in the publications of every preceding MFE minimization 
algorithm as well as Durbin & Eddy) to skip segments of the search space which cannot 
terminate in a MFE less than the current minimum.  This brings it to O(n3) or O(n4) 
depending on the sequence, with the pathological case running in O(n6) time.  Each of 
these programs uses approximately O(n3) memory. 
Given these competing criteria for successful mRNA structure prediction, the 
PRFdb currently is able to use pknots, NUPACK, HotKnots, Vienna RNAFold, and 
mFold.  TT2NE support is intended but has not been implemented while ilm is functional 
but has not yet had its output passed to a thermodynamic parameter evaluation (Vienna 
RNAeval is an excellent candidate but requires file-format conversion, indeed it should 
be used to re-evaluate the pknots MFE calculations) to provide a better predicted MFE. 
Sequence Randomization Strategies 
Once MFE minimization strategies have been performed and potential mRNA 
secondary structures predicted, the question shifts to one of scoring.  How does one 
decide among 190,000+ predictions (for Homo sapiens) which are the most significant?  
Previous work has compared 6 quantitation methods[148] for scoring mRNA structure 
predictions: MFE/base pair, Z-score, p-value, Shannon entropy, average base-pair 
distance, and the valley index.  This work suggests that MFE/base, Z-score, and p-value 
are sensitive to the strength of the given secondary structure while the Shannon entropy, 
average base-pair distance, and valley index indicate the uniqueness of the given 
structure.  Of the three measurements which are sensitive to the predicted structure’s 
strength, the Z-score was shown to be the most useful; however it depends on the 
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specific sequence randomization strategy employed.  Debate continues regarding the 
optimal sequence randomization strategy; some work suggests that simple Fisher-Yates 
shuffling is sufficient, while others debate the relative merits of maintaining dinucleotide 
frequencies[149,150], mononucleotide frequencies[151], amino-acid frequencies, etc.  
The differences in sensitivity between the Z-scores for these various methodologies are 
relatively small.  The current PRFdb implementation is able to perform them all, but 
defaults to a simple shuffle.   
Storage, Retrieval, and Visualization 
It is important not to lose sight of the primary goal of this work:  implement a 
simple to use method to search genomic sequence for potential -1 PRF signals.  The 
methodologies for searching through large amounts of sequence data for strong mRNA 
structures have been established.  Finding potential pseudoknots is NP-complete, but 
possible for limited cases via heuristics; and methods exist which provide some 
measurement of significance.  The final step is to put these pieces together.  
Bioperl[152], the “LAMP” (Linux, Apache, MySQL, Perl) software stack, and 
HTML::Masonaa provide a simple solution to this problem.  These tools make developing 
a medium-scale database of potential -1 PRF signals (currently containing 525,000+ 
ORFs, easily scalable to the 5,000,000+ of Genbank) simple.  The only remaining puzzle 
lies in how to visualize the results from the various MFE minimization algorithms.  
Bioperl provides methods to convert most of the various output formats, but one might 
want to see a dot-plot of the pseudoknotted sequence, linear Feynman diagram[153], or 
planar drawing[154].  The source code for jViz and accompanying thesis made 
implementing similar visualization strategies possible in Perl. 





Each of the preceeding fields informs one or more aspects of this thesis.  An 
understanding of programmed ribosomal frameshifting depends upon normal elongation; 
so too does creating a pipeline to search for strong mRNA secondary structures depend 
upon an understanding on the dynamic programming algorithm.  Similarly, one cannot 
search for changes in mRNA stability without some idea of the players involved from 
transcription to decay.  The most attractive aspect of the central hypothesis of this work 
lies in its interdependence on so many fields.  This is a two-edged sword: while it 
provides excellent opportunities to explore hypotheses across the spectrum of 
computational and molecular biology, it falls prey to the competing hypotheses of the 
fields and fractious nature of some emergent fields.  Thus changing observations in the 
field of mammalian nonsense mediated decay provide simultaneously worrisome 
changes in how this work will be interpreted as well as opportunities to fine-tune our 
hypotheses and experiments.  Similarly, the competing hypotheses in the field of 
microRNA make it difficult to forsee the best method to direct our hypotheses regarding 
PRF regulation; but provide wonderful new insights into the relationships between 
translational repression versus mRNA decay.  In this environment of astonishingly fast 
paced change, I hope this document provides a useful foundation to formulate new 





A Database of Computationally Predicted Programmed -1 
Ribosomal Frameshift Signals 
Introduction 
 Canonical decoding of the genetic code requires translating ribosomes to convert 
triplets of bases (codons) into amino acid sequences.  Although this is algorithm is 
employed for translation of the vast majority of mRNA sequences, in some special cases 
cis-acting mRNA elements direct ribosomes into alternative reading frames, dynamically 
“recoding” their sequence information (reviewed in [155]).  Programmed -1 Ribosomal 
Frameshifting (-1 PRF) was first discovered in RNA viruses where it enables viral 
genomes to encode multiple peptides from a single mRNA [10].  An individual -1 PRF 
signal consists of a heptameric 'slippery site' usually followed by an mRNA pseudoknot 
secondary structure separated by a suitable spacer region (reviewed in [13,156]).  Unlike 
their viral counterparts, eukaryotic genome-encoded  -1 PRF signals are predicted to 
direct elongating ribosomes into premature termination codons [23].  Such events have 
been shown to initiate rapid mRNA degradation in yeast through the Nonsense Mediated 
Decay (NMD) pathway[78].  As such, -1 PRF is hypothesized to add a novel modality for 
regulation of gene expression at the post-transcriptional level. 
There are currently three databases serving the translational recoding community.  
RECODE (http://recode.genetics.utah.edu/) is a browsable collection of all the published 
translational recoding signals[6,157,158]  RECODE’s strength is as central repository of 
all empirically proven translational recoding signals.  FSDB (http://wilab.inha.ac.kr/fsdb/) 
contains a compilation of a handful of known and predicted viral, prokaryotic and 
eukaryotic -1 and +1 PRF signals, and also allows users to input their own sequences to 
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search for frameshift signals using a program called FSFinder[159].  This site provides 
tools not available through RECODE, in particular it integration of PseudoViewer, a 
powerful graphics tool for that simplifies visualization of H-type pseudoknots[160].  
MLOGD (http://guinevere.otago.ac.nz/aef/MLOGD/index.html) is a suite of software that 
allows detection of new protein-coding sequences by identifying overlapping open 
reading frames[161].  While all three of these sites have their strengths, a common 
weakness it that they do not provide well catalogued, searchable databases of all 
potential recoding signals of any one kind.  To fill this gap, we have created PRFdb as a 
database of predicted -1 PRF signals in eukaryotic genomes.  The methods used to 
search for predicted -1 PRF signals have been previously described, and importantly, we 
have empirically demonstrated that a significant number of -1 PRF signals so identified 
actually promote significant levels of frameshifting[23].  The strength of the PRFdb is that 
it provides a tool for researchers outside of the translational recoding field to use to 
quickly search for and identify potential -1 PRF signals in genes in which they are 
interested.   
Database Description 
In the PRFdb, the predicted -1 PRF signals are represented by: 1) the genes in 
which they reside; 2) the identity and location of their slippery sites; 3) graphical 
representations of their predicted secondary structures; 4) computationally identified 
minimum free energies (MFE); and 5) the thermodynamic significance of these mRNA 
structures as compared to randomized variants.  Currently completed genomes in the 
PRFdb include: Saccharomyces cerevisiae, Homo sapiens, Mus musculus, Rattus 
norvegicus, Bos Taurus, Danio rerio, and Xenopus tropicalis.  A listing of examined 
genomes with more than 400 ORFs may be found in Appendix 11.  
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 Researchers can access data in the PRFdb through four means:  (i) Search 
(Figure 20) provides a way to query a gene of interest using the specific gene name, 
 
Figure 20: The PRFdb Search Interface 
The PRFdb search interface provides searches against the indexed description text, specific 
accessions, specific HGNC[162] gene names, or a BLAST interface which allows one to search 
for genes of interest with nucleotide or protein sequence. 
HGNC id or description.  The search interface also provides a means to use BLAST to 
search for genes in the PRFdb similar to a query sequence.  The initial result from a 
search provides further information about the ORF, other search tools, and a summary 
of the potential -1 PRF signals detected for the given search (Figure 21).  
 
Figure 21: A Representative Search Result. 
The top of this page provides information pertaining to a specific gene (S. cerevisiae EST2), its 
genome database (SGD) entry, a link to perform BLAST searches for similar genes, MFE minima 
graph, and a link to download its sequence. Following this information is a list showing the 
locations of the translational start site, potential slippery sites and the number of secondary 
structure solutions that have been computed for them, and the 0-frame termination codon. At the 
bottom is a display of the gene where the ATG start site is displayed in green, slippery sites are 
shown in blue, and -1 frame termination codons are shown in orange. The specific entry for each 
potential frameshift signal may be viewed by clicking on the slippery site's position or its link in the 
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sequence. In addition, locations of human single nucleotide polymorphisms catalogued in the 
NCBI Single Nucleotide Polymorphism Database rendered in maroon. Clicking these will open 
links to the database http://www.ncbi.nlm.nih.gov/projects/SNP/. 
 ii) Distribution (Figure 22) enables browsing for sequences containing statistically 
significant putative -1 PRF signals through a graphical representation of computed 
minimum free energies with respect to randomized Z scores for all sequence windows.  
It is also possible to limit this distribution to sequences that are preceded by a specific 
slippery site.  iii) Filter prints sequences from a given genome that meet specific criteria 
including: species, pseudoknotted sequence, sequences with a specific number of base  
 
Figure 22: The distribution of Saccharomyces cerevisiae sequences. 
Computed minimum free energy is on the x-axis, Z-score is on the y-axis. Black lines denote the 
mean values and gray lines define sequence windows that are one and two standard deviations 
less than mean. Clicking on any region links to the closest -1 PRF signals with respect to MFE 
and Z score.  Distributions of the numbers of sequences at each MFE and Z sorted by 
pseudoknot status and slippery site identity are along each axis, respectively.  It is possible to 
overlay the values an accession of interest or view the distribution using different MFE 
minimization algorithms using the fields at the top. 
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pairs and/or MFE.  iv) Download provides a format suitable for parsing all sequences of 
a given genome/sequence dataset.  The search, distribution, and filter interfaces lead to 
a detailed description (Figure 23) of individual putative PRF signals.  This provides a 
summary of all data gathered for a given sequence including: background information on 
the gene and location of the  -1 PRF signal, information regarding the program used to 
perform the MFE prediction, multiple methods to view the secondary structure, and a 
comparison of the distribution of randomized sequences to the MFE of the folded 
sequence. 
 
Figure 23: Details of the Homo sapiens CCR5 -1 PRF signal. 
This demonstrates that pknots was used to compute an MFE of -27.7 kcal/mol for the 100 bases 
following the UUUAAAA slippery site at position 473 of the CCR5 ORF. When randomized 100 
times using Fisher-Yates shuffling, a mean MFE of -25.4 kcal/mol was computed for a normal 
distribution of correlation coefficient 0.96. The MFE distribution of the randomized sequences is 
on the right; with the idealized normal distribution in red. The black vertical line marks the mean 
MFE of the randomized sequences, and the green vertical line marks the MFE of the native 
sequence.  This secondary structure is more stable than random (z score = -0.72). The predicted 
mRNA secondary structure of this sequence is shown below using both bracket notation, and 
using a Feynman diagram.  Links below provide download links for png/ps/pdf images, the bpseq 
format for this structure, a circular Feynman diagram, an overlap of all MFE predictions, and a 
microRNA prediction using miRanda.  
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 If a sequence of interest is not currently in the PRFdb, it can be imported via its 
NCBI accession number.  Sequences added in this manner will be filtered within hours 
of import.  Sequences imported into the PRFdb are also folded using sequential 
windows across the entire sequence in order to create a graphical minimum free energy 
'landscape.' This enables users to submit longer or shorter sequence strings for 
computational folding, a particularly useful feature e.g. for eliminating extraneous 
sequence that may not be involved in actual RNA folding.  For example, the 
computational analysis of the 100 nucleotide sequence downstream of the slippery site 
of the mouse Ma3 -1 PRF signal provided by the PRFdb predicts tandem stem loop 
structures.  However, when only 55 nt of downstream sequence are provided, PRFdB 
predicts the empirically documented pseudoknot structure[66]. 
Process 
Sequences to be analyzed by the PRFdb are imported into the database, filtered 
using RNAMotif[129], folded with secondary structure prediction algorithms, randomized 
using one or more randomization methods, and refolded.  To avoid complications of 
untranslated intronic sequences, the PRFdb contains only mature mRNA sequences 
(cDNA sequences primarily).  Sequences are imported into the PRFdb from a web 
interface using Genbank accession numbers, yeast genome accessions, or raw 
sequences.  Each new sequence is first passed through a simple text filter that searches 
for slippery sites following the International Union of Pure and Applied Chemistry 
(IUPAC) pattern 'N NNW WWH' (or X XXY YYZ), where N (X) denotes any three 
identical bases, W (Y) denotes AAA or UUU, H (Z) ≠ G, and spaces indicate the 
incoming (zero) reading frame.  Since the distance between the end of the slippery site 
and the downstream stimulatory sequence is important, a spacer of 1 to 8 nucleotides 
was incorporated into the search. Remaining sequences are passed to RNAMotif with a 
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descriptor looking for the potential to form an mRNA pseudoknot.  Sequence windows 
passing this minimal test are passed to multiple pseudoknot predicting mRNA secondary 
structure prediction algorithms, including Pknots[143], Nupack[146,163], Hotknots[164], 
Mfold[165], and the Vienna RNA package[136].  After folding, every sequence is 
randomized using one or more algorithms including: Fisher-Yates shuffling to maintain 
dinucleotide frequencies, codon frequencies, or nucleotide frequencies.  The resulting 
random sequence windows are then refolded without searching for pseudoknots.  This 
process is repeated a fixed number of times (100 by default) to create a distribution of 
sequence specific randomized MFEs.  These resulting  distribution of randomized MFEs 
is then compared the MFE of the original sequence window.  These values are used to 
compute a z score, thus providing a measurement of the significance of the native 
sequence. 
Discussion 
 The BLAST interface to the PRFdb is currently being used to discover Genbank 
sequences similar to the most statistically significant sequences in the database, thus 
providing a means to expand the PRFdb in a depth first manner.  As more similar 
sequences are completed, comparative genomics studies using sequence and/or mRNA 
structure alignments will be incorporated to enable identification of conserved -1 PRF 
signals across species and/or genes.  As time progresses, additional computational and 
empirical information will allow for improved scoring, helping to increase the statistical 
relevance of the predicted secondary mRNA structures.  These improvements will 
continue to make the PRFdb more useful and accessible to the research community, 
providing a resource allowing individual users to identify -1 PRF signals in genes of 
interest, and as a metasource of information for cross referencing with other databases, 




Endogenous Ribosomal Frameshift Signals Operate as mRNA 
Destabilizing Elements Through at least Two Molecular 
Pathways in Yeast. 
Introduction 
Programmed ribosomal frameshifting (PRF) is has been historically associated 
with viruses. PRF signals stochastically redirect ribosomes into new reading frames, and 
viral PRF promotes synthesis of C-terminally extended fusion proteins. The most well 
defined PRF signals direct ribosomes to slip by one nucleotide in the 5’ (-1) direction.  -1 
PRF signals typically contain three elements: a “slippery site” composed of seven 
nucleotides (N NNW WWH, incoming 0-frame indicated by spaces) where shifting 
occurs; a short spacer sequence; and a downstream stimulatory structure, typically an 
mRNA pseudoknot[1,13].  Current models posit that the pseudoknot directs ribosomes to 
pause with their aminoacyl- (aa-) and peptidyl-tRNAs positioned over the slippery 
sequence, where re-pairing of the non-wobble bases of both tRNAs with the -1 frame 
codons occurs[7,166,167] 
It is now clear that PRF is employed by organisms representing every branch in 
the tree of life, suggesting an ancient and possibly universal mechanism for controlling 
the expression of actively translated mRNAs[17].  The past few years have witnessed 
several reports describing in silico identification of recoding signals using a variety of 
computational approaches[16,23,24,168–171].  While the methodologies of each study 
covered a broad range of bioinformatics techniques, the general goal was to first find 
out-of-frame ORFs followed by the identification of PRF signals in the overlapping region 
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between them. While this can identify new classes of PRF signals, it is based on the 
assumption that PRF outcomes should mimic those observed in viral genomes and thus 
cannot identify new functional outcomes of frameshifting. 
While “outcome-neutral” approaches using mRNA motifs known to promote 
efficient PRF cannot identify new classes of frameshift signals, they enable an 
expansion of our understanding of functional uses for PRF. The seminal study in this 
field  searched the yeast genome for -1 PRF promoting motifs resembling well 
characterized examples of viral -1 PRF signals, identifying ~260 putative such 
elements[24].   This work was limited by incomplete annotation of the yeast genome and 
insufficient computational resources available at the time. New bioinformatics tools were 
subsequently developed and applied using faster and more robust computational 
platforms. The results showed that: pattern matching approaches coupled with a 
predictive method for folding RNA sequences provided a dramatic improvement in the 
results; -1 PRF motifs are widespread in the genome of S. cerevisiae; and many have 
predicted secondary structures with statistically significant measures of free energy[23].  
This analysis showed that ~11% of yeast genes contain at least one high probability -1 
PRF signal. Furthermore, we demonstrated that 9 putative -1 PRF signals selected from 
a variety of S. cerevisiae genes promoted efficient recoding in vivo.  More recently, this 
bioinformatics protocol has been applied to more genomes.  Currently, more than 25 
genomes have been analyzed, and it appears that 8-10% of genes contain at least one 
potential -1 PRF signal (See the PRFdb at: http://prfdb.umd.edu/)[172]. 
A key finding was that the outcome and function of -1 PRF differs significantly 
between the viral and ‘genomic’ contexts.  In viruses, PRF controls the stoichiometries of 
structural versus enzymatic proteins[65].  In contrast, ‘genomic’ PRF events redirect 
elongating ribosomes to premature termination codons, suggesting that -1 PRF is used 
to control cellular mRNA abundance and stability through the nonsense-mediated mRNA 
 51 
 
decay (NMD) pathway. A proof-of-principle experiment demonstrated that a viral -1 PRF 
signal can function as an mRNA destabilizing element and that mRNA destabilization 
required NMD[78].  Here, rapid degradation of a reporter mRNA by -1 PRF through NMD 
is demonstrated for four genomic yeast -1 PRF signals.  Further, the presence of the 
PRF-stimulating pseudoknot can promote mRNA destabilization through no-go 
decay(NGD)[45].  The EST2 gene, encoding the catalytic subunit of telomerase[173], 
was used to delve deeper into the relationships between -1 PRF and mRNA stability.  
The EST2 mRNA is destabilized by -1 PRF primarily via NMD, and ablation of its five -1 
PRF signals resulted in stabilization of the EST2 mRNA.   
Results 
Genomic -1 PRF signals are mRNA destabilizing elements.  Four functional 
yeast genomic -1 PRF signals derived from the BUB3, EST2, SPR6, and TBF1 genes 
were employed to test the hypothesis that -1 PRF function as mRNA destabilization 
elements. The slippery heptamers for these -1 PRF signals begin at nucleotides 858, 
1653, 279, and 1521 of their respective ORFs.  These were cloned into a yeast PGK1 
reporter gene so that frameshifted ribosomes are directed to PTCs.  All inserts were 
flanked by sequences derived from Renilla and firefly luciferase genes, providing unique 
exogenous sequences for specific detection of the reporter mRNAs. Two additional 
PGK1 reporters without -1 PRF signals, were used as controls:  a readthrough reporter 
encoded a continuous ORF, while a PTC control contained an in-frame UAA termination 




Figure 24: Schematic of PGK1 reporter vectors. 
The indicated Renilla and firefly luciferase derived sequences from pJD375 were cloned into the 
unique Kpn I restriction site in a high copy PGK1 expression vector to create the readthrough 
control (pJD753).  The indicated -1 PRF signals derived from BUB3, EST2, SPR6, and TBF1 
were cloned into Sal I/Bam HI digested pJD753.  Colored arcs depict computationally predicted 
base-paired stems[129].   The premature termination control (PTC) was constructed by 
mutagenizing pJD753 to create an in-frame TAA codon. 
Reporters were introduced into wild-type yeast cells; their steady state mRNA 
abundances were determined by RNA blot analysis and normalized to U3 snoRNA 
controls.  A minimum of three independent blots were performed for all experiments.  In 
wild-type cells, all four of the genomic -1 PRF signals and the in-frame PTC containing 




Figure 25: Genomic -1 PRF signals can function as mRNA destabilization 
elements in yeast. 
The -1 PRF signals from SPR6, EST2, BUB3, and TBF1 were cloned into a PGK1 reporter such 
that frameshift events would cause elongating ribosomes to encounter premature termination 
codons (PTC).  Readthrough (RT) and in-frame PTC containing reporters are included as 
controls.  Northern blots of total mRNAs extracted from logarithmically growing cells were probed 
with a reporter-specific oligonucleotide (PGK1), stripped and re-hybridized with a U3 snoRNA-
specific probe for normalization.  All blots were repeated at least two times.  A: steady-state 
abundance of reporter mRNAs in wild-type cells.  Each graph shows abundances of test mRNAs 
relative to the readthrough control.  B: Same as panel A, but in upf1∆ cells.  Graph plots 
abundance of specific test mRNAs in upf1∆ versus wild-type cells.  C – F are similar to panel B, 
except that samples were extracted from dom34∆, dcp1∆, xrn1∆, and ski3∆ cells respectively. 
The extent of mRNA destabilization varied from ~0.01 fold of the readthrough 
control (EST2) to ~0.19 fold of wild-type (TBF1).  Experiments were also performed in 
upf1∆ and dom34∆ strains, and the U3-normalized signal intensities were compared 
among the same signals between wild-type and mutant strains to determine the relative 
contributions of NMD and NGD to the ability of the -1 PRF signals to act as mRNA 
destabilization elements.  The PTC containing mRNA was only destabilized through the 
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NMD pathway: 28-fold stabilization in upf1∆ cells relative to wild-type cells, but no 
stabilization in dom34∆ cells.   The TBF1 -1 PRF signal similarly destabilized the 
reporter signal only through NMD (~4-fold).  In contrast, the EST2 and BUB3 -1 PRF 
signals functioned through both pathways: the EST2 signal stabilized the reporter ~35-
fold in upf1∆ cells and ~14-fold in dom34∆ cells, while the values for the BUB3 signal 
were ~7-fold and ~8-fold respectively.  The mRNA destabilization activity of the SPR6 -1 
PRF signal was primarily through NGD (~6.0-fold stabilization in dom34∆ cells).  
Deletion of DCP1, XRN1 and SKI3, all of which are epistatic to UPF1 and DOM34, also 
generally stabilized the reporter mRNAs.  We note however that, in the case of the 
dcp1∆ cells, the continued presence of Dcp2p likely provided residual decapping activity. 
These results establish that endogenous genomic -1PRF signals can function as mRNA 
destabilizing elements in yeast through at least two mRNA degradation pathways. 
The EST2 -1 PRF signal at Nucleotide 1653 is Destabilized by -1 PRF Induced NMD 
Figure 26 suggests that -1 PRF induced NMD is the major cause of mRNA 
destabilization by the EST2 -1 PRF signal beginning at nucleotide 1653.  To confirm this, 
a series of time course mRNA decay assays were performed employing the PGK1-EST2 
-1 PRF reporter, the readthrough control, and the PTC containing construct in cells 
harboring the temperature sensitive rpb1-1 allele of RNA polymerase II.  At the zero 
timepoint, cells were shifted to the nonpermissive temperature (42°) to arrest 
transcription of mRNAs, total cellular mRNAs were extracted at 0, 1, 2, 4, 8, and 16 
minutes following the temperature shift, and RNA blots were hybridized with the firefly 
luciferase and U3 snoRNA probes.  While the readthrough control was stable in wild-
type cells (Figure 26 A, D) both the PTC containing control and the reporter containing 
the EST2 -1 PRF signal promoted rapid exponential decay of the reporter mRNA 
(Figure 26 B, C, D).  In a parallel experiment using rpb1-1 upf1∆ cells, all of the reporter 
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mRNAs remained stable (Figure 26 E-H).  The rapid decay kinetic profile of the EST2 -1 
PRF containing reporter, and its stabilization in NMD-deficient cells are consistent with 
NMD being the major decay pathway triggered by this element[78].  To independently 
test this, the A AAA AAT slippery site was partially inactivated by mutating it to G AAG 
AAC.  This silent mutation stabilized the reporter mRNA ~19-fold compared to the wild-
type slippery site (Figure 26 I).  Interestingly, this is less than the 35-fold stabilization in 
upf1∆ cells.  One would expect that, since this destabilization is dependent on -1 PRF, 
then inactivation of -1 PRF should be quantitatively the same as inactivation of NMD.  
However, this particular slippery site mutant is predicted to have some residual 
frameshifting activity due to the ability of the uracils in the A- and P-site tRNA anticodons 
that base pair with the A residues at the first position of the two 0-frame codons to re-
pair with the G bases in the -1 frame.  Thus, we suspect that some low levels of -1 PRF 
may still contribute to destabilization of this reporter. 
Ablation of -1 PRF Signals Stabilizes the Yeast EST2 mRNA.   
The EST family of yeast genes is named after their “Ever Shortening Telomere” 
phenotype[174].  EST2 encodes the catalytic subunit of telomerase and the other three 
EST genes either encode protein subunits of telomerase (EST1 and EST3) or a 
telomere-associated regulator of telomerase (CDC13/EST4)[175].  Telomere elongation 
occurs in late S phase, although Est2p is associated to varying extents with telomeric 
chromatin throughout the cell cycle, and telomerase defects result in chromosome 
instability and rapid senescence[176].  The very low abundance EST2 mRNA is 





Figure 26: The EST2 -1 PRF signal at position 1653 destabilizes mRNA through 
NMD. 
Panels A – H: the readthrough control, in-frame PTC control, and EST2 -1 PRF containing PGK1 
reporters were introduced into either wild-type (A – D) or upf1∆ (E – H) cells harboring the 
temperature-sensitive rpb1-1 allele of RNA polymerase II.  Total mRNAs were harvested from 
cells after temperature shift at the indicated timepoints, and Northern blots were probed using the 
PGK1 reporter-specific and U3 snoRNA specific probes. Graph in panel D plots normalized PGK1 
reporter mRNA abundances in wild-type cells, and graph in panel H plots these data in upf1∆ 
cells. I: the wild-type A AAA AAT slippery site of the EST2 -1 PRF signal in the PGK1 reporter 
was changed to G AAG AAC, and steady state northern blot analyses were performed using 
mRNAs extracted from cells expressing the readthrough control, the in-frame PTC containing 
control, and cells expressing either the wild-type or mutant slippery sites.  Fold-RT denotes fold 
readthrough control.  S.D. (+/-) denotes standard deviation. 
 Computational analyses revealed that EST2 contains four additional high 
confidence -1 PRF signals beginning at positions 72, 1215, 1326, and 1995 (Figure 27).  
The positions of the five predicted -1 PRF signals in the EST2 ORF are shown in Figure 




Figure 27: Four additional high confidence -1 PRF signals in EST2. 
The predicted -1 PRF signal beginning at nucleotide 72 contains two overlapping slippery sites (A 
AAU UUA and U UUA AAA).  Slippery sites beginning at nucleotides 72, 1215, 1326, and 1995 
are underlined.  Colored arcs depict base pairing of stems. 
-1 PRF signals in a full-length EST2 clone expressed from a low copy vector 
pEST2wt, pEST2ssmut, and derivative plasmids share the backbone plasmid: pJD641. 
(pEST2ss∆, Figure 29).  Clones expressing either wild-type EST2 (pEST2wt) or 
pEST2ss∆ were introduced into isogenic est2∆ or est2∆ upf1∆ cells, and qRT-PCR 
analyses were performed.  These silent mutations resulted ~8.5-fold stabilization of the 
full-length EST2ss∆ mRNA relative to wild-type EST2 mRNA (Figure 28 B).  Similarly, 
abrogation of NMD stabilized the wild-type EST2 and EST2ss∆ mRNAs ~5.8-fold and 
~7.0 fold respectively, thus demonstrating that -1 PRF induced NMD plays a significant 




Figure 28: Silent mutations that disrupt slippery sites in EST2 gene stabilize its 
mRNA. 
A, schematic of the EST2 coding sequence.  Positions of the slippery sites of 5 predicted -1 PRF 
signals and their sequences are indicated.  The full-length gene including native 5’ and 3’ UTR 
sequences were cloned into a low-copy yeast vector to create pEST2.  Silent coding mutations 
that are predicted to inactivate -1 PRF were introduced to produce pEST2ss∆.  B. pEST2 or 
pEST2ss∆ were introduced into est2∆ or est2∆ upf1∆ cells and EST2 mRNA steady state 
abundances were determined by quantitative real-time PCR. 
 
Figure 29: Map of the full length EST2 low-copy plasmids. 
Of particular note is the Centromeric yeast origin of replication (12 o’clock) and the sequence 
flanking the EST2 ORF, this includes the endogenous UTRs and M13, T7, and T3 regions. 
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Programmed -1 Ribosomal Frameshifting, but not Specific -1 PRF Signals, Appears to be 
Conserved Among Yeasts. 
If regulation of gene expression through -1 PRF is biologically significant, then -1 
PRF signals should be present in homologous mRNAs from other budding yeast 
species.  To address this, the BUB3, EST2, SPR6 and TBF1 homologs were identified in 
S. paradoxus, S. mikatae, S. bayanus, S. castellii, S. kudriavzevii and S. kluyveri, and 
analyzed for potentially significant -1 PRF signals as previously described[23].  At first 
glance, these analyses reveal that no single -1 PRF signal is completely conserved 
among the budding yeasts (Appendix 14). 
 
Figure 30: MFE ‘landscape’ of SPR6 and predicted PRF signal at position 279. 
The minimum free energy of the SPR6 ORF decreases from approximately position 200 to 400.  
Though the structure at position 279 was studied, position 348 also appears significant.  
However, closer analysis shows that strong candidate -1 PRF signals can be 
identified in the homologs of all of these genes, although not in every species.  For 
example, as noted above, the S. cerevisiae EST2 mRNA contains 5 potential -1 PRF 
signals.  Similarly, the S. paradoxus homolog also contains 5 potential -1 PRF signals, 
although none share elements identical to S. cerevisiae. S. mikatae EST2 appears to 
harbor two potential -1 PRF signals, S. bayanus has three, and S. castelli contains two. 
However, none were identified in the S. kudriavzevii EST2 homolog, and we were not 
able to identify an Est2p homolog in S. kluyveri.  Turning to SPR6, the S. cerevisiae 
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mRNA contains a second potential -1 PRF signal beginning at nucleotide 348 (Figure 
30) in addition to that identified beginning at nucleotide 279. 
Both the S. paradoxus and S. kudriavzevii SPR6 homologs contains three 
potential -1 PRF signals, but none were identified in the S. mikatae or S. bayanus 
homologs. In addition, BLAST analyses failed to identify SPR6 homologs in S. castelli or 
S. kluyveri.  S. cerevisiae BUB3 contains the functional -1 PRF signal at nucleotide 858, 
plus potential -1 PRF signals beginning at nucleotides 27 and 732.  The homologous 
mRNAs in S. paradoxus, S. bayanus, S. castelli, and S. kudriavzevii each appear to 
have one potential -1 PRF signal, but the none were identified in S. mikatae or S. 
kluyveri. Lastly, the S. cerevisiae TBF1 mRNA has only the single confirmed -1 PRF 
signal.  The S. mikatae and S. kluyveri homologs appear to also have one, S. 
kudriavzevii contains two, but no -1 PRF signals were identified in either S. paradoxus or 
S. bayanus, while no Tbf1p homolog was identified in the S. castelli genome. 
Discussion 
In a prior proof-of-principle experiment, we utilized the well characterized -1 PRF 
signal from the yeast L-A dsRNA virus to demonstrate that these elements can generally 
function as mRNA destabilizing elements through the NMD pathway[78].  Subsequently, 
a bioinformatics approach was used to determine that potential -1 PRF signals are 
widely found in all genomes examined, and that the great majority of these are predicted 
to direct elongating ribosomes to premature termination codons[23,172].  Here, we show 
that these chromosomally encoded, endogenous -1 PRF signals can also function as 
cis-acting mRNA destabilizing elements, both in the context of a reporter mRNA, and 
also in one case in a natural context.  Further, we demonstrated that-1 PRF signals can 
differentially destabilize mRNAs through at least two pathways; NMD and NGD. 
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These are modeled in Figure 31.  In the case of a ribosome shifting reading 
frame into a PTC, the surveillance complex lead by the Upf proteins signals rapid 
decapping by Dcp1p/Dcp2p, followed by deadenylation and exonucleolytic decay via 
Xrn1p and the exosome.  In parallel, the NGD pathway can be activated by ribosomes 
that are stalled at strong secondary structures. are freed from mRNAs by 
Dom34p/Hbs1p, promoting exonucleolytic cleavage at unpaired nucleotides near the 
pause, thus resulting in two mRNA fragments which become substrates for decapping 
and exonucleolytic decay (reviewed in [179]).  The findings presented here suggest that 
cells are not only well equipped to deal with abhorrent messages which contain 
premature termination codons and to clear stalled ribosomes from mRNAs, but have 
also evolved to capitalize upon these functions to post-transcriptionally regulate gene 
expression. 
 
Figure 31: -1 PRF signals can destabilize mRNA via NMD and NGD. 
Left panel:  A -1 PRF event directs an elongating ribosome to encounter a premature termination 
codon (PTC).  This leads to recruitment of the surveillance complex (Upf proteins), leading to 
mRNA decapping and 5’  3’ degradation by Xrn1p and deadenylation and 3’  5’ degradation 
by the degradasome.  Right panel:  the mRNA pseudoknot in a -1 PRF signals causes 




The strength of these signals to function as mRNA destabilizing elements should 
be equal to a combination of 1) their strengths as -1 PRF signals, and 2) their abilities to 
block ribosome progression, i.e. their thermodynamic stability.  The EST2 signal is both 
highly efficient at promoting -1 PRF (~55%, see [23], and is predicted to be quite stable 
(approximately -27 to -24 kcal/mol depending on the particular folding solution).  It is 
important to note however that the software used to predict mRNA pseudoknots can 
neither identify base triples, which make major contributions to frameshifting [71,180–
183], nor calculate their contributions to thermodynamic stability. Regardless, this 
combination of high frameshifting and thermodynamic stability results in very strong 
destabilization via both NMD and NGD (Figure 25 C).  Interestingly, examination of 
Figure 26 D shows that the single exponential analysis of the EST2 data yielded a y-
axis intercept at ~80%.  From Figure 25 B and C, it can be calculated that the 
contribution of NGD to total destabilization of the PGK1 reporter mRNA was 
approximately 30%.  Taken together, these data suggest that the NGD component in the 
degradation of this message is very rapid, likely during the pioneer round of translation.  
In contrast, as discussed previously[78], the exponential decay profile shows that NMD 
can occur beyond the pioneer round. 
In contrast to EST2, the TBF1 signal promoted ~5% frameshifting, but is not 
predicted to be highly stable (-9.5 kcal/mol).  Thus, all of its mRNA destabilization activity 
was through NMD (compare Figure 25 B with C).  The thermodynamic stability of the 
BUB3 signal is predicted to have an intermediate value to EST2 and TBF1 
(approximately -12 kcal/mol), and hence the contribution of NGD to the stability of its 
reporter was significant.  Interestingly, this signal only promoted ~1% frameshifting, yet 
the contribution of NMD to its destabilization was greater than observed for TBF1.  One 
possible explanation for this apparent discrepancy may stem from the fact that, in order 
to measure frameshifting, one base had to be deleted from the spacer region between 
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the slippery site and the stimulatory pseudoknot.  Changes in the length and composition 
of this spacer are known to affect rates of -1 PRF[184], and thus the -1 PRF values so 
determined cannot be taken as absolute.  In contrast, the reporters used to monitor 
mRNA stability contained the native sequences.  In light of this, it is likely that the native 
BUB3 -1 PRF signal promotes more frameshifting than the TBF1 signal.  Lastly, the 
SPR6 -1 PRF signal is predicted to be quite stable (approximately -20 kcal/mol), yet 
promoted very low levels of frameshifting (~0.5%).  Accordingly, destabilization via NMD 
was negligible for this element, while NGD was the major contributor. 
Beyond the pro forma demonstration that -1 PRF signals can destabilize cellular 
mRNAs, it is important to begin to understand the biological function of this 
phenomenon.  As a first step in this direction, we showed that silently mutating the 
slippery sites in 5 predicted -1 PRF signals within a full-length clone of EST2 significantly 
stabilized its encoded mRNA (Figure 28).  Similarly, abrogation of NMD stabilized this 
message.  Est2p is the reverse transcriptase subunit of the telomerase 
holoenzyme[173].  Interestingly, prior studies have demonstrated that this mRNA, along 
with other mRNAs encoding proteins having telomere-associated functions, are 
stabilized in NMD- yeast cells  [85,177].  Analysis of the Programmed Ribosomal 
Frameshift Database (http://prfdb.umd.edu/) reveals that, along with the other 4 putative 
-1 PRF signals in the EST2 mRNA, the mRNAs encoding Est1p, Stn1p, Cdc13p, and 
Orc5p, all components or regulators of telomerase that are stabilized in NMD- cells, also 
contain high confidence -1 PRF signals (Figure 32).  In addition, the EST3 mRNA 




Figure 32: Computationally predicted -1 RF signals in EST1, STN1, CDC13, and 
ORC5. 
EST1 contains three predicted -1 RF signals beginning at nucleotides 1203/1206 (overlapping U 
UUU UUU UUA), 1272, and 1920.  STN1 contains two beginning at nucleotides 885 and 1203.  
CDC13 contains one beginning at nucleotide 2424.  ORC5 has one beginning at nucleotide 93.  
Colored arcs depict base pairing of stems. 
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 signal[185].    Intriguingly, telomerase is limiting in cells: while a yeast cell contains 64 
chromosome ends, there are only ~29 telomerase molecules per cell and that 
telomerase is preferentially recruited to short telomeres[186].  Additionally, Tbf1p is a 
telobox containing general regulatory factor that binds to TTAGGG repeats within 
subtelomeric anti-silencing regions[187].  Intriguingly, ablation of NMD [188] or 
overexpression of single components of telomerase-associated proteins, i.e. the TEL1 
RNA, Est2p, Stn1p, or Cdc13p results in changes in telomere length [186,189,190].   
We hypothesize that yeast cells use -1 PRF to limit the expression of these proteins in 
order to maintain the correct stoichiometric balance among telomere associated 
components.  Corollary to this, mutations that alter -1 PRF and/or NMD should affect 
telomere function, and should thus show phenotypic defects similar to those observed in 
telomerase mutants, e.g. cell cycle progression defects.  Indeed, we have isolated 
numerous such mutants(reviewed in [191]), and have reported that the mof2-1 and 
mof5-1 mutants, which affect both NMD and -1 PRF tend to accumulate large mother-
daughter cells, and/or multiply budded cells, typical of G2/M cell cycle defects[192].  
Similarly, upf1∆ cells have abnormally elongated buds, and decreased telomere lengths 
[193,194].  Intriguingly, mof6-1 mutants, which only affect -1 PRF, arrest as large, 
unbudded cells, typical of M-phase exit defects[192].   These observations suggest that 
stabilization of the mRNAs encoding multiple telomere-associated proteins may have 
dominant negative effects on telomere homeostasis, and that NMD and -1 PRF may 
regulate different aspects of the cell cycle.  Additionally, the central role of Bub3p at the 
mitotic cell cycle spindle assembly checkpoint and the progeroid phenotypes caused by 
Bub3p deficiency suggest a more general role for -1 PRF in control of cell growth and 
division.  Finally, the expression of Spr6p during sporulation[195] suggests a role for -1 
PRF in this developmental process as well.  Future studies will dissect the roles of the -1 




Finally, if -1 PRF is widely used to regulate gene expression, then it should be 
well conserved.  The major problem associated with attempting a phylogenetic analysis 
of -1 PRF signals is the inherent limitations of the software used to predict them.  In 
short, it is not well enough developed to automatically identify matching motifs.  In an 
attempt to begin to address this issue, BLAST alignments were used to identify the 
homologous BUB3, EST2, SPR6 and TBF1 ORFs in six closely related yeast species, 
their nucleotide sequences extracted, and analyzed for the presence of potential -1 PRF 
signals.  These analyses revealed that while specific -1 PRF signals do not appear to be 
evolutionarily conserved, -1 PRF itself may be relatively well-enough conserved as a 
mechanism to post-transcriptionally regulate the expression of these genes across many 
but not all species examined (See Appendix 11 and Appendix 14).  However, given the 
large degree of divergence among the budding yeast sequences so analyzed, if -1 PRF 
is so conserved, its usage in specific mRNAs would appear to be rapidly evolving. 
Materials and Methods 
Strains, Genetic Manipulations, and Media.   
Escherichia coli DH5α was used to amplify plasmid DNA.  Transformations of E. 
coli were performed as described previously using the calcium chloride method[196].  
Yeast cells were transformed using the alkali cation method[197].  Yeast strains used in 
this study are shown in Appendix 1.  Yeast were grown on YPAD and synthetic 
complete media (H-)[198].  yRP2056, yRP2077 were kind gifts from R. Parker.  YJB2659 
(generously provided by Judith Berman) was sporulated and strains JD1276, JD1281, 
JD1287 and JD1288 were obtained by tetrad dissection.   
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Generation of mRNA Stability Vectors.   
Dual luciferase and mRNA stability plasmids have been previously described[23].  
Oligonucleotide primers were purchased from IDT (Coralville, IA) and are shown in 
Appendix 4, the plasmids created are in Appendix 2.  Computationally identified 
putative -1 PRF signals were amplified from yeast genomic DNA using PCR using 
Oligonucleotide primers which terminated in a Sal I restriction site at the 5’ and Bam HI 
at the 3’.  The zero-frame dual-luciferase reporter plasmid (pJD375) along with the PRF 
signal containing dsDNA fragments were digested using these restriction enzymes and 
ligated together to generate endogenous PRF signal containing dual-luciferase vectors.  
Oligonucleotide primers were chosen to terminate in Kpn I restriction sites and amplify 
41 and 30 bases of Renilla and firefly luciferase derived sequences respectively.  The 
resulting amplicons were cloned into the Kpn I site 492 bases into the PGK1 open 
reading frame of the unmodified PGK1 containing vector (pJD741).  A premature 
termination codon vector (pJD828) was generated by cutting the readthrough (pJD753) 
with Bam HI and backfilling with Klenow fragment.   
Generation of EST2 Open Reading Frame Mutants. 
Full length EST2 in a centromeric plasmid and the diploid S. cerevisiae EST2 
deletion strain were generously provided by the Berman lab and have been previously 
described[86].   Individual mutant strains were obtained by tetrad dissection.  Five 
potentially significant -1 PRF signals were identified in the EST2 open reading frame 
using the Predicted Ribosomal Frameshift Database[172].  The wobble bases of 5 
slippery heptamers were synonymously mutagenized by oligonucleotide site-directed 
mutagenesis using the QuickChange II XL Site-Directed Mutagenesis Kit (Stratagene).  
Oligonucleotide design and reaction conditions were performed as recommended by the 
manufacturer with minor modifications.  All mutations were confirmed by sequencing, the 
oligonucleotides for sequencing are in Appendix 6. 
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Steady State and Time Course RNA Blot Analyses. 
mRNA stability vectors were transformed into wild-type yeast (JD1158), upf1∆ or 
upf2 ∆ (JD1181 or JD1367), xrn1∆ (JD1170), dcp1∆ (JD1122), ski2∆ (JD1345), ski3∆ 
(JD19), and dom34∆ (JD1363)  cells.  The EST2 mRNA stability vector (pJD754) was 
transformed into rpb1-1 (JD977) and rpb1-1/Upf- (JD978) cells and time courses were 
performed as described previously[199].  Total RNA was extracted with acid 
phenol/chloroform (pH = 4.5) from mid-logarithmic cell cultures [200], or with Trizole© 
Reagent following the manufacturer’s directions (Invitrogen, Carlsbad, CA). RNA 
(northern) blotting was performed as previously described[78].  Equal amounts of RNA 
(1 µg, 2 µg, or 4µg) were separated through 1% agarose-formaldehyde gels.  RNA 
samples were transferred and UV cross linked to Hybond-N-membranes (Amersham).  
Blots were hybridized with γ[32P] 5’-end-labeled oligonucleotides specific for U3 snoRNA 
(loading control) and the exogenous Renilla fragment (experimental); these 
oligonucleotides are displayed in Appendix 7.  Messenger RNAs were identified using a 
GeneStorm phosphoimager (Bio-Rad) and quantified using QuantifyOne (Bio-Rad).  
Blots were repeated three or more times and averaged to generate graphs. 
Quantitative Real Time Reverse Transcription PCR.   
Full length EST2 expression vectors (pJD641), EST2 mutant vectors (pJD796), 
and null plasmids (pJD315) were transformed into WT (JD1281), EST2 deletion 
(JD1287), UPF2 (JD1288) and EST2/UPF2 (JD1276) deletion strains. Total RNA was 
extracted with acid phenol/chloroform (pH=4.5) from mid-logarithmic cell cultures. In 
parallel, total RNAs were extracted from isogenic rpl3∆ strains expressing wild-type 
RPL3 (JD1228), the down-frameshifting rpl3-R247A allele (AM-L3R247A), or the up-
frameshifting rpl3-W255C/ P257S allele (JD1229). To prevent amplification from 
contaminating cellular DNA, RNA was treated with DNase I before reverse transcription 
using Turbo DNase (Ambion). cDNA was generated using the Bio-Rad iScript cDNA 
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synthesis kit and used in the LightCycler real-time PCR system. PCR reactions were 
performed with 2 µl of cDNA in 20 µl reactions containing ~10 nM each sense and 
antisense primer, and 1x LightCycler 480 SYBR Green I Master Mix (Roche). PCR 
cycles were run as follows: 1 cycle of 95° for 10 min; 40 cycles of 95° for 10 s, 54° for 20 
s and 72° for 20 s. U3 snoRNA was chosen as a reference gene. 
Comparative Analyses. 
The Spr6p, Est2p, Bub3p, and TBF1p peptide sequences for were extracted from 
the S. cerevisiae genome and local BLAST alignments were performed to identify the 
homologous peptides in the genomes of S. paradoxus, S. mikatae, S. bayanus, S. 
castellii, S. kudriavzevii, and S. kluyveri.  Homologs were identified in all cases except 
for Spr6p in the S. castelii and S. kluyveri genomes, for Est2p in the the S. kluyveri 
genome, or for Tbf1p in the S. castelli genome.  For the remaining cases, the nucleotide 







Ribosomal Frameshifting in CCR5: Regulation by NMD, miRNAs 
and Conformational Plasticity. 
Introduction 
Gene expression is a metabolic process: rates of mRNA transcription delineate 
the anabolic phase, while rates of mRNA degradation define the catabolic parameters.  
While much attention has been paid to transcription, the impact of mRNA stability on this 
equation is tremendously important.  Many mRNAs are post-transcriptionally regulated, 
and this field has mainly concentrated on identifying cis-acting elements in the 5’ and 3’ 
untranslated regions (UTRs) of mRNAs, and the trans-acting factors with which they 
interact. Less emphasis has been placed on identifying those regulatory elements 
located within protein coding regions.  A variety of cis-acting mRNA elements been 
identified that cause elongating ribosomes to “recode” the primary information contained 
in mRNAs[201].   
Programmed ribosomal frameshifting is one such translational recoding 
mechanism historically associated with viruses and retrotransposons. A PRF signal 
stochastically redirects translating ribosomes into a new reading frame (i.e. by +1 or -1 
nucleotide).  In the viral context, a PRF signal allows ribosomes to bypass the 0-frame 
encoded stop codon and continue synthesis of a C-terminally extended fusion protein.  
PRF is likely employed by organisms representing every branch in the tree of life, 
suggesting an ancient and possibly universal mechanism for controlling the expression 
of actively translated mRNAs [17].  Computational analyses revealed that approximately 
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10-15% of genes in the 20+ eukaryotic genomes analyzed thus far contain at least one 
potential -1 PRF signal [172].  A key observation was that the outcome and function of -1 
PRF differs significantly between viruses and eukaryotic cellular mRNAs.  More than 
95% of ‘cellular’ -1 PRF signals are predicted to direct elongating ribosomes to 
encounter premature termination codons (PTC), suggesting that -1 PRF may be used by 
cells to control mRNA abundance and stability through the nonsense-mediated mRNA 
decay (NMD) pathway.  While this hypothesis has been demonstrated in yeast using -1 
PRF signals of both viral and cellular origin[78,202], it has not yet been tested in higher 
eukaryotes.   Furthermore, if -1 PRF is used to control expression of cellular genes, it 
should be subject to regulation: the issue of how sequence-specific regulation of -1 PRF 
may be achieved has been a central unanswered question in this field. 
This study addresses these questions using a functional -1 PRF signal identified 
in the CCR5 mRNA, which encodes the co-receptor for HIV-1[203].  We demonstrate 
that it is able promote efficient levels of -1 PRF, and that it can function as an mRNA 
destabilizing element which is dependent on both NMD and efficient -1 PRF.  CCR5-
mediated -1 PRF is specifically stimulated by at least two human microRNAs (miRNA), 
hsa-miR-1224-3p (MI0003764) and hsa-miR-141(MI0000457).  miR-1224 specifically 
interacts with the CCR5 -1 PRF signal in vitro and in vivo, suggesting a mechanism 
through which sequence-specific regulation of -1 PRF may be effected.  Chemical 
protection, native polyacrylamide gel electrophoresis (PAGE), and single molecule 
optical trap experiments suggest that the -1 PRF mRNA stimulatory element can 
assume multiple dynamic structures, suggesting inherent structural plasticity as the 
biophysical basis for regulation of -1 PRF.  Importantly, hsa-miR-1224 does not change 
the chemical protection pattern, nor does it result in the presence of new species 
resolvable by PAGE.  Rather, the PAGE analyses show that hsa-miR-1224 alters the 
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distribution of the existing CCR5 -1 PRF signal containing RNA conformers, consistent 
with the optical trap experiments. 
Operational -1 PRF signals were also identified in the mRNAs encoding the 
interleukin 7 α-chain receptor subunits in both humans and in mice, in the mRNAs 
encoding the human IL8 receptor α- and β-chains, and IL27 receptor α-chain.  These 
findings increase our understanding of cytokine receptor expression, how the immune 
response may be controlled at the local level (i.e. by individual cells), and presents a 
potentially new approach to the control of HIV/AIDS and the immune response. 
Results 
A functional -1 PRF signal in the H. sapiens CCR5 receptor mRNA. 
A computational analysis of 18,709 human coding sequences (CDS) revealed 
that 1943 (~10.4%) contain at least one high confidence -1 PRF signal (Figure 33 B).  
The distribution of Homo sapiens signals is shown in Figure 33 A.  High confidence -1 
PRF signals are defined as those having acceptable slippery sites followed closely by 
predicted mRNA pseudoknot structures in which the computed minimum free energies  
(MFE) with respect to randomized sequences result in probabilistic z-scores greater than 
one standard deviation from the population of all sequences.  These criteria revealed a 
strong candidate -1 PRF signal beginning at nucleotide 473 in the human CCR5 mRNA 
(NM_000579) that begins with the classic U UUA AAA slippery site.  This sequence is 
100% conserved in the Pan troglodytes CCR5 mRNA beginning at nucleotide 408. 




Figure 33: Distributions of potential -1 PRF signals from Homo sapiens. 
A. All potential -1 PRF signals from Homo sapiens are plotted as the z-score with respect to 
minimum free energy.  The z-score is defined as the number of standard deviations between the 
predicted minimum free energy and the mean predicted free energy of the same sequence 
shuffled 100 times.  Using these criteria, a significant PRF signal is one which is predicted to form 
a pseudoknot, has a minimum free energy less than one standard deviation from the mean of the 
population of Homo sapiens predictions, and a z-score less than one standard deviation from the 
mean of the population of Homo sapiens z-scores.  B. Pie chart showing number and fraction of 
human genes without predicted -1 PRF signals (no match), with potential, but non-significant -1 
PRF signals, and with predicted significant -1 PRF signals. 
downstream mRNA pseudoknot structures, two less stable pseudoknots, and a stable 
stem-loop.  A dual-luciferase reporter system[204] was used to test the ability of this 
sequence to promote -1 PRF in cultured mammalian cells (Figure 34). 
The putative human CCR5 -1 PRF sequence promoted 8-10% -1 PRF in HeLa 
(Figure 34 B) using an in vivo assay, 4-7% in CHO or Vero cells (Figure 35 see “none”), 
and 20-25% using an in vitro assay (Figure 36).  Mutagenesis of the slippery site from T 
TTA AAA to G CGC GCG (ssM) reduced -1 PRF to 1-4%.  This degree of -1 PRF in the 
mutant was unexpectedly high, and suggested the possibility that an mRNA splicing 
donor site or internal ribosome entry signal (IRES) may have been introduced into the 




introduced into the reporter immediately 3’ of the Renilla luciferase open reading frame, 
but 5’ of the CCR5-derived sequence (PTC control).  This mutation reduced apparent -1 
PRF levels by more than two orders of magnitude. Similarly, placing the firefly luciferase 
reporter out of frame (Oof) with respect to Renilla without any intervening sequences 
resulted in even lower levels of frameshifting (Figure 34B, Oof).  A rabbit reticulocyte 
based in vitro translation assay independently observed that the CCR5 derived 
sequence promoted synthesis of a peptide consistent with a -1 PRF event, and at levels 
comparable to that promoted by the HIV-1 PRF signal(Figure 36).  While they do not 
directly demonstrate -1 PRF, these two independent sets of experiments are consistent 
with the hypothesis that the computationally identified sequence in the CCR5 mRNA 
promotes efficient -1 PRF. 
 
Figure 34: A cis-acting element in the CCR5 mRNA promotes efficient -1 PRF. 
A. Schematic of dual luciferase constructs used to test the CCR5 frameshifting signal.  
Transcription is driven from the SV40 early enhancer/promoter and transcription termination and 
polyadenylation utilizes the SV40 late poly(A) signal. The in-frame control is p2luci[204], encoding 
a firefly/Renilla luciferase fusion protein. In the out of frame reporter (Oof), firefly luciferase lies in 
the -1 reading frame with respect to the Renilla open reading frame.  In the HIV -1 PRF reporter, 
the -1 PRF signal of HIV-1 was cloned in between the two luciferase reporters, and the firefly 
ORF is in the -1 frame with respect to Renilla.  The CCR5 -1 PRF reporter is the same, except 
that it contains the CCR5 -1 PRF signal.  In the CCR5 slip site mutant (ssM), the UUUAAAA 
slippery heptamer of the CCR5 -1 PRF signal was mutated to GCGCGCG.   The PTC reporter is 
based on the CCR5 -1 PRF reporter in which a premature termination codon was inserted 
following the Renilla open reading frame.  B.  Measurements of -1 PRF in HeLa cells using these 
constructs.  Error bars approximate standard error[205].   
 
RLuc FLuc (in frame)
RLuc FLuc (-1 frame)
RLuc FLuc (-1 frame)






RLuc FLuc (-1 frame)
CCR5 slip site
mutant U UUA AAA GCGCGCG




















Figure 35: The CCR5 -1 PRF signal is active in CHO and Vero cells. 
Efficient -1 PRF is also promoted by the CCR5 sequence in CHO and Vero cells.  Furthermore, -1 
PRF is stimulated by hsa-miR-141 in these cell types.     
 
 
Figure 36: Rabbit reticulocyte lysates confirm CCR5 frameshifting. 
Efficient -1 PRF promoted by the CCR5 sequence in vitro.  Left: autoradiogram of in vitro 
translation reaction using synthetic mRNAs harboring CCR5 or HIV-1 derived -1 PRF signals.  
Green arrows denote 0-frame encoded products. Red arrows denote -1 PRF encoded peptides.  
RT indicates the readthrough control.  Right:  Percent -1 PRF promoted by CCR5 and HIV-1 







The CCR5 -1 PRF Signal Destabilizes a Reporter mRNA through the NMD 
Pathway in Mammalian Cells. 
 
A -1 PRF event at the slippery site is predicted to direct elongating ribosomes to 
a premature termination codon (PTC) 45 codons after the beginning of the slippery site, 
suggesting that this may function as an mRNA destabilizing element through the NMD 
pathway as described in Saccharomyces cerevisiae[202].  To test this hypothesis, the 
human CCR5 -1 PRF signal was cloned into exon 1 of a rabbit β-globin reporter 
construct (Figure 37), and its effects on mRNA stability were assayed in HeLa cells.  A 
reporter containing a TNFα-derived AU-rich element (ARE) cloned into the 3’ UTR was 
employed to independently monitor mRNA destabilization by AUF1[206], this construct 
was mutagenized to contain both the CCR5 -1 PRF signal and ARE, and a fourth 
contained an in-frame PTC at the same site as the CCR5 -1 PRF signal insertion.  All  
 
Figure 37: The rabbit β-globin mRNA stability reporter. 
A rabbit β-globin reporter containing a doxycycline repressible promoter and SV40 derived polyA 
signal is shown.  The native CCR5 -1 PRF signal was cloned into exon 1.  Controls included 
insertion of a PTC at this position, or insertion of the 27 nucleotide TNFα derived A-U rich 
element (ARE) immediately following the rabbit β-globin open reading frame[207]. 
cells were co-transfected with the dual-luciferase readthrough control plasmid to control 
for transfection efficiency variation.  The steady-state mRNA abundance of the CCR5 -1 














frameshift signal (Figure 38).  Similarly, the TNFα-derived ARE reduced the steady-
state abundance of the reporter to ~22% of the readthrough control.  In combination, the  
 
Figure 38: The CCR5 -1 PRF signal acts as an mRNA destabilizing element. 
Quantitative reverse-transcriptase PCR (qRT-PCR) analysis of rabbit β-globin steady-state 
abundance in HeLa cells co-transfected with reporters shown in Figure 37, and with the 
readthrough dual-luciferase reporter; reported as fold of the control, native β-globin reporter 
(denoted as C).  The readthrough dual-luciferase reporter mRNA was used to control for 
differences in transfection efficiencies.   Error bars denote standard error. 
CCR5 -1 PRF signal and ARE decreased β-globin reporter mRNA steady state 
abundance to ~6% of the control, suggesting that the two elements promote mRNA 
destabilization by two independent pathways.  As expected, the presence of an in-frame 
PTC strongly decreased reporter mRNA abundance (~1% of readthrough). 
A transcriptional arrest time course experiment employing a Tet-repressible 
system was performed[206,207] to determine whether introduction of the CCR5 -1 PRF 
signal rendered the β-globin reporter a direct substrate for NMD.  This experiment 
revealed that while the native β-globin mRNA was very stable, the CCR5 -1 PRF signal 
lowered the half-life of the reporter mRNA to 80-160 minutes (Figure 39).  The ARE 
containing reporter also promoted rapid decay of its mRNA (t1/2 120-160 minutes).  Time-








































Figure 39: Rabbit β-globin reporter half-life measurements. 
Time course measurements of rabbit β-globin reporter abundances transcriptionally arrested with 
doxycycline.  Measurements of the PTC control were undetermined because its abundance was 
too low to determine after the first time point. 
uninterpretable due to consistently low levels of expression.  Figure 40 shows that 
siRNA depletion of either hUPF1 (hRENT1) or hUPF2 resulted in ~4.4-fold increase in 
the abundance of the CCR5 -1 PRF signal containing reporter mRNA as compared to 
control cells transfected with a scrambled siRNA.  In contrast, the in-frame PTC  
 
Figure 40: siRNA knockdown of NMD increases the amount of CCR5 reporter 
mRNA. 
siRNA transfection experiments for hRent1 (Upf1) and hUpf2.  Rabbit β-globin abundance in cells 
transfected with scrambled, hRent1, or hUpf2 siRNAs.  The differences between un-normalized 
RT abundances compared to one another in the different siRNA-treatments were insignificant.  
Error bars denote standard error.  Knockdown efficiency of hRENT1 and hUPF2 mRNA are 






























containing reporter was increased ~8.5 fold.  Figure 40B shows the siRNA depletion of 
hUPF1 and hUPF2 ranged from 30% - 50% in these experiments; interestingly, 
knockdown of either NMD factor significantly increased expression of the other (Figure 
41), as has been recently described[208]. 
 
Figure 41: NMD knockdowns increase other NMD mRNA abundance. 
Successful hUPF2 knockdowns were observed at [5 µM] siRNA but increase the amount of 
hRENT1 mRNA.  Interestingly, hUPF2 knockdown did not significantly affect hRENT1in this 
experiment, but in other trials increased expression by as much as 180% (lower panel).  Other 
trials display a strong inverse relationship between hRENT1 and hUPF1 after knockdown and 
provide a useful benchmark to assay success. 
Specific stimulation of CCR5-mediated -1 PRF by miR-1224 in HeLa cells. 
If -1 PRF is used by cells to post-transcriptionally control gene expression, then it 
is reasonable to hypothesize that this process may be regulated in a sequence-specific 
manner.  One mode includes small ncRNAs that are capable of interacting with the 
frameshift promoting mRNA pseudoknot through base-pairing.  This hypothesis dovetails 
observations that antisense oligonucleotides induce +1 programmed ribosomal 






























































oligonucleotides increase rates of -1 frameshifting [210–212].  A search of the NCBI 
miRNA database revealed that hsa-miR-1224, hsa-miR-711, and hsa-miR-141 are 
potentially able to interact with the CCR5 -1 PRF signal in multiple locations (Figure 42 
A).  To test this, HeLa cells were transfected with constructs expressing each of these 
three miRNA precursors [5nM], or with a construct containing scrambled sequences.  A 
 
Figure 42: Stimulation of CCR5-mediated -1 PRF by hsa-miR-1224. 
a.  Sequence of the CRR5 -1 PRF signal is shown.  The UUUAAAA slippery site is italicized, 
stems 1 and 2 of the mRNA pseudoknot are colored blue and red respectively, and unpaired 
bases are black.  Sequences of hsa-miR-1224-5p, hsa-miR-711, and hsa-miR-1413, and their 
predicted hybridization patterns with CCR5 sequence are indicated.  b.  HeLa cells were 
transfected with [5nM] of the indicated miRNA expressing constructs, or mock transfected.  After 
24 hours, cells were transfected with the indicated -1 PRF dual-luciferase reporters, and 
frameshift assays were performed 24-36 hours later.  c.  HeLa cells were transfected with 
indicated concentrations of hsa-miR-1224 miRNA expressing constructs, transfected 24 hours 
later with either HIV-1 or CCR5 -1 PRF dual-luciferase reporters, frameshift assays were 
performed 24-36 hours later.  Error bars approximate standard error. 
control set of cells were also mock transfected.  Either immediately, or 24 hours post-
miRNA transfection, cells were transfected with -1 PRF reporters containing the native 
CCR5 sequence, CCR5PTC, or HIV-1 frameshift signal, and frameshifting assays were 
performed after an additional 24 hour incubation.   Figure 42 B shows that hsa-miR-
3’GAAUGCAGAGAGGGACCCAGG_G5’
.::.:::::::::: :: .: .
5’UUUAAAAGCCAGGACGGUCACCUUUGGGGUGGUGACAAGUGUGAUCACUUGGGUGGUGGCUGUGUUUGCGUCUCUCCCAGGAAUCAUCUUUACCAGAUCUCAAAAAG 3’
.:::::.. :.:: : :: . :.: :..:.:: : .: :::::::::::::::














































1224 promoted ~1.5-fold enhancement CCR5-mediated -1 PRF (~19.1% PRF compared 
to ~12.8% in mock transfected controls).  HIV-1 frameshifting was affected by neither 
hsa-miR-1224, nor by the scrambled miRNA control.  To determine whether this effect 
was dose-dependent, cells were first transfected with a hsa-miR-1224 precursor at 
[30nM], [10nM], [5nM], and [2nM], and then transfected with either the HIV-1 or CCR5 
reporters.  In this experiment, [30nM] and [10nM] of hsa-miR-1224 greatly enhanced 
CCR5-mediated -1 PRF while [2nM] promoted little to no effect (Figure 42 C). hsa-miR-
1224 did not affect HIV-1 mediated -1 PRF. We note however that the higher doses of 
hsa-miR-1224 were toxic to cells, resulting in much lower baseline levels of the reporter 
proteins.  This added a significant amount of noise into the system as reflected by the 
larger error bars. While neither hsa-miR-141 nor hsa-miR-711 affected -1 PRF in the 
HeLa cell based assay, the presence of endogenous hsa-miR-711, and/or hsa-mIR-141 
in these human derived cells may have masked the ability of these transfected miRNAs 
to affect -1 PRF.  Transfection of these miRNAs at [5nM] into CHO and Vero cells 
revealed that hsa-miR-141 was also able to specifically stimulate CCR5-mediated -1 
PRF (Figure 35). 
hsa-miR-1224 directly interacts with the CCR5 -1 PRF signal. 
Two different assay systems were employed to determine whether the effects of 
hsa-miR-1224 on CCR5-mediated -1 PRF were direct or indirect.  In vitro gel shift 
experiments were performed using increasing concentrations of a 247 nucleotide T3-
RNA polymerase generated transcript containing the CCR5 -1 PRF signal and a 
constant amount of γ[32P]-labeled synthetic hsa-miR-1224-5p.  In one experiment, the 
two RNAs were mixed, incubated at 37° for 30 min, and then resolved through native 
PAGE (“native”).  In parallel, the RNAs were mixed, heated to 90° and then allowed to 
slowly re-fold (“refolded”).  Both experiments show that hsa-miR-1224-5p interacted with 
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the CCR5 -1 PRF signal containing RNA with subnanomolar Kd’s (Figure 43 a-c).  In 
contrast, hsa-miR-1224 did not interact with a 315 nt. transcript containing the HIV-1 
PRF signal (Figure 43 d-f).  The CCR5/miR-1224 gelshift experiments generated some 
additional interesting observations.  First, hsa-miR-1224 interacted with the CCR5-
derived sequence ~ 2-fold more strongly in the “native” as opposed to the “refolded” 
context.  Second, addition of miR-1224 enhanced the appearance of three pre-existing 
conformers, particularly in the “refolded” context.  The significance of these observations 
is discussed below. 
  
Figure 43: hsa-miR-1224 directly interacts with the CCR5 -1 PRF signal in vitro. 
Two-fold dilutions of a CCR5 -1 PRF signal containing transcript were mixed with equal volumes 
of 1.0 nM [32P]-labeled synthetic hsa-miR-1224 RNA, and incubated for 30⁰C for 30 min (a,c, 
Native), or incubated at 90⁰ for 5 sec, cooled quickly to 60⁰ and then slowly to 37⁰ (b,d, 
Refolded).  Samples were separated through 10% native PAGE, dried, and radioactive activities 
were determined using a phosphorimager.  e,f. Single site binding isotherms generated for CCR5 
and HIV-1.  KD values and standard deviations are indicated.  These experiments were performed 
by Dr. Meskauskas. 
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To ascertain whether hsa-miR-1224 interacts with the CCR5 -1 PRF signal in 
vivo, a biotin-labeled hsa-miR-1224 precursor was transfected into HeLa Tzm-BL cells 
expressing CCR5[213], cell lysates were passed through a streptavidin-agarose slurry, 
washed extensively, bound RNAs were eluted, and qPCR was used to quantify the 
amount of CCR5 mRNA relative to a GAPDH loading control[214].  These miRNA-
mediated mRNA pulldown experiments demonstrated ~3-fold enrichment for CCR5 
mRNA (Figure 44 a).  Repetition of the experiment using lysates from HeLa cells 
transfected with the CCR5 PRF signal containing dual luciferase reporter plasmid 
revealed a >2000-fold enrichment for this mRNA as compared to no-miRNA controls 
(Figure 44 b).  In contrast, enrichment of a dual-luciferase reporter harboring the HIV-1 
PRF signal was approximately 10-fold above the no-miR-1224 control.  These findings 
 
Figure 44: hsa-miRNA-1224-5p interacts with the CCR5 mRNA in vivo. 
a. In vivo pulldown of native CCR5 mRNA in live cells. Biotinylated hsa-miR-1224 precursor (+ 
miR-1224) or a scrambled control (- miR-1224) were transfected into HeLa TZM BL cells 
expressing CCR5.  Cell lysates were passed through a streptavidin slurry and bound mRNAs 
were eluted after washing.  qPCR using CCR5 or GAPDH specific primer sets were used to 
quantitate the enrichment of CCR5 mRNA relative to GAPDH in the samples.  b. HeLa cells were 
co-transfected with dual luciferase plasmids containing either the CCR5 or HIV-1 -1 PRF signal 
sequences, and with biotinylated miR-1224 (+) or scrambled precursor  RNAs  (-).  Cell lysates 
were processed and analyzed as in panel a.  Error bars approximate standard error. 
directly demonstrate that hsa-miR-1224 specifically interacts with the CCR5 PRF signal 





















































-1 PRF sig: CCR5 HIV-1





The Native CCR5 mRNA is Affected by NMD and hsa-miR-1224.     
The 5’ UTR of the CCR5 gene contains two introns, while the CDS and 3’ UTR 
are encoded by a single large exon (Figure 45 a).  The CDS is 3402 base-pairs in 
length, and the -1 PRF signal begins at nucleotide 473.  HeLa Tzm-BL cells expressing 
CCR5 were transfected with siRNAs targeting hUpf1, hSmg1, containing scrambled 
sequences ([5nM] each), or mock transfected.  qPCR analyses of total RNA revealed  
 
Figure 45: Effects of NMD abrogation and miR-1224 on the native CCR5 mRNA. 
a. The full length CCR5 locus is diagrammed, showing two introns in the 5’ UTR, the relative 
position of the -1 PRF signal at position 437, the termination codon at nt 3402, and the long 3’ 
UTR.  b. CCR5 mRNA steady-state abundance in TZM-BL cells was monitored by qPCR.   
hSmg1, hUpf1, and argonaute (Ago) were partially knocked down by siRNA.  miR-1224 indicates 
transfection with precursor expressing this miRNA.  Scrambled denotes transfection with a 
scrambled siRNA precursor, and mock denotes mock transfected cells.  c. Time course 
measurements of native CCR5 mRNA reporter abundances transcriptionally arrested with 
actinomycin D.  Cells were transfected with Smg1 siRNA or scrambled siRNA control. d. 
Immunoblot analysis: HeLa TZM-BL cells were either mock transfected, transfected with siRNAs 
targeting hUpf2, hSmg1, or scrambled RNA controls. Top panel: Immunoblots of total lysates 
were probed with anti-CCR5 or anti-tubulin monoclonal antibodies. Lower panel:  Relative 
abundance of Ccr5p in each sample normalized to tubulin loading controls.  Error bars 
approximate standard error. 
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that partial knockdown of hUpf1 (64% knockdown) or hSmg1 (48% knockdown) 
increased the steady-state abundance of the CCR5 mRNA ~2-fold each relative to 
controls (Figure 45 b), consistent with the previous reporter construct experiments and 
the hypothesis that the native CCR5 mRNA is a substrate for NMD.  Transfection of cells 
with hsa-miR-1224 decreased CCR5 mRNA steady-state abundance to ~40% of 
controls, while co-transfection of cells with hsa-miR-1224 and siRNA directed against 
Argonaute (Ago) reversed this effect.  Transfection with the Ago siRNA alone had no 
effect on CCR5 steady state abundance.  These results are consistent with the notion 
that argonaute-mediated processing of hsa-miR-1224 is required for stimulation of -1 
PRF, and that this stimulation increases the proportion of ribosomes directed to the -1 
frame PTC.  To determine whether the CCR5 mRNA is a direct substrate for NMD, cells 
were transfected with hSmg1 or scrambled siRNAs, transcription was arrested with 
actinomycin D, and mRNAs were harvested at 30 min timepoints.  While the CCR5 
mRNA was decreased to ~50% of initial levels after 3.5 hours in cells transfected with 
the scrambled siRNA control, hSmg1 siRNA transfection stabilized this mRNA.  
Immunoblot analysis showed that abrogation of NMD by transfection of Tzm-BL cells 
with hSmg1 or hUpf2 siRNAs resulted in a nearly 4-fold increase in Ccr5p compared to 
mock or scrambled siRNA controls (Figure 45 d).  These experiments demonstrate that 
the native CCR5 mRNA is directly regulated by NMD, and that the extent of mRNA 
degradation is in turn inversely proportional to frameshifting efficiency. 
The CCR5 -1 PRF Signal Encodes a Complex and Dynamic set of mRNA 
Conformers.   
As previously noted, multiple folding solutions can be predicted for the sequence 
downstream of the slippery site. While the Stem 2 structures of the two most stable 
predicted pseudoknots are identical, the slippery-site proximal ends of the Stem 1 
structures differ in their base-pairing solutions (Figure 46 A).  Three additional mRNA 
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folding solutions for this sequence are also shown.  While denaturing polyacrylamide gel 
electrophoresis (PAGE) of a γ[32P]-3’ end labeled transcript containing this element 
showed that it contained a single transcript of uniform size, native PAGE of the same 
transcription reaction revealed the presence of two major, and multiple minor bands, 
demonstrating that this sequence is able to fold into multiple conformers (Figure 46 B). 
 
Figure 46: Prediction and summary of the CCR5 PRF signal. 
A. Five computationally predicted folding solutions for the CCR5 -1 PRF signal as annotated in 
the PRFdb.  The predicted stems 1, 2 and 3 are displayed as red, blue, and green respectively.  
B.  Native and denaturing PAGE of a CCR5 -1 PRF signal containing RNA and synthetic miR-
1224. C.  miR-1224 does not change the SHAPE pattern of the CCR5 -1 PRF signal.  These 
experiments were performed by Dr. Meskauskas. 
To further investigate its structural aspects, a runoff transcript containing the 
CCR5 -1 PRF signal was subjected to chemical protection methods and the products 
were analyzed by primer extension.  Dimethylsulfate, kethoxyl and CMCT were used to 




Figure 47: Chemical protection analysis of the CCR5 -1 PRF signal. 
a, b. Autoradiograms of reverse transcriptase primer extensions performed on T7 transcribed 
RNA amplified from the CCR5 containing dual luciferase plasmid.  Bands correspond to strong 
RT stops 1 nucleotide 5’ of bases modified by chemical reagents.  a. The CCR5 mRNA was 
either left unmodified (un), or modified with 3 increasing concentrations of dimethyl sulfide (DMS, 
reacts with A and C), 1-cyclohexyl-(2-morpholinoethyl)carbodiimide metho-p-toluene sulfonate 
(CMCT, reacts with U), or  1,1-Dihydroxy-3-ethoxy-2-butanone (Kethoxal, reacts with G) 
respectively.  b. Primer extension reactions were performed on unmodified samples and samples 
incubated with 30, 65, and 110 nM NMIA (N-methylisatoic anhydride).  These are labeled 1, 2 
and 3 respectively beneath each sample, and un denotes untreated RNA. c. Data from panels a 
and b mapped onto a flat representation of the CCR5 -1 PRF signal.  Stems 1 and 2 (S1 and S2) 
are boxed, and the loop is indicated as L.  Alternative base-pairing schemes for the base of Stem 
1 are indicated by dashed lines.  The five different segments of Stem 1 are labeled a – e.  Sugars 
protected from 2’OH attack by NMIA and bases strongly protected from chemical modification by 
DMS, CMCT, and kethoxal are noted as dark red or blue filled circles respectively.  Weakly 
protected sugars and bases are denoted by light pink or light blue filled circles.  Strongly modified 
(unprotected) sugars and bases are represented as light blue or pink open circles.  d. Cartoon 




employed to probe ribose 2’-OH groups (Figure 47 b)[215].   Analyses of these data 
revealed a single solution for the structure of Stem 2 that roughly consists of 4 semi- 
helical segments (labeled a, b, d, e in Figure 47 d) and a small segment in the middle 
(c), each of which is separated by unpaired bases.  This stem 2 closely conforms to the 
most stable computationally predicted structure (see the top two examples in Figure 46 
A).  Importantly, these unpaired bases should allow the entire structure to bend,  
enabling U23 to bridge the gap between C22 and U24 (Figure 47 d).  Analysis of the 
Stem 1 forming region was consistent with the computational predictions: that while the 
distal region of Stem 1 is relatively stable, the proximal region is conformationally 
dynamic.  Specifically: G8 and C9 were protected; the 3’ half of Stem 1 (G62 – U66) was 
more deprotected than predicted; and four bases in loop 2 that are predicted to be single 
stranded (G70, and C72  U75) were protected from chemical modification. These data 
suggest that the 5’ half of the base of Stem 1 can interact with either the 3’ half of the 
base of Stem 1, or with the 3’ bases in the loop (L), thus accounting for the two main 
conformers observed in the native gels (Figure 46 b).  Similarly, when this mRNA was 
stretched many times in an optical trap, two or three main conformers were consistently 
observed (Figure 48).   These alternative interactions are shown as dashed lines in 
Figure 47 c and half cylinders in Figure 47 d.  These experiments probed the structural 
ensemble as it exists in steady-state equilibrium; thus the two alternate conformations 
denoted with an arrow in Figure 47 d are likely represented by the two major, slowly 
migrating species shown in the gelshift experiments.  In contrast, the optical trap 
experiments monitor pre-steady state refolding.  In those experiments, the blue species 
(Figure 48 and Figure 49) correlates very well with the pseudoknot, while the forms 
designated by red, green and yellow may correspond to the minor species observed in 
native gels (Figure 43 b).  Together, these data reveal the presence of a complex and 
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dynamic ensemble of mRNA pseudoknot structures that can be formed by the CCR5 -1 
PRF stimulating sequence.  Importantly, SHAPE analysis did not reveal any 
 
Figure 48: Force-extension curves and dE/dx density plots of the CCR5 structure. 
Black lines: Worm-like chain theory[216] for hybrid DNA/RNA handles with and without 97 
additional bases of extended single-stranded RNA.  Change in energy per opening distance 
(dE/dx) calculated as described previously[217].  Gray scale density plot: The accumulated result 
from all scans.  Colored squares: The result from the single scan shown in the force-extension 
curve.  This work was performed by Michel deMessieres in the LaPorta laboratory. 
differences in protection patterns of the CCR5 -1 PRF signal containing RNA in the 
presence of miR-1224 (Figure 46 c).  This suggests that that hsa-miR-1224 does not 
function to alter the topology of this sequence per se, but that it may help to drive the 
equilibrium toward structures that promotes elevated rates of -1 PRF. This is further 
supported by changes between Figure 43 a/b as well as the distribution changes seen 




Figure 49: Observed sub-steps when pulling apart the CCR5 -1 PRF signal. 
a. An alternate view of the dE/dx data in Figure 48 a. Each disruption path is composed of one or 
more substeps, plotted where x is the initial opened bases and y is the change in bases for that 
substep.  b. Arrows indicate the mean behavior of the disruptions plotted in a.  Numbers indicate 
how many bases were released for the given substep on average.  Double-ended arrows indicate 
substeps which were observed to be reversible.  Thinner arrows indicate substeps observed with 
less frequency.  This work was performed by Michel deMessieres in the LaPorta laboratory. 
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Identification of Additional -1 PRF Signals in Other Human Interleukin 
Receptor mRNAs. 
A search of the PRFdb revealed the presence of putative -1 PRF signals in 
mRNAs encoding seven additional interleukin receptor subunits (Figure 50).  These  
 
Figure 50: Computationally predicted human cytokine receptor -1 PRF signals. 
One predicted solution structure for each predicted -1 PRF signal is shown as a linear Feynman 
diagram.  The name, accession, position, predicted MFE and Z score against randomized 
sequence is provided in the inset table.  Two conserved sequences in the P. troglodytes IL-8 
receptor α-chains are also shown. 
were cloned into dual-luciferase reporters and in vivo frameshifting assays were 
performed in HeLa cells (Figure 51).  Efficient -1 PRF, as defined by the ability of a 




Figure 51: Efficient -1 PRF is promoted by sequences in additional cytokine 
receptors. 
Computationally identified putative -1 PRF signals cloned into dual luciferase reporters were 
assayed in HeLa cells.  Numbers in hIL8Rα and hIL22Rα denote the nucleotide positions of the 
slippery sites in the native mRNAs.   Error bars denote standard error. See Appendix 15 for more 
information regarding these sequence elements.  This work was performed by Sharmishtha 
Musalgaonkar, Vivek Advani, and ATB. 
beginning at nucleotide 1012 of the human IL-2 receptor γ-chain mRNA was a strong 
promoter of -1 PRF (8.4%).  The human (9.8%) and mouse (2.5%) IL-7 receptor α chain 
mRNAs contain each contain one functional -1 PRF signal; this mRNA was recently 
identified as an NMD substrate[208].  The human IL-8 receptor α chain mRNA harbors 
two functional -1 PRF signals (3.4% and 4.9%), and like CCR5, these are conserved in 
the P. troglodytes IL8RA mRNA (Figure 50).  The human IL-8 receptor β chain and the 
human IL-27 receptor α chain mRNAs harbor one functional -1 PRF signal each (3.0% 
and 1.9% -1 PRF respectively).  Potential -1 PRF signals identified in the mRNAs 
encoding the human IL-2 receptor γ chain and the human IL-22 receptor α chain were 
not initially functional as defined in this assay, although they did promote frameshifting 





























































IL-2 receptor γ was modified to lengthen rather than shorten the spacer, its rate of 
frameshifting increased from ~1% to >8%. 
 Some informative trends may be gleaned from these data.  While strong stem 1 
structures appear to be important stimulators of -1 PRF, large internal loops may hinder 
this activity.  However, the presence of overlapping slippery sites, e.g. A AAA AAU UUA 
AAU (human IL7RA) and U UUA AAA AAA (mouse IL7RA) may compensate for weaker 
stem 1 structures.   
Discussion 
Prior to the current study, only three -1 PRF signals were known to exist in 
mammalian genomes, all of which are thought to be remnants of ancient retroviral 
insertion events[66,67,218].  The discovery of operational -1 PRF signals in the mRNAs 
encoding 5 different human and one mouse cytokine receptor mRNAs represents the 
first such examples in mammalian genes of non-retroviral origin, and as demonstrated 
with CCR5, the first in which -1 PRF may be used to control gene expression through 
mRNA stability. 
-1 PRF and the Immune System. 
Each of the cytokine receptors identified in the current study have significant 
roles in human health as described in greater detail in Appendix 15.  The discovery of 
operational -1 PRF signals in the mRNAs encoding five cytokine receptors, a subset of 
which appear to be evolutionarily conserved, has a potentially profound impact on our 
understanding of immune homeostasis.  While a robust immune response is critical for 
limiting and controlling infection, left uncontrolled, it can rapidly result in pathology and 
death.  Although there is a large body of literature describing how expression of small 
peptide mediators of the immune response (i.e. cytokines) are regulated at the level of 
mRNA stability, typically through cis-acting elements in their long 3’ UTRs[219], this only 
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provides a global mechanism of immune regulation by controlling production of effector 
molecules.  In contrast, the ability to control expression of cytokine receptors through -1 
PRF induced NMD, and how rates of -1 PRF in turn may be controlled by miRNAs, 
represents a way for individual recipient cells to modulate responses to cytokines; this 
would provide the means to fine tune immune responses at the local level, and suggests 
a novel molecular mechanism underlying immune desensitization. 
Modes of -1 PRF Regulation. 
The central unanswered question in the field of -1 PRF centers on its regulation.   
The characterization of numerous mutants in yeast[220], and the demonstration that 
siRNA knockdown of eRF1 stimulated -1 PRF in human cells[221] suggests that PRF 
could be regulated through production of “specialized ribosomes”[218,222].  However, 
over the course of numerous studies spanning the past 20 years, we have observed that 
mutants and treatments that globally affect -1 PRF generally promote deleterious 
phenotypes[191], suggesting that this may not be the preferred way to regulate -1 PRF.  
Indeed, global increases in -1 PRF in human and mouse cells due to rRNA 
pseudouridylation defects suggests that dysregulation of -1 PRF may contribute to the 
pathology associated with X-linked dyskeratosis congenita and Hoyeraal-Hreidarsson 
syndrome[223].  Alternatively, regulation of -1 PRF could be effected in a sequence-
specific manner by ncRNAs capable of interacting with individual -1 PRF signals.  A 
major advantage of this strategy is that it could enable individual cells to rapidly regulate 
-1 PRF on specific mRNAs by synthesizing or releasing ncRNA species.  Not only does 
this confer sequence specificity, but it is also more rapid and energetically less 
expensive than producing new or modifying pre-existing ribosomes.  The demonstration 
that oligonucleotides capable of disrupting -1 PRF mRNA pseudoknot formation can 
inhibit -1 PRF in vitro provided proof-of-principle for this concept[224].  Similarly, 
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antisense RNAs have been shown to stimulate -1 PRF[209,212,225], while an antisense 
peptide nucleic acid has been used to inhibit SARS-CoV mediated -1 PRF[226].  Here, 
the demonstration that expression of hsa-miR-1224 and hsa-miR-141 specifically 
stimulated CCR5-promoted -1 PRF, and that hsa-miR-1224 can directly interact with the 
CCR5 -1 PRF signal, solves the central, heretofore unanswered question of how -1 PRF 
may be regulated in a sequence-specific manner.  To our knowledge, this is also one of 
the few demonstrations of an miRNA affecting the expression of a cellular gene through 
an interaction with its ORF[227–229].     
Little is known about hsa-miR-1224: its expression is induced by 
lipopolysaccharide[230], consistent with a role in modulating the immune response, and 
its dysregulation may be associated with bladder cancers[231] and lupus nephritis[232].  
has-miR-141 is a member of the miR-200 family: its overexpression has been implicated 
in numerous cancers (see[233–235] and references therein), and post-transcriptional 
regulation of hsa-miR-141 has been implicated in cellular plasticity and remodeling in 
response to changes in cell adhesion[236].  We suggest that -1 PRF is used to control 
the expression of a significant number of mammalian genes through the NMD, is in turn 
regulated by ncRNAs such as miRNAs, and that of changes in rates of -1 PRF through 
dysregulation of miRNA expression may in part contribute to human disease 
phenotypes. 
Structural Plasticity. 
Inspection of (Figure 42a) suggests that the miRNAs may interfere with mRNA 
pseudoknot formation, and thus should inhibit CCR5-mediated -1 PRF.  Thus, the 
observation that hsa-miR-1224 and hsa-miR-141 stimulated CCR5-mediated -1 PRF 
was unanticipated. The computational and experimental observations of multiple CCR5 -
1 PRF signal conformers (Figure 46 and Figure 47) suggest a solution to this problem.  
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While hsa-miR-1224 associates with the CCR5 -1 PRF signals (Figure 43), chemical 
protection experiments did not reveal any structural changes (Figure 46), suggesting 
that hsa-miR-1224 does not stimulate -1 PRF by creating any new RNA conformational 
state.  Consistent with this, the “optical trap” monitored the folding/unfolding dynamics of 
the CCR5 -1 PRF signal revealed 4 major folding/unfolding pathways for this RNA 
(Figure 48). Importantly, addition of hsa-miR-1224 to this system did not create any new 
pathways, but rather altered their relative abundances (Figure 49). Additionally, both 
hsa-miR-1224 and hsa-miR-141 can potentially participate in multiple, non-exclusive 
base-pairing interactions with different segments of the CCR5 -1 PRF signal. While the 
experiments described in this study cannot define the specific binding sites for these 
miRNAs, the finding that hsa-miR-1224 may suppress pseudoknot formation (Figure 49) 
suggests that the slippery-site proximal binding site may be responsible for -1 PRF 
stimulation. In sum, we suggest that: A) the CCR5 -1 PRF signal is structurally plastic; B) 
different conformers promote greater or lesser rates of -1 PRF; and C) different miRNAs 
are used to drive the structural equilibria toward specific conformational states.  Further, 
we hypothesize that RNA conformational plasticity is the underlying biophysical basis 
through which cells may utilize miRNAs to regulate CCR5-mediated -1 PRF.  In support 
of this, pH-dependent switching between mRNA pseudoknot conformers was recently 
shown to control termination codon reassignment and -1 PRF in in Murine Leukemia 
Virus and beet western yellows virus respectively[237].  To borrow a term from the prion 
field, conformational plasticity is ‘enciphered’ within i.e. is an inherent property of, the 
primary mRNA sequences of translational recoding elements such as these and the 
CCR5 -1 PRF signal.  We also suggest that single nucleotide polymorphisms (SNPs) 
that may alter the slippery site or change the conformational dynamics of -1 PRF 
promoting pseudoknots could also affect -1 PRF efficiency, and thus mRNA stability, 
ultimately affecting gene expression.  If so, this may account for disease phenotypes 
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associated with SNPs that do not alter the primary amino acid sequences of their 
encoded proteins. 
Effects on the Viral Context. 
RNA viruses such as retroviruses, coronaviruses, and totiviruses require 
stringent levels of -1 PRF for their propagation[65,238,239]. We suggest that their -1 
PRF promoting structural elements have evolved in two different ways so as to ensure 
set rates of -1 PRF.  First, their -1 PRF stimulatory elements should not interact with any 
ncRNAs present in the cells in which they replicate. Second, these elements should only 
have a single folding solution under physiological conditions.  Thus, minimization of RNA 
conformational plasticity and avoidance of sequence-specific regulation of -1 PRF by 
ncRNAs may explain why -1 PRF-dependent RNA viruses are able to efficiently replicate 





Where do we go from here? 
The amount of data available to those interested in mRNP dynamics is 
increasing at a rate which defies description.  High-throughput SHAPE[240], next-
generation sequencing of RNA and ribosome protected messages[241], and genome-
wide measurements of RNA structure[242] provide three immediate examples of 
fantastically powerful new tools which have the potential to transform observations of 
mRNA structure and function from a view of individual molecules through an opaque, 
dirty lens to clear observations of every RNA molecule, in concert, throughout the life-
cycle of the cell. 
Data provided by these techniques will prove to be a tremendous boon to anyone 
searching for physiologically active RNA species in the cell; and the best part, we have 
not even figured out what to search for.  There are huge new playgrounds of information 
just waiting for someone to come along and ask a new question.  This of course has 
always been true, but at a personal level I never thought the exponential growth of 
information was so dramatic or immediately exciting.  This project attempted to perform 
a predictive search for interesting mRNA secondary structures and develop the results of 
that search in the eukaryotic context.  Transitioning from Saccharomyces cerevisiae to 
cultured mammalian cells provided an opportunity to change the focus of the work 
slightly and observe the effects of ncRNA on -1 PRF.  Each of these three foci has the 
potential to be completely reworked given the new techniques and technologies 
available; and thus provides nearly infinite space for future experimentation.  This text 
aims to provide a glimpse into a few of the possibilities for future work in the context of 
computational searches for interesting mRNA structures, different directions which may 
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be followed in Saccharomyces cerevisiae, and potential new avenues to explore in the 
mammalian context. 
Computational Next Steps 
The current implementation of the PRFdb may be easily extended to: continue 
searching more sequence databases; make use of phylogenetic information, RNA 
alignments, and other statistical measurements to improve the existing set of analyses; 
cross-reference to other datasets to add new metrics of “interesting” to the existing 
predictive criteria; and search itself and other sequence databases for specific functional 
motifs. 
In the first instance, this merely requires pointing the code at a list of GenBank 
accessions and letting it run; as long as database storage needs are met, search times 
should not become a problem until ~108 sequences have been analysed.  If one wishes 
instead to improve the sensitivity of the measurements provided by the PRFdb via a 
solid statistical framework or phylogenetic information, the list of already existing tools 
contains some excellent candidates.  Indeed, some of these are already supported by 
Bioperl and so should be instantly available.  In this context, the challenge lies in 
properly curating a training set of data, or devising a sensitive strategy to infer that 
specific sequences are related and therefore available to use as components of an RNA 
alignment.  Similarly, it is possible with some small improvements to add other metrics of 
“significance;” a primary candidate is the Valley Index score mentioned in Freyhult et 
al.[148].  Another simple but potentially powerful improvement would be to extend the 
existing RNAMotif parser and descriptor generator to automatically perform database 
searches as per Lupták et al.[131].  This approach has the neat side-effect of turning the 




While all of the above approaches have merit, they do not leverage the new 
datatypes and approaches which are so exciting.  The single most potentially sensitive 
search tool for substrates of No-Go decay, NSD, NMD, and functional genomic -1 PRF 
signals already exists in the dataset from Ingolia et al. (Figure 52).  With minor  
 
Figure 52: Position of 28mer reads with respect to reading frame in ribosome 
profiling. 
One search strategy for functional PRF signals includes finding the positions where this ratio of 
ribosomes/mRNA is significantly increased in alternate reading frames.  This figure is from Ingolia 
et al. [241]. 
improvements, and potentially more reads, it is possible to pinpoint every actively 
translated base in the yeast genome upon which a ribosome changes reading frame.  
Furthermore, this same data was recently made available for mouse[243] and 
human[244] cells. 
Using the same data, it is also possible to compare ribosome profiles to predicted 
MFE with respect to ORF (Figure 53).  A simple version of this was implemented as part 




Figure 53: MFE prediction vs. ribosome footprint density vs. PARS score for 
PDR5. 
Top: The predicted MFE using pknots, Nupack, and RNAFold for a floating window of 115 bases 
along the PDR5 ORF is plotted above.  Only the first 1,400 bases are shown.  Middle:  Below is 
a histogram showing the number of ribosomal footprints detected along the PDR5 ORF.  Using 
this, it is possible to visualize the reads of full mRNA and footprints in yeast cells fed rich or 
amino-acid poor media.  Bottom:  PARS score at each position along the PDR5 ORF.  In this 
implementation, the score is: log2(S1 reads/V1 reads) so that strongly dsRNA is less than 0 in the 
hopes of finding similar trends to the predicted MFE. 
ribosomes protecting the same position, then it is reasonable to hypothesize that the 
mRNA is causing actively translating ribosomes to pause.  In order to properly perform 
this type of analysis, these statistics will need to be more thoroughly developed, 
including metrics to properly exclude ORFs with a low signal/noise ratio as well as 
proper metrics to compare the ratio of footprint reads / mRNA reads.  Another 
application of similar technology was introduced with the PARS score, which provides a 
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measurement of the observed ratio of reads observed after RNAse V1 cleavage (thus 
measuring double-stranded bases) vs. the reads observed after RNAse S1 (single-
stranded).  This data, like the ribosomal footprinting data, needs to be more fully 
developed before any real conclusions can be made, but its potential power is 
astonishing when taken in concert with these other data types.  It is also possible to 
further interpret the information already existing in the database.  For example, Figure 
54 plots the distribution of potential -1 PRF signals with respect to open reading frame 
for a series of genomes.  In many cases, there is a simultaneous sharp decrease in the 
total number of potential -1 PRF signals and an increase in the percentage of those few 
that remain hich are predicted to extend the -1 reading frame by more than 30 amino 
acids.  This observation is one of many which may be found in the existing database by 
only looking more closely at the extant data.  
Possible next steps in Saccharomyces cerevisiae 
Improvements in the strategies for computationally searching for potential -1 PRF 
signals may yield a larger and more accurate set of signals to examine. The signals 
which have already been identified pose far more questions than they answer.  When 
looking at the work performed in Saccharomyces cerevisiae, one candidate ORF stands 
out as particularly interesting: EST2.  As previously noted, this gene harbors five 
computationally identified high-confidence -1 PRF signals.  In addition, there is already a 
tremendous wealth of data which examines cellular homeostasis when telomere 
maintenance is dysregulated, including reporter systems and assays to directly assay 
steady-state telomere length, the rate of telomere shortening, and the proportion of cells 





Figure 54: Histograms of potential genomic -1 PRF signals 
Potential -1 PRF signals are plotted from 12 genomes.  Red lines count the number of potential -1 
PRF signals with respect to ORF.  In green the percentage of -1 PRF signals which are predicted 
to result in a long -1 frame extension with respect to ORF.  In many species there is an increase 
in the percentage instances which extend by more than amino acids at the 3’ end (visible as a 
spike in the green plot).  Simultaneously, these species exhibit fewer total -1 PRF signals at the 
end. 
The EST2 mRNA contains some interesting and strong secondary structures 
(Figure 55) and is illustrative of another potentially powerful future experiment.  It should 
be technically trivial, but expensive, to perform a hybrid experiment of hSHAPE and 
next-generation sequencing.  The results would be analogous to those observed in the 
PARS dataset, but query the relative flexibility of every base.  Depending on the 




Figure 55: The EST2 mRNA is strongly protected position 1653 -1 PRF signal 
SHAPE was performed on EST2 PRF signal containing mRNA showing strong protection from 
attack by NMIA.  When the same assay was performed on sequence 100 bases downstream of 
this, little protection was observed (not shown). 
protein binding (crosslinking as performed in Zhang et al.[245] to find binding partners 
for AUF1), directly observe mRNA dynamics through the cell cycle, or as a function of 
active translation (by adding cycloheximide to stop translation). 
The PGK1 reporter constructs containing the EST2 -1 PRF signal was a strong 
substrate for NMD (Figure 25 A and B, lane 4, and Figure 26).  Furthermore, the full 
length message with silent mutations in each of the 5 putative slippery sites was 
significantly stabilized (Figure 28).  Therefore it is reasonable to hypothesize that the 
slippery site mutant containing full length mRNA should act similarly in vivo from wild-
type to NMD deficient cells. 
Testing this hypothesis is made possible because yeast telomeric regions include 
some well characterized and useful restriction sites[246].  These sites have been used to 
perform Southern blots which are sensitive to relatively small variations in telomere 
length, and therefore changes in aging of the cells.  When this was performed in NMD 
deficient cells, the telomere size was shown to decrease; suggesting that an NMD 
mediated shift in the equilibrium of the telomere cap components leads to deficient 
telomere repair.  The same assay was performed in EST2 deficient cells supplemented 
with either a wild-type or mutant copy of EST2 and a similarly counterintuitive result was 




Figure 56: NMD deficient and EST2 slipsite mutant cells have shorter telomeres. 
The left Southern blot is from Lew et al.[86], genomic DNA of wild-type and NMD deficient cells 
was probed with an end-labeled telomere specific probe and a decrease in telomere length was 
observed (lane 1 compared to lane 3).  When a similar experiment was performed using EST2 
deficient cells supplemented with a low-copy plasmid borne copy of either wild-type or slippery 
site mutant EST2, a similar effect was observed.  The UPF∆ and UPF∆/EST2∆ lanes recapitulate 
the previous result and suggest that the EST2 mutant mediated effects are hypostatic to NMD 
mediated shortening. 
One avenue of future inquiry therefore includes expanding these analyses to attempt to 
understand the relative contributions of each -1 PRF signal from EST2 (Figure 57), or 
the contributions of other telomere associated proteins (as speculated upon in the 
Discussion of Chapter 3 and Figure 32).  It is also possible to ask about how -1 PRF 
mediated changes in EST2 expression affect the yeast cell cycle; in this realm there are 
some wonderful possible experiments using FACS, cellular staining and microscopy, 
and even assays which observe the maximum generation number of yeast strains 





Figure 57: Initial attempts to quantify the relative contributions of each EST2 PRF 
signal. 
Left: Dual luciferase assays were performed to assess the quality of each of the 5 potential EST2 
-1 PRF signals.  Positions 1215 and 1653 (previously identified) were shown to be strong.  Right: 
qPCR analyses followed and showed minor effects on full length EST2 stability from positions 
1215 and 1653 alone, but a much stronger effect when all were mutated. 
 
Figure 58: Counting the maximum number of generations of mutant EST2 
harboring cells 
While silent mutation containing cells live longer in both the NMD knockouts and mutant 
harboring cells, the surviving cells are significantly sicker, have a slower doubling time, and 
display significant morphological differences from wild-type.  This analysis was performed in the 
laboratory of Dr. Brittenbach-Koller. 
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As these few examples illustrate, there are some exciting possibilities for future 
inquiry of -1 PRF in yeast.  Some of the most interesting seek affects of -1 PRF upon 
cellular homeostasis or use recent technological advances to query the entire yeast 
transcriptome for strong candidates.  The transition from yeast to the metazoan context 
provides an opportunity to reverse this logic and instead ask: how do other regulatory 
systems affect -1 PRF? 
Future Mammalian Work 
We performed some initial experiments which implicate specific miRNA species 
as effectors of -1 PRF in mammalian cells.  The possible questions this allows us to ask 
will certainly increase as the ncRNA field continues to mature.  Likely candidate 
questions include: cell type specificity, effects during development, and changes via -1 
PRF as miRNA species are dysregulated in disease states such as cancer. 
One path we started following in the mammalian context is an attempt to 
correlate predictions from the PRFdb to microarray data from 200 patients with 
hepatocellular carcinoma.  These patients donated one healthy and one cancerous liver 
tissue sample for analysis as well as diagnostic information including: tumor size, AFP, 
viral status for Hepatitis, lifespan post-diagnosis, etc.  The resulting dataset provides 
approximately 14,000 points of expression between healthy and diseased liver cells per 
patient.  Initial analyses focused upon improving the existing HCC subclasses[247].  A 
mixture of PLS and K-means clustering reduced the dataset from 14,000 genes to 
approximately 340 candidates which were then cross-referenced against the PRFdb, 






ORF Position MFE Z Prediction 
ACTL6A 




(BC014621) 649 -23.0 -0.54 
 
ATIC (BC008879) 1656 -33.2 -1.59 
BCHE 
(BC018141) 
503 -25.1 -1.89 
 
CKAP5 
(NM_014756) 212[3|6] -20.1 -0.48 
 
CKAP5 
(NM_014756) 2906 -32.2 -4.53 
 
CKAP5 
(NM_014756) 2927 -36.1 -3.23 
DLK1 
(BC014015) 509 -41.0 -0.99 
 
DNAJC9 
(NM_015190) 264 -32.3 -1.20 
FAM21A 
(NM_001005751) 3307 -39.2 -0.30 
FOS (BC004490) 408 -46.8 -1.70 
 
GABRE 
(BC059376) 735 -27.8 -3.63 
GOLT1B 
(NM_016072) 437 -14.3 -0.43 
 
KIF20A 
(BC012999) 2668 -30.9 -1.66 
 
KIN 
(NM_012311) 1083 -18.9 0.42 
 
LPCAT1 
(BC020166) 1110 -41.2 -1.75 
MCM5 





(NM_018728) 3527 -23.3 -1.48 
 
NT5DC2 
(BC014550) 841 -33.5 -0.07 
 
NUP37 
(BC000861) 719 -29.1 -2.51 
 
OLA1 
(NM_013341) 513 -27.4 -2.44 
PNMA1 
(NM_006029) 1740 -38.6 -1.52 
 
PPP4R1 
(NM_005134) 2197 -22.4 -1.65 
 
RNASEN 
(BC054003) 284[5|8] -22.3 -0.94 
 
SLC38A 
(BC040342) 981 -23.0 -0.55 
 
TDO2 
(BC005355) 732 -24.0 -3.79 
 
TDO2 
(BC005355) 744 -24.0 -3.66 
 
ZGPAT 
(BC032612) 664 -37.5 -0.76 
 
Table 5: -1 PRF Candidates Significantly Disregulated in HCC 
24 candidates were chosen by cross-referencing microarray data to the existing PRFdb.  11 of 
these were cloned into the dual-luciferase reporter system and analysed. 
 Thus far 11 of the 24 strongest candidates have been successfully cloned into 
the dual-luciferase reporter system.  Two of them, OLA1 and TDO1 promote significant 
levels or frameshifting (Figure 59).  A simple search with miRanda against the 
annotated Homo sapiens miRNA database showed that hsa-miR-101 may hybridize 
strongly with this potential -1 PRF signal (Figure 60).  Interestingly, hsa-miR-101 has 






Figure 59: Dual luciferase of HCC involved -1 PRF signals 
When the dual-luciferase assay was performed with the successful clones of HCC involved -1 
PRF signals, two candidates displayed significant (> 1%) -1 PRF: OLA1 and TDO1. 
Figure 60: Possible interaction of hsa-miR-101 with the OLA1 -1 PRF signal 
hsa-miR-101, hsa-miR-1182, hsa-miR-1226, and hsa-miR-564 have potentially strong 
interactions with stem 1 of the OLA1 -1 PRF signal (-26.1, -22.5, -28.3, and -27.9 kcal/mol 
respectively). 
Taken as a whole, I find myself a little envious of new students who will get to 
play in the new fields of inquiry which are opening today.  I am certain this experience is 







 Experimental Procedures 
Introduction 
 The techniques of Molecular Biology are fundamentally difficult for a new student 
to understand.  It is my hope in this document to provide two apparently contradictory 
things at the same time:  a concise summary for each process suitable for using in a 
scientific publication followed by a longer, explicit, and usable protocol.  A much 
expanded version of this document containing examples, sample results, precursor 
protocols, and buffer recipes is separately maintained and periodically copied to the 
Dinman lab website: http://dinmanlab.umd.edu/Information/protocols/ 
Cell Culture 
The HeLa cell line[249] (ATCC), its derivative cell lines: HeLa Tet-Off[250] 
(Clonetech), Tzm-BL[213] (aidsresearch.org and kindly provided by Dr. J. DeStefano); 
CHO[251] (kindly provided by Dr. D. Mosser); and Vero[252] (kindly provided by Dr. B. 
Frederickson) were cultured according to the manufacturers’ instructions, which are 
summarized here. 
All Vero and HeLa cell lines were cultured at 37° with 5% CO2 using Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% irradiated fetal bovine serum 
(FBS), 1x non essential amino acids (NEAA), and [4 mM] glutamine.  1% 
Penicillin/Streptomycin was neither added when performing assays which are sensitive 
to changes in translation, nor when using Tet-Off cells.  Instead Tet-Off cells received 
200 µg/ml G418 in order to sustain the transactivator protein containing plasmid.  CHO 
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cells were maintained in the same fashion except Modified Eagle’s Medium α (MEM α) 
supplemented with 1x proline, [4 mM] glutamine, and 1x NEAA. 
 These cells are all best passaged when growing exponentially.  In most cases 
this suggests 70-80% confluency, however CHO cells will commonly grow to 100% 
confluency in less than 24  hours.  HeLa derived cell lines will tire after 20-25 passages, 
while the existing Vero cell lines begin at earliest passage 85+. 
 Pre-warm Media, 0.05% trypsin (or EDTA containing PBS) and 1x PBS  to 37°.  
Aspirate old medium from the T75 flask with a sterile pipette tip.  Wash cells with 3-7 ml 
1x PBS to remove residual media and cell debris. 
 Add 3-5 ml 0.05% (w/v) trypsin-EDTA and evenly disperse by rocking.  (Storage 
note:  After thawing, trypsin may be stored at 4° for up to 2 weeks, do not freeze thaw.  
In practice, trypsin may be stored significantly longer)  Incubate at 37° 5-10 minutes to 
detach cells.  If using non-enzymatic PBS-EDTA, a cell scraper may be required to 
detach cells, otherwise most (except Vero) cells are usually detached. 
 Add 5 ml fresh media to wash cells from the plate surface, pipette to dissociate 
cell clumps. (Avoid making foam, it somehow kills my cells)   Remove to 15 ml conical 
tube and spin down 2 minutes at  <= 100 g.  Remove media and resuspend in 1 ml 
DMEM.  Mix gently, add 1 µl cells to hemacytometer with <= 1 µl of trypan blue to count 
viable cells.  100 undiluted cells in the square on our hemacytometer correspond to 
1,000 cells / µl. 
 Aliquot cells according to requirements: 30,000-40,000 / well of a 24 well plate is 




The Dual Luciferase Assay 
Dual luciferase assays were performed as previously described[204] using a 
Turner Biosystems GloMax-Multi Microplate Multimode Reader  with some 
modifications.  Data analysis follows the process outlined in Jacobs et al.[205]. 
The reference material provided by Promega is excellent.  When working with 
mammalian cells, no changes are required.  In yeast however, the provided passive lysis 
buffer should not be used.  When cells are disrupted in the bead-beater, this buffer 
makes a foam which leads to large variance in the final results.  Instead, use a PBS 
buffer with PMSF and (an optional) protease inhibitor cocktail. 
150 mM PMSF:  0.2613 g of PMSF into 10 ml methanol.  PMSF is extremely 
hydroscopic. 
10x PBS:  30.47 g Na2HPO4, 0.155 g NaH2PO4, 2.19 g NaCl, pH this to 7.4 with 
HCl, add water to 250 ml and autoclave. 
Protease inhibitor: 150 µl Aprotinin (2mg/ml), 150 µl leuprotinin (1mg/ml), 150 µl 
Pepstatin A (1mg/ml), 550 µl water. 
3 ml 10x PBS, 0.2 ml protease inhibitor, 0.2 ml 150 mM PMSF, water to 30 ml. 
Grow overnight cultures to exponential growth (This varies from an OD of 0.7-2.0 
depending on strain.  Different strains require different ODs, do a growth curve.  Harvest 
cells by spinning down gently in the Sorvall (1200 rpm for 2 min) and removing media.  
Wash the cells with 1ml lysis buffer and move them to a fresh eppendorf.  Spin them 
gently and remove lysis buffer.  Add 500ul fresh lysis buffer and 500ul glass beads and 
chill on ice/cold room for 5 min.  Vortex in the cold room at minimum 5 minutes or bead 




Flow Cytometry, Fluorescence Activated Cell Sorting and Western Blotting 
FACS 
TZM-BL cells were harvested with a PBS dissociation buffer without enzyme.  
They were washed and stained with: primary antibody Mab hCCR5 (aidsreagent.org part 
numbers: 45531.111, 45523.111), which contains the IgG2a isotype from a Balb/c 
mouse; and secondary antibody Goat Anti-Mouse IgG2a (γ2a chain specific) conjugated 
to Fluorescein (Southern Biotech #1080-02).  Fluorescence intensity was analyzed by 
flow cytometry of 10,000 events (using a BD FACS Canto II). 
 Perform transfections in 12 well plates as if repeating mRNA abundance: [10 nM] 
siRNA applied once per day for two days.  Most printed protocols are for intracellular 
proteins.  As a result they permeabilize the cells with Tween-20 or methanol, then fix 
them with 0.4-1.0% formaldehyde; while some protocols work in reverse order.  In this 
particular case, the CCR5 antibody is theoretically specific to the second extracellular 
loop, but the antibody performs much better when applied to permeabilized cells. 
 After cells grow with siRNA for 48 hours, harvest them into 1.6 ml eppendorf 
tubes by rinsing with non-enzymatic PBS dissociation buffer; aliquot cells to 1 ml and let 
cells incubate 3-8 minutes at 37°.  Fix cells by applying 0.2-0.6% formaldehyde at 25° for 
5-10 minutes as per [203].  Pellet cells at 400 g for 2 minutes, suspend in 100 µl 5% FBS 
in PBS.  Permeabilize cells with either 1 ml PBS-Tween (the same formulation used in 
Western blotting, in my hands both work equivalently) or 1 ml methanol.  Sit on ice for 
20-30 minutes as per[253]. 
 Pre-rinse cells with 5% FBS PBS and pellet.  Block with 10% FBS PBS for 15-30 
minutes.  Rinse with 5% FBS PBS and pellet.  Incubate with 1:500 – 1:5,000 dilution 
primary antibody for 30-60 minutes on ice.  Rinse three times in 5% FBS PBS.  Incubate 
with 1:500 secondary antibody on ice in the dark for 15-60 minutes.  Rinse three times in 
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5% FBS PBS.  Aliquot cells for FACS analysis by resuspending in 500 µl 5% FBS PBS 
in a 12x75 Fisher FACS polystyrene culture tube (14-956-3C) and keep on ice. 
Western Blotting 
 Cell lysates were prepared from TZM-BL cells transiently transfected with siRNA 
against hSmg1, hRent1, hUPF2 and analyzed by sodium dodecyl sulfate-poly- 
acrylamide gel electrophoresis and Western blotting as previously described  [254] with 
changes as per [255]. Westerns were performed with antibodies against 
hCCR5(BioLegend Mouse IgG anti hCCR5  #321702) followed by secondary antibodies 
conjugated to horseradish peroxidase (HRP) (SantaCruz Goat IgG-HRP #sc-2005).   
The lysates were also probed with anti- tubulin antibodies (Mouse IgG anti Tubulin, a 
kind gift from the Song laboratory) followed by secondary antibodies against mouse IgG 
conjugated to HRP.  (unsuccessfully with SantaCruz #sc-20227 Lot # A0307 Goat 
polyclonal  IgG followed by SantaCruz #sc-2020 Donkey anti-goat IgG-HRP)  After 
probing, blots were exposed using Luminol (SantaCruz #sc-2048) and a Fujifilm CCD 
camera. 
Northern Blotting 
All RNA for northern blots was extracted with acid phenol/chloroform (pH = 4.5) 
from mid-logarithmic cell cultures [200], or with TRIzol© Reagent following the 
manufacturer’s directions (Invitrogen). RNA (northern) blotting was performed as 
previously described[78].  Equal amounts of RNA (1 µg, 2 µg, or 4µg) were separated 
through 1% MOPS-formaldehyde-agarose.  RNA samples were bottom-up transferred to 
Hybond-N (Amersham) membranes for 4-10 hours and UV cross linked.  Blots were 
hybridized with γ[32P] 5’-end-labeled oligonucleotides specific for U3 snoRNA (loading 
control) and the exogenous Renilla fragment (experimental) for 4-24 hours at 52-60° in a 
rolling incubator.  End-labelling was performed using the Roche T4 DNA kinase with 1 µl 
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of enzyme and 30-50 mCi γ[32P]-ATP at 25° (this is explicitly in contradiction to the 
protocol listed in the manual for the enzyme which states 37°, but I found 5-10x more 
specific product at RT).  After incubation, blots were rinsed 3-6 times in 2x SSC / 0.1% 
SDS for 15-30 minutes.  Messenger RNAs were identified using a GeneStorm 
phosphoimager (Bio-Rad) and quantified using QuantifyOne (Bio-Rad).  Due to the large 
size differences in the mRNAs observed, no stripping was performed, but blots were 
rinsed with 1x SSC / 0.2% SDS between probes.  Blots were repeated three or more 
times and averaged to generate graphs. 
Plasmid Construction 
Synthetic oligonucleotides (IDT DNA) used for plasmid construction are listed in 
appendices D and E.  The plasmids generated are in appendices B and C.  Insertions 
were amplified using PCR and ligated into appropriate backbone plasmids.  Mutagenesis 
was performed using QuikChange (Agilent) site-directed mutagenesis kits.  Clones were 
confirmed by sequencing (Genewiz).  Examples of each cloning method and site-
directed mutagenesis method follow: 
PCR Amplification, Restriction Enzyme Digestions, and Ligation. 
The PRF signal from Homo sapiens CCR5 was amplified from pCMV-XL4 
(pJD819) containing the CCR5 open reading frame (Origene) using oligonucleotides with 
Bam HI and Sal I restriction sites.  PCR products were ligated into p2luci 
(pJD175e)[204]. 
Choose oligonucleotides in two pieces: the first includes an appropriate spacer 
(often 4A), a restriction enzyme cutting site unique to both the cloned sequence and the 
multiple cloning site of the backbone plasmid; the second includes a region which is 
identical to the sequence of interest.  Take note of the melting temperature (Tm) of the 
identical sequence.  This will define the PCR annealing temperature. 
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The 4-6 nucleotidet spacer is important to ensure that restriction endonucleases 
efficiently cut the resulting dsDNA fragment.  The length of the identical sequence is not 
very important, but should be long enough to be unique against the genome(s) of the 
organisms used to maintain the resulting plasmid.  In practice, a Tm of 55-60° is often 
ideal.  The most common mistake when choosing oligonucleotides is to inappropriately 
reverse or complement the 3’ oligonucleotide.  Dilute the lyophilized oligonucleotides to 
[100 µM] when they arrive. 
Perform a PCR reaction using 10-100 pMol of each oligonucleotide and 10-200 
ng of template (usually plasmid).  The annealing temperature should be 3-7° less than 
the Tm of the overlapping sequence.  Annealing temperatures set too low result in non-
specific products or primer-dimers, while too high results in no product.  When using the 
Taq polymerase, the approximate rate of incorporation is 1 kb/min with an error rate of 1 
base / 11,000 incorporated nucleotides.  Thus products larger than 4 kb might require 
another polymerase. 
The fragment should be gel-purified to remove unincorporated oligonucleotides.  
The gel-purification process uses TAE and may leave behind large amounts of EDTA; 
DNA ligase and some restriction enzymes require Mg+2.  Therefore, ethanol precipitate 
the PCR product and elute in 10-30 µl water. 
Digest the resulting dsDNA fragment and template plasmid with the appropriate 
restriction enzymes.  Clean the resulting linearized plasmid and fragment before ligation.  
This may be done by PCR purification, gel purification, or ethanol precipitation.  Ideally 
the final elution should result in a 3:1 insert:vector molar ratio (This ration may change 
significantly depending on size and restriction site, blunt ends for example use 7:1 while 
very small fragments use 10:1).  Using OD260 to quantify the insert:vector is unreliable if 
the fragment is very short (< 200 bp) due to a skewed extinction coefficient or 
 118 
 
contaminants from gel purification.  Thus it is often useful to quantify by electrophoresis 
and compare to a DNA ladder. 
Ligate the fragment and plasmid and transform bacteria for amplification.  While 
most  protocols now use rapid ligation (5 minutes at 25°), I have found that difficult 
ligations work best when using T3 DNA ligase (NEB) overnight at 16°. 
Oligonucleotide Annealing and Ligation. 
Oligonucleotides encoding the -1 PRF signals from the hIL2γ, human and mouse 
IL7α, hIL8α, hIL8β, hIL22α, and hIL27α receptor chains were purchased containing 15-
18 bases of internal overlap, PCR extended into a single Bam HI and Sal I containing 
product, and ligated into p2luci. 
This process is effectively the same as above, but the oligonucleotides are 
chosen specifically to anneal to each other and the PCR product is explicitly intended to 
be “primer-dimer.”  Therefore, the oligonucleotides chosen are longer and might need to 
be purified.  Perform all ligations at a 10:1 molar ratio of insert:vector and use T3 DNA 
ligase (NEB) overnight. 
Site Directed Mutagenesis and “Mega-oligo” Mutagenesis. 
pTRE-Rβ (pJD976), pTRE-Rβ-ARE (pJD975), and pTET-Off (pJD979) were kind 
gifts from Dr. G. Brewer[207].  Insertions of the CCR5 -1 PRF signal were performed via 
a modified version of the “mega-oligo” site directed mutagenesis protocol[256].  
Oligonucleotides (IDT) were chosen to include 23 nucleotides of the β-globin exon 1, 36 
nucleotides of Renilla luciferase on the 5’ side; and 23 nucleotides of β-globin exon 1, 15 
nucleotides of firefly luciferase on the 3’ side; and amplified from the CCR5 dual 
luciferase plasmid (pJD827).  The resulting 330+ nucleotide oligos were used with 
pTRE-Rβ template to generate pTRE-Rβ-CCR5 and variants (pJD973, wt CCR5; 
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pJD974, wt CCR5 and ARE; pJD977, synonymous mutation of CCR5 slippery heptamer; 
and pJD1058, mutation of CCR5 slippery heptamer to GCGCGCG). 
Choose primary oligonucleotides so that the 5’ contains all of the mutagenized 
bases and the 3’ is reverse complement of the template.  Secondary oligonucleotide 
generation is performed via PCR using 10-100 pMoles each primary oligonucleotide and 
10-100 ng template plasmid.  30-45 cycles of PCR are used with an appropriate 
annealing temperature (2-6° less than the Tm of the wild-type) and an appropriate 
extension time (often 30 seconds) at 64-68°. 
The resulting short double-stranded DNA product is gel-purified, ethanol precipitated 
and eluted in 5-20 µl water.  50-100% of this purified secondary oligonucleotide is used 
in the agilent Quikchange SDM protocol without modification. 
Quantitative Real Time Reverse Transcription PCR. 
Mammalian Cells 
For qPCR analyses of the β-globin based reporters, assays were performed as 
previously described [207] with the following modifications.  The dual luciferase 
readthrough control was used for co-transfections rather than EGFP.  RNA samples for 
qPCR were isolated using the RNAqueous kit (Ambion), digested with rDNAse (Ambion) 
and assayed for DNA contamination using agarose gel electrophoresis and/or OD260/280 
measurements.  The remaining samples were reverse transcribed using the iScript 
cDNA kit (Bio-Rad).  The resulting cDNAs were diluted to 1:50-10,000 depending on 
mRNA concentration. Reactions were performed using 10 µl of LightCycler 480 SYBR 
Green I Master mix (Roche), 0.2-0.3 µM of each oligonucleotide, 2 µl of cDNA, and 
water to 20 µl/well.  Best results were observed when all volumes were increased by 
10%.  All samples were assayed for genomic DNA contamination by performing the 
assay using wells containing 1-2 µl of digested mRNA instead of cDNA.  Reactions were 
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amplified using either a Roche 480 LightCycler or a Bio-Rad CFX 96 thermocycler as 
follows: 25⁰C for 10 seconds, 95⁰C for 5 min, followed by 45-60 cycles of 95⁰C for 10 
seconds, 52⁰C for 15 seconds, and 72⁰C for 15 seconds.  Melting curves were 
monitored by taking readings every 0.5⁰C from 55-95⁰C.  The time-course qPCR 
analyses were performed with a 53⁰C and 54⁰C annealing temperatures and 20 second 
extension times with no significant changes in results.  For qPCR analyses of the full 
length CCR5 mRNA, assays were performed as described for the β-globin assays, but 
using oligonucleotides specific for β-micoglobulin and CCR5 [257].  Reactions were 
amplified using the same conditions as for the β-globin constructs except all reactions 
used 20 seconds at 55⁰C for extension. 
Yeast Cells 
Full length EST2 expression vectors (pJD641), EST2 mutant vectors(pJD796), 
and null plasmids(pJD315)  were transformed into WT(JD1281), EST2 deletion(JD1287), 
UPF2(JD1288) and EST2/UPF2(JD1276) deletion strains.  Total RNA was extracted 
with acid phenol/chloroform from mid-logarithmic cell cultures.  To reduce nonspecific 
amplification, RNA was treated with DNase I before reverse transcription using Turbo 
DNase (Ambion).  cDNA was generated using the Bio-Rad iScript cDNA synthesis kit 
and used in the LightCycler real-time PCR system.  PCR was performed as in 
mammalian cell cultures with the following cycle conditions: 1 cycle of 95°C for 10 min; 
40 cycles of 95°C for 10 s, 54°C for 20 s, and 72°C for 20 s.  U3 snoRNA was chosen as 
a reference gene. 
RNA Extraction 
 Mammalian Cells 
All RNA extractions of mammalian RNA were performed using either the Trizol 
reagent[258] or the Ambion RNAqueous kit with no modifications. 
 121 
 
 Yeast Cells 
RNA extractions from yeast require an initial step to disrupt the cell wall.  This 
may be performed using a lysis buffer and agitating the cells in 200-500 µl of glass 
beads for 1-5 minutes.  Once this is complete, the rest of the extraction process 
continues with no modification. 
SHAPE 
SHAPE was performed as previously described[215] with no known changes.  
RNA for SHAPE was generated by PCR amplifying T7 or T3 containing dsDNA from 
dual-luciferase plasmids and using the mMessage Machine transcription kit.  The 
resulting RNA was passed through a sephadex G-25 column and ethanol precipitated 
before analysis. 
Southern Blotting 
Southern blots were performed to observe telomere differences as previously 
described with changes[86].  Yeast genomic DNA was collected using the bust n’ grab 
method[259].  Instead of end-label synthetic telomere-template oligonucleotides, the 
telomere template was PCR amplified from a plasmid (pJD972) which flanks the 
telomerase region with M13 and T7.  ssRNA was transcribed using the mMessage 
Machine kit (Ambion) and α[32P] ATP to generate probes with high specific activity.  
Unincorporated nucleotides were removed by passing the probe through a sephadex G-
25 (or G-50) column.  Yeast genomic DNA was cut with Pst I (Xho I when Pst I was 
exhausted) and electrophoresed through a 1% agarose gel.  DNA was nicked in a 
crosslinker and denatured in 0.5 M NaOH, 1.5 M NaCl for 30-45 minutes.  The gel was 
rinsed in water before placing in a blotting solution of 0.2 M NaOH, 1.5 M NaCl while 
preparing a bottom-up blotting apparatus (identical to that used for Northerns) with a 
Hybond N+ membrane.  Blots transferred overnight, were rinsed 2-3 times in 2x SSC 
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and crosslinked.  After crosslinking, blots were pre-incubated with Church’s buffer at 65° 
for 15-60 minutes before adding the probe.  Blots hybridized overnight at 57-60°, 
washed 4 times with 1x SSC, 0.5% SDS followed by 1-3 washes with 0.1x SSC, 0.1% 
SDS.  The blots were wrapped in a plastic baggie, sealed, exposed to a phosphoimager 
screen, and analyzed as per a Northern.  Church’s buffer contains:  2 ml 0.5 M EDTA pH 
8.0 (1 mM), 2 ml 85% (w/v) H3PO4, 67.5 g Na2HPO4, 70 g SDS, and water to 1 L.  On at 
least one occasion 200 µl ssDNA as added to the Church’s buffer with no noticeable 
effect. 
Time Course Assays 
Mammalian 
mRNA decay time course assays were performed as previously described with 
minor changes[207].  RNA isolations were performed immediately at each timepoint after 
transcriptional arrest using the RNAqueous kit (Ambion) rather than after freezing 
samples on dry ice. 
Yeast 
mRNA decay time course assays were performed as previously described with 
minor changes[199].  The EST2 mRNA stability vector (pJD754), a readthrough control 
(pJD753) and premature stop codon containing control (pJD828) were transformed into 
rpb1-1 (JD977) and rpb1-1/Upf1∆ cells. 
Transformations of rpb1 mutant cells must be performed entirely at room 
temperature, otherwise the temperature sensitive RNA polymerase may kill the cells.  In 
order to accommodate this strain, transformations were performed with 2-3x more cell 
mass than usual, the ssDNA was boiled and then allowed to return partially to room 
temperature before addition, and the incubation with plasmid before plating was 
extended to 6-8 hours.  Transformed cells were grown at 25° or 30° with no noticeable 
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difference.  At collection time, media was pre-warmed to 52° and added so that the 
average temperature rose to 42°, the non-permissive temperature.  Cells were collected 
and frozen immediately in liquid N2.  mRNA was collected and Northern analyses/qPCR 
were performed as usual.  
Transfections 
Plasmid 
 All plasmid transfections were performed using the Fugene 6 (initially Roche, 
now Promega) reagent.  Most efficient transfections were observed using the 3:1 ratio. 
 Allow cells to grow to 50-100% confluency, trypsinize and split into 6-24 well 
plates.  Let them grow in the plates to 50-75% confluency.  Assuming 24 well plates, 
refresh the media with 500 µl DMEM+ (DMEM supplemented with 10% irradiated fetal 
bovine serum (FBS), 1x non-essential amino acids (NEAA), and [4 mM] glutamine).  In 
eppendorf tubes, mix 20 µl DMEM(without additives), 0.6 µl Fugene, and 300 ng 
plasmid, in that order for every well transfected.  Let sit for 30-90 minutes and add 
dropwise to each well.  Wait 1-2 days and assay. 
miRNA 
 Cells were transfected with the following miRNA precursors:  hsa-miR-141, hsa-
miR-711, hsa-miR-1224-5p, and hsa-miR-1205 using the siPORT reagent (Applied 
Biosystems/Ambion), or Lipofectamine for miRNA pulldowns (Invitrogen).  When 
performing initial miRNA transfections for dual luciferase, [30 nM] was used.  When 
performing the miRNA titration, four 1:10 dilutions were used starting at [5 nM].  
Transfections were performed into 15,000-40,000 cells in 500 µl DMEM+ using 25 µl of 
DMEM and 1 µl of siPORT reagent after incubating for 20 minutes at room temperature 
per well.  Media was replaced with fresh DMEM+ after 8-12 hours.  Dual luciferase 
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plasmid transfections were either performed at the same time or 24 hours later using the 
FuGene 6 reagent. 
siRNA 
Cells were transfected with synthetic RNA oligonucleotides specific to the mRNA 
of interest (AUF1, hRENT1, hUPF2, hSMG1, argonaute, hDKC1) or scrambled 
oligonucleotides using the HiPerFect transfection reagent (Qiagen).  Initial transfections 
were performed at [1, 5,10 nM], and [20 nM] for optimization.  Most final transfections 
were performed at [10 nM], but some used [5 nM].  Transfections were performed into 
30,000-40,000 cells (via hemacytometer) immediately after splitting cells in 500 µl of 
DMEM+ using 100 µl of DMEM and 3 µl of HiPerFect reagent after incubating for 15-20 
minutes at room temperature.  Media was replaced with fresh DMEM+ after 8-12 hours.   
Assays were performed 48-72 hours after siRNA transfection.  When other plasmids 
were also transfected, they were performed separately 24-48 hours after siRNA 
transfection using the Fugene 6 (Roche) reagent. 
Transformations 
Bacteria 
 Transformations of E. coli were performed as described previously using the 
calcium chloride method[196].  When transformations were performed for difficult 
plasmids (larger than 10,000 bp or SDM products), a slightly modified method was using 
as described in the QuikChange SDM manual.  Incubate 20-50 µl of cells with 1-4 µl β-
mercaptoethanol for 10 minutes on ice.   Add plasmid, incubate on ice for 30-120 
minutes.  Heat shock at 42° for 30 seconds.  Incubate again on ice for 10 minutes.  Add 




Yeast cells were transformed using the alkali cation method[197] with some changes.  
First check yeast genetic background and plasmid maps to ensure that the proper 
auxotrophies are maintained.  Grow 2-3 ml yeast overnight in appropriate non-selective 
(for your plasmid) media.  Start an aliquot of salmon sperm ssDNA boiling.  Aliquot yeast 
into 1.6 ml eppendorf tubes and spin down at < 500 g.  (2,000 rpm on a desktop 
centrifuge, 1,200 rpm on the Sorval at maximum.)  Remove media and resuspend in 200 
µl 0.1 M LiOAc/TE, repeat and resuspend in 100 µl 0.1 M LiOAc/TE.  Add 15 µl ssDNA 
for each transformation (this is approximately double the original protocol).  Add 500-
2,000 ng plasmid and 500-700 µl PEG/LiOAc/TE (this consists of 8 ml PEG 5,000, 1 ml 
1.0 M LiOAC , and 1 ml 10x TE, which is more PEG than the default protocol due to a 
labeling mistake, but seems to work better).  Incubate 90-900 minutes at 30°.  Heat 
shock at 42° for 15 minutes.  Pellet the cells, rinse and resuspend them in 100-400 µl 









JD1158 BY4742 MATα  his3∆1 leu2∆0 lys2∆0 ura3∆0   WT strain for steady states assays 
and frameshifting 
JD1181 BY4742 MATα upf3::KanR his3∆1 leu2∆0 lys2∆0 
ura3∆0  
NMD deficient strain for steady 
states 
JD1367 yRP2077  MATa upf1::KanMX4 his3∆ leu2∆ met15∆ 
ura3∆ 
NMD deficient strain for steady 
states, Parker lab 
JD1170 MATα xrn1::Kan
R




 his3∆1 leu2∆0 ura3∆0 Exosome / 3’ -> 5’ deficient for 
steady states 
JD19 MATα leu2∆0 ade2∆0 ura3∆0 PEP4::HIS3 
NUC1::LEU2 ski3 [L-AHN M1] 
Exosome / 3’ -> 5’ deficient for 
steady states 
JD1122 MATa lys2∆0 ura3∆0 ho::LYS2 leu2::hisG, his4b  
dcp1::hisG  [L-AHN M1] 
Decapping deficient for steady 
states 
JD1363 yRP2056  MATa;   his3∆ leu2∆ met15∆ ura3∆ 
dom34::KanMX4 
No-go decay deficient for steady 
states, Parker lab 
JD977 MATα ura3-52 trp1-∆1 his4-38 leu2-1 rpb1-1 RNA pol2β, temperature sensitive 
for time courses 
JD978 MATα ura3-52 trp1-∆1 his4-38 leu2-1 rpb1-1 
upf1∆::HISG 
RNA pol2β, temperature sensitive 
and NMD deficient 
JD1263 MAT a/α trp1∆ /trp1∆ leu2∆/leu2∆ can1-100/can1-100 
ade2-1/ade2-1 est2∆::URA3/EST2 upf2∆::HIS3/UPF2 
VR-ADE2-TEL/VR-TEL (YJB2659) 
Parental strain of est2 mutant 
strains used in this study, Berman 
lab 
JD1281 MAT a trp1∆ leu2∆ can1-100 ade2-1 ura3-1 his3-11 
VR-ADE2-TEL 
WT strain for assaying telomere 
activity 
JD1287 MAT α trp1∆ leu2∆ can1-100 ade2-1 est2∆::URA3 
his3-11 VR-ADE2-TEL 
Telomerase deficient strain to 
assay telomeres 
JD1288 MAT a trp1∆ leu2∆ can1-100 ade2-1 ura3-1 
upf2∆::HIS3 VR-ADE2-TEL 
NMD deficient strain to assay 
telomeres 
JD1276 MAT a trp1∆ leu2∆ can1-100 ade2-1 est2∆::URA3 
upf2∆::HIS3 VR-ADE2-TEL 
Telomerase and NMD deficient 
strain to assay telomeres 




Appendix 2: Yeast Plasmids 
Plasmid Name Backbone 
Plasmid 
Insertion 
pJD0375[200] pRS316[260] Dual luciferase cassette in pRS316, genomic context (b) 
pJD0376[200] pJD0375 LA frameshift signal sequence inserted in dual luciferase reporter, 
viral context (b) 
pJD0520[23] pJD0375 SPR6 PRF sequence inserted in dual luciferase reporter, viral 
context (c,d) 
pJD0521[23] pJD0375 EST2 PRF sequence inserted in dual luciferase reporter, viral 
context (c,d) 
pJD0519[23] pJD0375 BUB3 PRF sequence inserted in dual luciferase reporter, viral 
context (c,d,a) 
pJD0518[23] pJD0375 TBF1 PRF sequence inserted in dual luciferase reporter, viral 
context (c,d) 
pJD0476[23] pJD0375 PPR1 PRF sequence inserted in dual luciferase reporter, viral 
context (e,a) 
pJD0477[23] pJD0375 NUP82 PRF sequence inserted in dual luciferase reporter, viral 
context (e) 
pJD0478[23] pJD0375 TBF1 PRF sequence inserted in dual luciferase reporter, viral 
context (e) 
pJD0522 pJD0375 FLR1 PRF sequence inserted in dual luciferase reporter, viral 
context (e) 
pJD0523 pJD0375 FKS1 PRF sequence inserted in dual luciferase reporter, viral 
context (e) 
pJD0624 pJD0375 NUP82 PRF sequence inserted in dual luciferase reporter, genomic 
context (e) 
pJD0625 pJD0375 CTS2 PRF sequence inserted in dual luciferase reporter, genomic 
context (e) 
pJD0626 pJD0375 SPR6 PRF sequence inserted in dual luciferase reporter, genomic 
context (e) 
pJD0753[202] pJD0741[78] Readthrough containing small amounts of Renilla and Firefly in 
PGK1 reporter (e) 
pJD0765[202] pJD0753 Premature termination codon in PGK1 reporter (e,a) 
pJD0748[202] pJD0753, 
pJD0520 
SPR6 PRF sequence inserted in PGK1 reporter (a) 
pJD0938[202] pJD0753, 
pJD0520 
SPR6 PRF sequence inserted in PGK1 reporter v2 (a,f) 
pJD0754[202] pJD0753, 
pJD0521 
EST2 PRF sequence inserted in PGK1 reporter (a) 
pJD0755[202] pJD0753, 
pJD0519 
BUB3 PRF sequence inserted in PGK1 reporter (a,e) 
pJD0756[202] pJD0753, 
pJD0518 
TBF1 PRF sequence inserted in PGK1 reporter (a) 
pJD0818[202] pJD0753, 
pJD0520 
SPR6 slipsite mutant in PGK1 reporter (a) 
pJD0806[202] pJD0753, 
pJD0521 
EST2 slipsite mutant in PGK1 reporter (a) 
pJD0812[202] pJD0753, 
pJD0519 
BUB3 slipsite mutant in PGK1 reporter (a) 
pJD0813[202] pJD0753, 
pJD0518 
TBF1 slipsite mutant in PGK1 reporter (a) 
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pJD0638[188] YEplac128 Full length EST2 high copy plasmid 
pJD0641 pJD0638 Full length EST2 low copy plasmid (e) 
pJD0796[202] pJD0641 Mutated full length EST2 low copy plasmid (a,e) 
pJD0972[188] pTNT Yeast telomeric sequence under T7 promoter control 
pJD0659 pJD0375 EST2 PRF sequence (position 72) inserted in dual luciferase 
reporter, genomic context (e,a) 
pJD0660 pJD0375 EST2 PRF sequence (position 1215) inserted in dual luciferase 
reporter, genomic context (e,a) 
pJD0661 pJD0375 EST2 PRF sequence (position 1326) inserted in dual luciferase 
reporter, genomic context (a,e) 
pJD0662 pJD0375 EST2 PRF sequence (position 1653) inserted in dual luciferase 
reporter, genomic context (e,a) 
pJD0667 pJD0375 EST2 PRF sequence (position 1995) inserted in dual luciferase 
reporter, genomic context (a,e) 
pJD0673 pJD0641 Full length EST2 low copy plasmid with mutations to the position 
1215 PRF sequence (e) 
pJD0674 pJD0641 Full length EST2 low copy plasmid with mutations to the position 
1995 PRF sequence (e) 
pJD0685 pJD0641 Full length EST2 low copy plasmid with mutations to the position 
1326 PRF sequence (a) 
pJD0686 pJD0641 Full length EST2 low copy plasmid with mutations to the position 72 
PRF sequence (a) 
pJD0742 pJD0375 PPR1 PRF sequence (position 660) inserted in dual luciferase 
reporter, viral context (a) 
pJD0743 pJD0375 PPR1 PRF sequence (position 1188) inserted in dual luciferase 
reporter, viral context (a) 
pJD0744 pJD0375 PPR1 PRF sequence (position 1260) inserted in dual luciferase 
reporter, viral context (a) 
pJD0745 pJD0375 PPR1 PRF sequence (position 2094) inserted in dual luciferase 
reporter, viral context (a) 
pJD0746 pJD0375 PPR1 PRF sequence (position 525) inserted in dual luciferase 
reporter, viral context (a) 
pJD0757 pJD0753 CTS2 PRF sequence inserted in PGK1 reporter (a) 
pJD0758 pJD0753 PPR1 PRF sequence (position 660) inserted in PGK1 reporter (a) 
pJD0759 pJD0753 PPR1 PRF sequence (position 1188) inserted in PGK1 reporter (a) 
pJD0760 pJD0753 PPR1 PRF sequence (position 1260) inserted in PGK1 reporter (a) 
pJD0761 pJD0753 PPR1 PRF sequence (position 2094) inserted in PGK1 reporter (a) 
pJD0766 pJD0753 EST2 PRF sequence (position 1215) inserted in PGK1 reporter (a) 
pJD0797 pJD0375 SPR6 PRF sequence inserted in dual luciferase reporter, viral 
context, mutated slip site (a) 
pJD0806 pJD0754 EST2 PRF sequence inserted in PGK1 reporter, slip site mutant (a) 
pJD0807 pJD0757 CTS2 PRF sequence inserted in PGK1 reporter, slip site mutant (a) 
pJD0808 pJD0521 EST2 PRF sequence inserted in dual luciferase reporter, viral 
context, mutated slip site (l) 
pJD0811 pJD0754 EST2 PRF sequence inserted in PGK1 reporter, stem 1 mutant (a) 
pJD0812 pJD0755 BUB3 PRF sequence inserted in PGK1 reporter, slip site mutant (a) 
pJD0813 pJD0756 TBF1 PRF sequence inserted in PGK1 reporter, slip site mutant (a) 
pJD0814 pJD0756 TBF1 PRF sequence inserted in PGK1 reporter, stem 1 mutant (a) 
pJD0815 pJD0757 CTS2 PRF sequence inserted in PGK1 reporter, stem 1 mutant (a) 
pJD0816 pJD0759 PPR1 PRF sequence inserted in PGK1 reporter, slip site mutant (a) 
pJD0817 pJD0748 SPR6 PRF sequence inserted in PGK1 reporter, stem 1 mutant (a) 
pJD0818 pJD0748 SPR6 PRF sequence inserted in PGK1 reporter, slip site mutant (a) 
pJD0859 pJD0375 PDR5 PRF sequence (position 300) inserted in dual luciferase 
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reporter, viral context (a) 
pJD0860 pJD0837 PDR5 PRF sequence (position 3027) inserted in dual luciferase 
reporter, viral context (a) 
pJD0972 pBC6 Yeast telomeric sequence flanked by M13 
pJD0984 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1215 PRF sequence (a,j) 
pJD0985 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1215,1326,1653 PRF sequence (a,j) 
pJD0986 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1215,1326,1995 PRF sequence (a,j) 
pJD0987 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1326,1653 PRF sequence (a,j) 
pJD0988 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1215,1995 PRF sequence (a,j) 
pJD0989 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1326 PRF sequence (a,j) 
pJD990 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1215,1653 PRF sequence (a,j) 
pJD0991 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1326,1653,1995 PRF sequence (a,j) 
pJD0992 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
1653 PRF sequence (a,j) 
pJD0993 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
72,1995 PRF sequence (a,j) 
pJD0994 pJD0641 Full length EST2 low copy plasmid with mutations to the positions 
1215,1326 PRF sequence (a,j) 
pJD0995 pJD0984 Full length EST2 low copy plasmid with mutations to the positions 
1215,1326 PRF sequence (a,j) 
pJD0996 pJD0989 Full length EST2 low copy plasmid with mutations to the positions 
72,1326,1995 PRF sequence (a,j) 
pJD0997 pJD0674 Full length EST2 low copy plasmid with mutations to the positions 
1215,1995 PRF sequence (a,j) 
pJD0998 pJD0990 Full length EST2 low copy plasmid with mutations to the positions 
72,1215,1653,1995 PRF sequence (a,j) 
pJD0999 pJD0673 Full length EST2 low copy plasmid with mutations to the positions 
72,1653 PRF sequence (a,j) 
pJD1000 pJD0375 STN1 PRF sequence (position 885) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1001 pJD0375 STN1 PRF sequence (position 1203) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1002 pJD0375 EST1 PRF sequence (position 1203) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1003 pJD0375 EST1 PRF sequence (position 1272) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1004 pJD0375 EST1 PRF sequence (position 1920) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1005 pJD0375 CDC13 PRF sequence (position 1270) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1010 pRS316 CBF5 wild-type in pRS316 (k,a) 
pJD1011 pRS316 CBF5 S36A in pRS316 (k,a) 
pJD1012 pRS316 CBF5 D95A in pRS316 (k,a) 
pJD1013 pJD0685 Full length EST2 low copy plasmid with mutations to the position 
1326,1995 PRF sequence (a,j) 
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pJD1014 pJD0992 Full length EST2 low copy plasmid with mutations to the position 
1326,1995 PRF sequence (j,a) 
pJD1015 pJD0999 Full length EST2 low copy plasmid with mutations to the position 
1326,1995 PRF sequence (a,j) 
pJD1016 pJD0994 Full length EST2 low copy plasmid with mutations to the position 
1215,1326,1995 PRF sequence (j,a) 
pJD1017 pJD0659 EST2 PRF sequence (position 72) inserted in dual luciferase 
reporter, viral context (a) 
pJD1018 pJD0660 EST2 PRF sequence (position 1215) inserted in dual luciferase 
reporter, viral context (a) 
pJD1019 pJD0661 EST2 PRF sequence (position 1326) inserted in dual luciferase 
reporter, viral context (a) 
pJD1020 pJD0667 EST2 PRF sequence (position 1995) inserted in dual luciferase 
reporter, viral context (a) 
pJD1021 pJD0659 EST2 PRF sequence (position 72) inserted in PGK1 reporter (a) 
pJD1022 pJD0992 Full length EST2 low copy plasmid with mutations to the positions 
72,1215,1995 PRF sequence (j,a) 
pJD1023 pJD1014 Full length EST2 low copy plasmid with mutations to the position 
72,1326,1995 PRF sequence (a,j)  CHECK THIS AGAIN 
pJD1024 pJD1014 Full length EST2 low copy plasmid with mutations to the position 
1215,1326,1995 PRF sequence (j,a) 
pJD1025 pJD0994 Full length EST2 low copy plasmid with mutations to the positions 
1215,1326,1653 PRF sequence (a,j) 
pJD1026 pJD0992 Full length EST2 low copy plasmid with mutations to the positions 
1326,1653 PRF sequence (j,a) 
pJD1027 pJD1016 Full length EST2 low copy plasmid with mutations to the position 
1215,1326,1653,1995 PRF sequence (j,a) 
pJD1028 pJD0375 FKS1 PRF sequence inserted in dual luciferase reporter, genomic 
context (a) 
pJD1029 pJD0375 FLR1 PRF sequence inserted in dual luciferase reporter, genomic 
context (a) 
pJD1030 pJD0375 PPR1 PRF sequence (position 660) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1031 pJD0375 PPR1 PRF sequence (position 1260) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1032 pJD0375 PPR1 PRF sequence (position 2094) inserted in dual luciferase 
reporter, genomic context (a) 
pJD1036 pRS314 CBF5 wild-type in pRS314 (a) 
pJD1037 pRS314 CBF5 D95A in pRS314 (a) 
pJD1038 pJD1000 STN1 PRF sequence (position 885) inserted in dual luciferase 
reporter, viral context (a) 
pJD1039 pJD1001 STN1 PRF sequence (position 1203) inserted in dual luciferase 
reporter, viral context (a) 
pJD1040 pJD1002 EST1 PRF sequence (position 1203) inserted in dual luciferase 
reporter, viral context (a) 
pJD1041 pJD1003 EST1 PRF sequence (position 1272) inserted in dual luciferase 
reporter, viral context (a) 
pJD1043 pJD1004 EST1 PRF sequence (position 1920) inserted in dual luciferase 
reporter, viral context (a) 
pJD1048 pRS313 CBF5 wild-type in pRS313 (a,l) 
pJD1049 pRS313 CBF5 D95A in pRS313 (a,l) 
pJD1070 pJD0753 EST2 PRF sequence (position 72) inserted in PGK1 reporter (a) 
pJD1071 pJD0753 EST2 PRF sequence (position 1326) inserted in PGK1 reporter (a) 
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pJD1072 pJD0753 EST2 PRF sequence (position 1995) inserted in PGK1 reporter (a) 
pJD1073 pJD0753 STN1 PRF sequence (position 885) inserted in PGK1 reporter (l,a) 
pJD1074 pJD0753 STN1 PRF sequence (position 1203) inserted in PGK1 reporter (l,a) 
pJD1075 pJD0753 EST1 PRF sequence (position 1203) inserted in PGK1 reporter (l,a) 
pJD1076 pJD0753 EST1 PRF sequence (position 1272) inserted in PGK1 reporter (l,a) 
pJD1077 pJD0753 EST1 PRF sequence (position 1920) inserted in PGK1 reporter (l,a) 
Table 7: Plasmids used with yeast 
The complete sequences of these plasmids may be found at http://github.com/abelew/plasmids/.  
“Genomic context” notes that the downstream ORF is in the same reading frame as the upstream 
ORF; “viral context” notes that the downstream ORF is in the -1 frame with respect to the 
upstream ORF. 
Created by: a.  Ashton Belew;  b. Jason Harger; c. Rasa Rakauskaitė; d. Ewan Plant; e. Jonathan Jacobs; f. Hamid-Reza 
Shahshahan; g. Sharmishtha Musalgaonkar; h. Bryan Fleming; i. Lara Hause; j. Curt Kugel; k. Rachel Niederer; l. Vivek 




Appendix 3: Mammalian Plasmids 
Plasmid Name Backbone 
Plasmid 
Insertion 
pJD0175e P2luc[204] pJD175e is identical to p2luc 
pJD0175f P2luci [204] pJD175f is identical to p2luci 
pJD0187.wt[261] P2luci Insertion of the HIV-1 PRF signal into the dual luciferase plasmid 
pJD0827 pJD0175e Insertion of the CCR5 PRF signal into the dual luciferase plasmid (a) 
pJD0835 pJD0175e Insertion of the homo sapiens IL7α PRF signal into the dual 
luciferase plasmid (g,a) 
pJD0836 pJD0175e Insertion of the mus musculus IL7α PRF signal into the dual 
luciferase plasmid (i,a) 
pJD0844 pJD0827 Mutation of the CCR5 slip site in the dual luciferase plasmid (n,a) 
pJD0845 pJD0827 Mutation of the CCR5 stem 2, 5’ side in the dual luciferase plasmid 
(n,a) 
pJD0846 pJD0827 Mutation of the CCR5 stem 2, 3’ side in the dual luciferase plasmid 
(n,a) 
pJD0847 pJD0175e Insertion of the homo sapiens IL27 PRF signal into the dual 
luciferase plasmid (a) 
pJD0848 pJD0827 Complementation mutation of the CCR5 stem 2 in the dual luciferase 
plasmid (h,a) 
pJD0850 pJD0827 Partial mutation (3 bases) of the CCR5 stem 1, 3’ side in the dual 
luciferase plasmid (h,a) 
pJD0851 pJD0827 Partial mutation (3 bases) of the CCR5 stem 1, 5’ side in the dual 
luciferase plasmid (h,a) 
pJD0852 pJD0827 Complementation mutation (3 bases) of the partial CCR5 stem 1 in 
the dual luciferase plasmid (h,a) 
pJD0854 pJD0827 Partial mutation (9 bases) of the CCR5 stem 1, 5’ side in the dual 
luciferase plasmid (h,a) 
pJD0855 pJD0827 Complementation mutation (9 bases) of the partial CCR5 stem 1 in 
the dual luciferase plasmid (h,a) 
pJD0856 pJD0827 Partial mutation (12 bases) of the CCR5 stem 2, 5’ side in the dual 
luciferase plasmid (h,a) 
pJD0857 pJD0827 Partial mutation (12 bases) of the CCR5 stem 2, 3’ side in the dual 
luciferase plasmid (h,a) 
pJD0858 pJD0827 Complementation mutation (12 bases) of the partial CCR5 stem 2 in 
the dual luciferase plasmid (h,a) 
pJD0973 pTET Rabbit Β-globin reporter containing CCR5 PRF signal in exon 1 
(a,m) 
pJD0974 pTET Rabbit Β-globin reporter containing CCR5 PRF signal in exon 1 and 
the TNF-α ARE immediately after the stop (a) 
pJD0975 [207] pTET Rabbit Β-globin reporter containing the TNF-α ARE immediately after 
the stop 
pJD0976 [207] pTET Rabbit Β-globin reporter, readthrough 
pJD0977 pTET Rabbit Β-globin reporter containing a mutated CCR5 PRF signal in 
exon 1 (a) 
pJD0978 pTET Rabbit Β-globin reporter containing mutated CCR5 PRF signal in 
exon 1 and the TNF-α ARE immediately after the stop (a) 
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pJD0979 [207] pCMV The Cytomegalovirus transactivator protein used to increase 
pJD1009 pJD175e Insertion of the Dyskerin PRF signal into the dual luciferase plasmid 
(j,a) 
pJD1033 pEGFP GFP plasmid from Clonetech 
pJD1058 pJD973 Rabbit Β-globin reporter containing mutated CCR5 PRF signal to 
GCGCGCG in exon 1 (a) 
pJD1059 pJD1009 Rabbit Β-globin reporter containing dyskerin PRF signal in exon 1 
(j,a) 
pJD1060 pJD827 Insertion of the CCR5 PRF signal into the dual luciferase plasmid 
with slip site mutation to GCGCGCG (a) 
pJD1078 pJD827 Insertion of the CCR5PRF signal into the dual luciferase plasmid 
with a stop codon immediately after Renilla (a) 
pJD1214 pJD175f Insert OLA1(position 513) PRF signal into dual luciferase plasmid 
pJD1215 pJD175f Insert PNMA1(position 1740) PRF signal into dual luciferase plasmid 
pJD1216 pJD175f Insert NT5DC(position 841) PRF signal into dual luciferase plasmid 
pJD1217 pJD175f Insert SLC38A(position 981) PRF signal into dual luciferase plasmid 
pJD1218 pJD175f Insert MCM5(position 1004) PRF signal into dual luciferase plasmid 
pJD1219 pJD175f Insert MYO5C(position 3527) PRF signal into dual luciferase plasmid 
pJD1220 pJD175f Insert TDO2(position 744) PRF signal into dual luciferase plasmid 
pJD1221 pJD175f Insert ZGPAT(position 664) PRF signal into dual luciferase plasmid 
pJD1224 pJD175f Insert ATIC(position 1656) PRF signal into dual luciferase plasmid 
pJD1225 pJD175f Insert GABRE(position 735) PRF signal into dual luciferase plasmid 
pJD1226 pJD175f Insert GOLT1B(position 437) PRF signal into dual luciferase plasmid 
Table 8: Mammalian plasmid list 
The complete sequences of these plasmids may be found at:  http://github.com/abelew/plasmids   
Created by: a.  Ashton Belew;  b. Jason Harger; c. Rasa Rakauskaitė; d. Ewan Plant; e. Jonathan Jacobs; f. Hamid-Reza Shahshahan; g. 
Sharmishtha Musalgaonkar; h. Bryan Fleming; i. Lara Hause; j. Curt Kugel; k. Rachel Niederer; l. Vivek Advani; m. Sergey Sulima; n. 





Appendix 4: Cloning Oligonucleotides 



































































































17964081 ppr1_1_L pJD0746 AAAAGTCGACCAAGTCTATGGCAAGCCCAC 
16573903 ppr1_1_R pJD0746 AAAAGGATCCGTCACCAGGAGATGTCCACAGTGTGCGGTG 
15189677 ppr1_2_L pJD0742 CCCCGTCGACCCGAGACAGGCAGCCCTATGAC 
15611268 ppr1_2_R pJD0742 CCCCGGATCCTGGATTGTTTTCAGCCTCTGC 
15611269 ppr1_3_L pJD0743 CCCCGTCGACCAACATGCGTCCGATAGTTG 
15611270 ppr1_3_R pJD0743 CCCCGGATCCCAATGCCTCCAACCTGTCTG 
16573905 ppr1_4_L pJD0744 TTTTGTCGACCATCACCACCAGGTATCCTAGCCTTTTGG 
16573904 ppr1_4_R pJD0744 AAAAGGATCCGATCTCGAGAGCTGGCGGATTGAAACCTAC 
16573906 ppr1_5_L pJD0745 AAAAGTCGACTGGTTACACGTGGGTAGCAGTTCAT 
































15896741 FKS1 left pJD1028 CCCCGTCGACGCTTCGTGGTGGTCGTATCAAG 
15896742 FKS1 right pJD1028 CCCCAGATCTCAAATGGAAACCAGGATGGGC 
15896743 FLR1 left pJD1029 CCCCGTCGACATCGTGCTCTGAATCCTCTACC 





















































































































































































































































































































































































































































Table 9: Oligonucleotides used for cloning. 




Appendix 5: Site Directed Mutagenesis Oligonucleotide List 











































































































































23810600 pJD754 SS 
SDM_L 
pJD0806 GGATACTCAAGGATGCGCTGAAGAACGAAAATGGGTTTTTCG 
23810601 pJD754 SS 
SDM_R 
pJD0806 CGAAAAACCCATTTTCGTTCTTCAGCGCATCCTTGAGTATCC 














































































































































































Table 10: Oligonucleotides used for Site Directed Mutagenesis 





















































49375507 est1 1272 
minus1bp 
pJD1041 CCCTCCTGGCAAAAAAACAGGAAGACTTTCGATATCTAGCC 























Appendix 6: Oligonucleotides Used for Sequencing 
Order # Name Template Sequence 





14892453 EST2 Seq1 pJD0641 
based 
CTTAACCATAACTAACACGCCCTC 
14892454 EST2 seq2 pJD0641 
based 
TGGTCGGTACATACGCATTCG 
14892455 EST2 seq3 pJD0641 
based 
GCAATCACCAAAGGAACGAGTC 
14892456 EST2 seq4 pJD0641 
based 
TCACAAAAATGCTATCCAGCCCAC 
14892457 EST2 seq5 pJD0641 
based 
CAACAGACCAACAGCAAGTG 
14892458 EST2 seq6 pJD0641 
based 
CAGCGGTTGTCCAATTACGAAATG 
14892459 EST2 seq7 pJD0641 
based 
CCTGATTAAATGTGCCCGGTCTC 
15728281 ppr1_seq_1 pJD0746 CGAAGATGATGATTAAATCATG 
15728282 ppr1_seq_2 pJD0742 GAGCGGAAGAGCTAC 
15728283 ppr1_Seq_3 pJD0743 GCTATTGGCCATGCTAC 
15728284 ppr1_seq_4 pJD0744 GACGTTCCCAAAAACTTTG 























































Table 11: Oligonucleotides used for sequencing 

























Appendix 7: Oligonucleotides Used for qPCR and Northern 
Analyses 
Order # Name Template Sequence 
16743856 EST2 qPCR Left Yeast cDNA TGGTCGGTACATACGCATTC 
16743857 EST2 qPCR 
Right 
Yeast cDNA CGGCAGATGAGGTTCGTTAC 
17425701 18S qPCR Left Yeast cDNA GGAATTCCTAGTAAGCGCAAG 
17425702 18S qPCR Right Yeast cDNA GCCTCACTAAGCCATTCAATC 
17470908 Fluc qPCR Left Dual lux cDNA AACATCACGTACGCGGAATAC 












These give heterogeneous products. 
19855886 Left, RDN18 1 
qRT-PCR 
Yeast cDNA GGAATTCCTAGTAAGCGCAAG 
19855887 Right, RDN18 1 
qRT-PCR 
Yeast cDNA GCCTCACTAAGCCATTCAATC 
19855888 LEFT PGK1/PRF Yeast RNA GTCGGTCCAGAAGTTGAAGC 
19855889 RIGHT, 
PGK1/PRF 
Yeast RNA TGAGAACTCGCTCAACGAAC 
20699366 PGK1 5' AntiS 
probe 
Yeast RNA TTGACAGCGGCTTCAACTTCTGGACCGACACAGTCG 






Yeast RNA CATTTTTGAGAACTCGCTCAACGAACGAGGTACC 
20699369 FireflyMCS 
Antisense Probe 
Yeast RNA TACCGGCGTCTTCCATGAGCTCCC 
22036012 U3_qRTPCR 
Forward 
Yeast cDNA CGACGTACTTCAGTATGTAATATACCCCAA 
22036013 U3_qRTPCR 
Reverse 
Yeast cDNA TTGTCAGACTGCCATTTGTACCCA 
23277727 U3 Forward Yeast cDNA TCCAACTTGGTTGATGAGTCC 
23277728 U3 Reverse Yeast cDNA CGAACCGCTAAGGATTGC 
23277729 UPF1 Forward Yeast cDNA TACTCTGGCATGCAACATCC 
23277730 UPF1 Reverse Yeast cDNA ATGTGAATGTGTCCTGGAAGC 
23277731 UPF2 Forward Yeast cDNA ACACCGAACACAGAGTCAGC 
23277732 UPF2 Reverse Yeast cDNA CATCGTCATCGTCATCATCC 
23277733 UPF3 Forward Yeast cDNA TGGTTGGAACTGGTGATAAGG 









27163194 Firefly northern 
probe 
Yeast mRNA GGCGTCTTCCATGAGCTCCCCGGGGGATCC 
30469750 est2 northern 
probe 
Yeast mRNA GGATGATCGTTGGACCCATTTGGGC 
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Table 12: Oligonucleotides used as probes for qPCR and Northerns 
Full specifications may be found by using the order number at http://www.idtdna.com  
 
  
46469611 Actin qrtpcr 5p H.s. cDNA CCAATTTACGCTGGTTTCTCTCTACC 
46469612 Actin qrtpcr 3p H.s. cDNA CCTTGATGTCACGGACAATTTCTC 
46469614 Bglobin qrtpcr 
3p-changed 
H.s. cDNA ATGATGAGACAGCACAATAACCAG 
46469618 Bglobin qrtpcr 
3p-original 
H.s. cDNA ATGAGTAGACAGCACAATAACCAG 
46469613 Firefly qrtpcr 5p H.s. cDNA GGTTTTGGAATGTTTACTACACTCG 
46469615 Firefly qrtpcr 3p H.s. cDNA CCTGAAGGGATCGTAAAAACAGC 
46469616 Renilla qrtpcr 5p H.s. cDNA GCGTTGATCAAATCTGAAGAAGG 
46469617 Renilla qrtpcr 3p H.s. cDNA GGTTCTAACTTTCTCATGATTTTTGATGG 
46659195 Bglobin qrtpcr-5p H.s. cDNA GTGAACTGCACTGTGACAAGC 








49103336 auf1 qpcr_5p H.s. cDNA GCGAAGATTGACGCCAGTAAG 
49103337 auf1 qpcr_3p H.s. cDNA CTGTGATAGGATCTAACTTCAGAGTG 
49103338 upf1 qpcr_5p H.s. cDNA AGCTCGCAGACTCTCACTTTC 
49103339 upf1 qpcr_3p H.s. cDNA CGTCTGGCTAGGAAGAGTAAAG 
49629004 Hs brf1 qpcr_3p H.s. cDNA CTTGAGGCTGCTGAGGAG 
49629005 Hs brf1 qpcr_5p H.s. cDNA GACAGAAAGGCAGTGGGC 
49629006 Hs upf2 qpcr_5p H.s. cDNA CAGTGAGCAGCAAGGAGAG 
49629009 Hs upf2 qpcr_3p H.s. cDNA CTTTTTTCTCTTATCATCTTCCAGTCTC 
50158852 Gapdh 5p_qpcr 
forward 
H.s. cDNA TCGGAGTCAACGGATTTGGTCG 
50158853 Gapdh 5p 
qpcr_reverse 
H.s. cDNA TAAACCATGTAGTTGAGGTCAATGAAGG 
50158854 Gapdh 3p 
qpcr_forward 
H.s. cDNA AAGCTCATTTCCTGGTATGACAACG 
50158855 Gapdh 3p 
qpcr_reverse 
H.s. cDNA TCTTCCTCTTGTGCTCTTGCTGG 
50312511 Renilla 5p 
qpcr_v2 
H.s. cDNA AGGTGAAGTTCGTCGTCCAACATTATC 
50312512 Renilla 3p 
qpcr_v2 
H.s. cDNA GAAACTTCTTGGCACCTTCAACAATAGC 
50312513 eGFP 5p_qpcr H.s. cDNA AGAAGAACGGCATCAAGGTGA 
50312514 eGFP 3p_qpcr H.s. cDNA CGGACTGGGTGCTCAGGTAG 
50312515 Hs u6 5p_qpcr H.s. cDNA CGCTTCGGCAGCACATATAC 
50312516 Hs u6 3p_qpcr H.s. cDNA AAAATATGGAACGCTTCACGA 
52335636 CCR5 forward H.s. cDNA GTCCCCTTCTGGGCTCACTAT 
52335637 CCR5 reverase H.s. cDNA CCCTGTCAAGAGTTGACACATTGTA 
59501271 BAG1 qpcr_F H.s. cDNA TGCCGGGTCATGTTAATTGGG 
59501272 BAG1 qPCR_R H.s.cDNA GCAGAGAGCTTCAGCTTGCAAATCC 
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Appendix 8: RNAi Oligonucleotides 
Table 13: Oligonucleotides used in RNAi studies 
Synthetic dsRNA oligonucleotides include the sense and antisense strands with 2 base pair 
overhangs.  Full specifications for the hsa-miR-1224 oligonucleotides may be found by using the 
order number at http://www.idtdna.com.  The details for the overhang containing nucleotides may 
be found at https://www.qiagen.com/geneglobe/ by searching for the ORF name. 
 
  
Order # Name Sequence 
59828675 1224-5p 5’ GUG AGG ACU CGG GAG GUG G 3’ 
78135739 mir1224_r 5’ CGA CCU CCC GAG UCC UCA C 3’ 
78135740 mir1224_f 
biotin 
5’ /Biotin/ GUG AGG ACU CGG GAG GUG G 3’ 
 hUPF2 Target: 5’ CA CCA TGA GCG TGG AGG CGT A    3’ 
Sense:  5’    CCA UGA GCG UGG AGG CGU Att  3’ 
Anti:   3’ gt GGU ACU CGC ACC UCC GCA U    5’ 
 hHNRPD 
(AUF1) 
Target: 5’ AA CAG CCA AGG TTA CGG TGG T    3’ 
Sense:  5'    CAG CCA AGG UUA CGG UGG Utt  3' 
Anti:   3' tt GUC GGU UCC AAU GCC ACC A    5' 
 hBRF1 Target: 5’ CA CCA GTC AGT TGA CCA TTG A    3’ 
Sense:  5’    CCA GUC AGU UGA CCA UUG Att  3’ 
Anti:   3’ gt GGU CAG UCA ACU GGU AAC U    5’ 
 hMAPK Target: 5’ CC CCG GTA CCT CGT TCG TTG AGC GAG TTC    3’ 
Sense:  5’    CCG GUA CCU CGU UCG UUG AGC GAG UUC tt 3’ 
Anti:   5’ gg GGC CAU GGA GCA AGC AAC UCG CUC AAG    5’ 
 hSMG1 Target: 5’ CA CCA TGG TAT TAC AGG TTC A    3’ 
Sense:  5’    CCA UGG UAU UAC AGG UUC Att  3’ 
Anti:   5’ gt GGU ACC AUA AUG UCC AAG U    5’ 
 hEIF2C1 
(argonaute 1) 
Target: 5’ TA GTC TTA ACA TAA AGC CGA A    3’ 
Sense:  5’    GUC UUA ACA UAA AGC CGA Att  3’ 
Anti:   3’ at CAG AAU UGU AUU UCG GCU U    5’ 
 hRENT1 
(UPF1) 
Target: 5’ CA CCA TGA GCG TGG AGG CGT A    3’ 
Sense:  5’    CCA UGA GCG UGG AGG CGU Att  3’ 
Anti:   3’ gt GGU ACU CGC ACC UCC GCA U    5’ 
 Scrambled Target: 5’ AAT TCT CCG AAC GTG TCA CGT     3’ 
Sense:  5’ UUC UCC GAA CGU GUC ACG Utt     3’  
Anti:   3’ ACG UGA CAC GUU CGG AGA Att     5’ 
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Appendix 9: Oligonucleotides Used for SHAPE / in-vitro 
Translation 
Order # Name Template Sequence 









39376817 est2 mrna 
oligo t7kozak 
5prime 
pJD0641 etc CAATATTTTCCTTATCAGCATCATAAGCTGTCAGTA 
39376818 est2 mrna 
oligo 3prime 
pJD0641 etc CAATATTTTCCTTATCAGCATCATAAGCTGTCAGTA 
39376819 EST2 mRNA est2 shape 
10bp-down 
TTGAGATCTAACGAAAA 
39376820 EST2 mRNA est2 shape 
56bp-down 
CAACATTAAATAACTTC 
39376821 EST2 mRNA est2 shape 
113bp-down 
CCGTCCTCACATTATCT 
39376822 EST2 mRNA est2 shape 
170bp-down 
CTGTTTTAAATATTTCC 
























39997805 PDR5 mRNA pdr5 200 
revcomp 
GGTTTCAAGATTTGGAAAGTATTGGTTTCTTTAG 
39997806 PDR5 mRNA pdr5 150 
revcomp 
GGATTTTGTATGGAATATTAACC 
39997807 PDR5 mRNA pdr5 100 
revcomp 
GCGGAAGCACCAGAAGCACTTAAGTTC 
39997808 PDR5 mRNA pdr5 50 
revcomp 
GGAATAAGGCTTATAAAAGTCAGGGTCTGCC 





















Table 14: Oligonucleotides used for SHAPE and in-vitro transcription 



























Appendix 10: Code Summary 
pymol/plug_helices.py: Top level pymol plugin, reads ribosome PDB publication 
spreadsheet, parses pdb files, labels chains, reads data files containing ribosomal 
helices and base modifications. 
 
pymol/movies/render.py:  Submits pdb sessions for rendering on the University of 
Maryland High Performance Computing cluster. 
 
prfdb/prf_daemon:  Top level perl interface to the prfdb.  Handles importing sequences, 
running them through the filtering pipeline, randomization, and data storage. 
 
prfdb/lib/PRFConfig.pm:  Primary configuration object.  This combines configuration 
file parsing and command line options into a single namespace.  In addition it ensures 
that webservers and compute nodes follow the same configuration. 
 
prfdb/lib/PRFdb.pm and prfdb/lib/PRFdb/*.pm:  Database abstraction layer.  Contains 
interfaces for all database activities and schema. 
 
prfdb/lib/PRFGraph.pm:  Graphing library.  Takes data from PRFdb and uses 
GD::Graph, SVG::TT::Graph, JSON, etc to create graphs. 
 
prfdb/lib/PRFBlast.pm:  Layer for Bio::Tools::Run::Blast*, handles running various blast 
searches against the local database as well as ncbi. 
 
prfdb/lib/SeqMisc.pm:  Reads in sequences and provides various nucleotide 
frequencies, randomizations, translations, etc.  Simpler than Bio::SeqIO. 
 
prfdb/lib/HTMLMisc.pm:  Commonly reused html fragments. 
 
prfdb/handler.pl:  Defines how the apache webserver responds to requests to the 
PRFdb, initializes connections to the databases. 
 
prfdb/lib/MyDeps.pm:  Perl dependency resolver.  Uses CPAN to locally install any 
missing dependencies without user intervention. 
 
prfdb/lib/PRFsnp.pm:  Integrates ncbi SNP data into the PRFdb.  Initially written by Nic 
Hepler. 
 
prfdb/lib/PkParse.pm:  Parser for RNA secondary structure output, provides bpseq, 
parentheses, fasta outputs. 
 
prfdb/lib/Bootlace.pm:  Randomization and refolding library. 
 
prfdb/lib/Agree.pm:  Measures amount of agreement among various RNA structure 
prediction programs. 
 




prfdb/lib/RNAMotif.pm:  Provides interfaces to rnamotif. (Should be superseded by 
Bio::Tools::Run::RnaMotif.pm) 
 
prfdb/lib/RNAFolders.pm:  Provides interfaces to various secondary structure 
programs including:  Vienna’s RNAfold, pknots, Nupack, Hotknots, mfold, ilm. 
 
prfdb/lib/MyGenbank.pm: Wrapper for Bio::DB::Universal and Bio::SeqIO to place all of 
the annotation data therein into a single namespace. 
 
prfdb/lib/Overlap.pm:  Computes length of +1 and -1 frame ORF extensions. 
 
prfdb/*.sh:  Maintenance tasks including pbs queues, database backup, etc. 
 
prfdb/*.html:  HTML::Mason objects defining the web interface to the PRFdb. 
 





Appendix 11: Partial Summary of the PRFdb 
Species ORFs Windows 1std_mfe 1std_z 1std_both 
Caenorhabiditis elegans 50,914 46,725 5,731 5,158 4,694 
Branchiostoma floridae 50,729 164 20 24 16 
Strongylocentrotus purpuratus 42,275 66 10 7 7 
Homo sapiens 37,337 62,272 8,428 8,197 6,205 
Danio rerio 33,997 8,731 1,249 1,242 979 
Ricinus communis 28,270 91 13 12 7 
Xenopus laevis 26,537 26,689 3,543 3,514 2,852 
Drosophila yakuba 16,095 21,741 3,056 1,952 1,605 
Mus musculus 15,683 28,948 4,101 3,913 3,193 
Drosophila willistoni 15,426 5,025 649 698 561 
Ciona intestinalis 13,921 34 4 7 4 
Kluyveromyces waltii 10,888 0 0 0 0 
Nasonia vitripennis 9,495 71 7 6 4 
Apis mellifera 9,266 77 11 9 9 
Bos taurus 9,225 16,449 2,242 2,260 1,628 
Saccharomyces paradoxus 8,955 37,274 4,481 4,310 3,891 
Drosophila virilis 7,725 9,497 1,339 52 46 
Saccharomyces cerevisiae 6,354 37,423 4,441 4,133 3,991 
Kluyveromyces polysporous 5,526 80,234 4,451 3,537 3,254 
Rattus norvegicus 5,376 9,035 1,308 1,307 1,020 
Bacillus anthracis 5,287 6,067 771 801 664 
Candida glabrata 5,237 1 3 1 3 
Kluyveromyces 
thermotolerans 
5,171 0 0 0 0 
Kluyveromyces lactis 5,138 10 2 3 2 
Xenopus tropicalis 5,126 14,742 1,968 1,905 1,509 
Schizosaccharomyces pombe 5,091 33,760 3,916 3,620 3,505 
Zygosaccharomyces rouxii 5,051 2 3 1 3 
Drosophila melanogaster 5,013 9,847 1,372 1,216 1,104 
Saccharomyces bayanus 4,970 23,438 2,868 2,782 2,474 
Ashbya gossypii 4,753 0 0 0 0 
Saccharomyces castellii 4,684 24,289 2,936 2,842 2,616 
Gallus gallus 4,450 10,467 1,328 1,361 1,027 
Escherichia coli 4,322 5,446 820 804 633 
Xenopus silurana 3,901 0 0 0 0 
Saccharomyces kudriavzevii 3,778 15,769 2,050 1,937 1,758 
Haloarcula marismortui 3,412 425 69 58 42 
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Saccharomyces mikatae 3,109 13,048 1,729 1,664 1,509 
Salmo salar 2,986 32 7 7 7 
Saccharomyces kluyveri 2,977 11,217 1,433 1,406 1,232 
Arabidopsis thaliana 2,903 73 11 10 10 
Staphylococcus aureus 2,538 10,515 1,298 1,338 1,137 
Thermus thermophilus 1,973 319 45 42 34 
Streptococcus pyogenes 1,939 6,369 848 808 708 
Oncorhynchus mykiss 844 0 0 0 0 
Pan troglodytes 774 1,522 213 210 154 
Oryzias latipes 472 20 6 5 6 
Viral 599 5,850 600 17,700 300 






Table 15: A partial summary of the PRFdb 
This summary of the PRFdb counts only those species for which there are more than 450 open 
reading frames.  It shows the number of ORFs, the number of significant folds with respect to 
MFE, Z-score, and both.  Some species have been imported but not examined, notable examples 




Appendix 12: Categorized Recoding Signals 




































oaz: antizyme From S. pombe 
to invertebrates 




oaz1/2: antizymes 1, 2 Mammals +1 FS UCC UGA Stop codon, 
polyamines 
oaz3: antizyme 3 Mammals +1 FS UCC UGA Unknown 
p45: telomerase component Euplotes +1 FS AAA UAA Unknown 
est3: telomerase component S. cerevisiae +1 FS CUU AGU Hungry codon in A site 
Actin-filament binding protein S. cerevisiae +1 FS CUU AGU Hungry codon in A site 
Retrotransposons Ty1, Ty2, Ty4 S. cerevisiae +1 FS CUU AGG Hungry codon 
prfB: Peptide release factor 2 Most bacteria +1 FS CUU AGU U Shine-Dalgarno  
dnaX: DNA pol III E. coli -1 FS A AAA AAG Shine-Dalgarno 
dnaX: DNA pol III T. thermophilus slippage (- n) UUUUUUUUU None! 
cdd: Cytidine deaminase B. subtilis -1 FS A CGA AAG Shine-Dalgarno 
arg1: Ornithine 
carbamoyltransferase 
E. coli +1 FS UUU C Shift into termination 
at 5’ end of ORF 
Multiple viral mobile elements Bacteria -1 FS Various Pseudoknots  
kel: Kelch D. melanogaster suppression UGA Developmental 
regulation 
oaf: Out at first D. melanogaster suppression UGA Developmental 
regulation 
hdc: Headcase D. melanogaster suppression UAA Developmental 
regulation 
topA: DNA topoisomerase I B. firmus suppression UGA Unknown 
Adhesion factors E. coli suppression UAG Unknown 
Selenocycteine incorporation All kingdoms suppression UGA Multiple mechanisms, 
stem-loops, tRNAs 














gag-pol, gag-pro-pol HIV, MMTV, etc -1 FS N NNW WWH 3’ pseudoknot/stem-
loop 
gag-pol, gag-pro-pol MuLV, TMV suppression UAG Pseudoknot 
pol: RNA polymerase BYDV -1 FS G GGU UUU Stimulatory element 
3kb downstream! 
gene 60: Topoisomerase 
subunit 







Coat protein RNA phage Qβ suppression UGA Unknown 
Coat lysis hybrid RNA phage MS2 +1 FS Unknown Stem loop 
Capsid-RNA replicase Sindbis suppression UGA  
Genes g-t tail assembly proteins Lambdoid 
phages 
-1 FS G GGA AAG  
Gene 10: Major coat protein Phage T7 -1 FS G GUU UUC 3’ stimulatory element 
in UTR 
Table 16: A partial bestiary of recoding signals 
This is a short listing of characterized recoding signals sorted from chromosomal to viral 
elements.  This is mostly transcribed from Baranov et al.[158].  Many hundreds of new examples 




Appendix 13: Observed Viral Origin -1 PRF Signals. 
Family/Group Genus Virus Gene 
Overlap 
References 
Retroviridae Lentivirus Human Immunodeficiency 
Virus type 1 
gag-pol Jacks et al (1998) 
Retroviridae Lentivirus Feline Immunodeficiency 
Virus 
gag-pol Morikawa and Bishop 
(1992) 
Retroviridae ALSV Rous Sarcoma Virus gag-pol Jacks and Varmus 
(1985) 
Retroviridae B-type Mouse Mammary tumor 
virus 
gag-pro Moore et al (1987), 
Jacks et al(1987) 
Retroviridae D-type Simian Retrovirus Type 1 gag-pro ten Dam et al.(1994) 
Retroviridae HTLV Human T cell leukemia 
virus Type 1 
gag-pro Nam et al.(1988) 
Retroviridae HTLV Human T cell leukemia 
virus Type 1 
pro-pol Nam et al.(1993) 
Retroviridae HTLV Human T cell leukemia 
virus Type 2 
gag-pro-
pol 
Mador et al.(1989) 
Coronaviridae Coronavirus Infectious Bronchitis Virus orf1a-
orf1b 
Brierley et al.(1988) 




Coronaviridae Coronavirus Human Coronavirus orf1a-
orf1b 
Herold et al.(1993) 
Coronaviridae Coronavirus Transmissible 
gastroenteritis virus  
orf1a-
orf1b 
Eleouet et al.(1995) 
Coronaviridae Torovirus Berne Virus orf1a-
orf1b 
Snijder et al.(1990) 
Coronaviridae Arterivirus Equine Arteritis Virus orf1a-
orf1b 
den Boon et al.(1991) 




Marczinke et al.(1994) 
Totiviridae Totivirus Giardia lamblia virus orf1-orf2 Wang et al.(1993) 
Totiviridae Totivirus Saccharomyces cerevisiae 
L-A 
gag-pol Dinman et al.(1991) 
Totiviridae Totivirus Saccharomyces cerevisiae 
L-1 
cap-pol Diamond et al.(1989) 
Podoviridae T7 phage Bacteriophage T7 10A-
10B 
Condron et al.(1991) 
Siphoviridae Λ phage Bacteriophage Λ gpG-T Levin et al.(1993) 
Luteoviridae Luteovirus Barley Yellow Dwarf Virus 39K-
60K 
Brault and Miller(1992) 
Luteoviridae Luteovirus Beet Western Yellow Virus orf2-orf3 Garcia et al.(1993) 
Luteovirdiae Luteovirus Potato Leaf Roll  orf2a-
orf2b 
Prufer et al.(1992) 
Dianthoviridae Dianthovirus Red clover necrotic mosaic 
virus 
P27-p57 Xiong et al.(1993) 
Family/Group Number of 
Signals 
Non-viral Genus Number  
Potyvirus 59 Drosophila 20  
Alphavirus 20 E. coli 7  
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Poleovirus 12 Salmonella 4  
Lentivirus 12 Neisseria 3  
Deltaretroviru
s 
10 Mus 2  
Coronavirus 9 Bacillus 1  
Betaretrovirus 8 Bombyx 1  
P2-like viruses 7 Ceratitis 1  
Flavivirus 7 Homo 1  
Luteovirus 6 Vibrio 1  
Bymovirus 4    
Tritimovirus 4    
Umbravirus 4    
Rymovirus 3    
Dianthovirus 3    
Ipomovirus 3    
Sobemovirus 3    
Giardiavirus 3    
Mamastroviru
s 
3    
Totivirus 3    
Alpharetroviru
s 
2    
Avastrovirus 2    
Lambda-like 
virus 
1    
T-7 like 
viruses 
1    
Torovirus 1    
Okavirus 1    
Table 17: A catalog of known viral origin -1 PRF signals 





Appendix 14: -1 PRF Signals are not Conserved across Yeast 
Species 
SPR6 -1 PRF signals in Saccharomyces species 
 
S. cerevisiae 



































































































































































































































BUB3 -1 PRF signals in Saccharomyces species 
 
S. cerevisiae 













































































   
 























































None predicted   
 
S.kudriavzevii 495 GGGAAAC -12.4 
 











 1293 AAAAAAC  -22.6  
S. castellii 537 UUUAAAA -20.1 
 
 
Table 18: -1 PRF signals are not conserved across yeast species 
The predicted -1 PRF signals for the ORF homologs in this study are listed; including the location 
of slippery sites, predicted minimum free energies (MFE) and downstream pseudoknots  (3’ of  
the slippery site) from Saccharomyces cerevisiae, S. paradoxus, S. mikatae, S. bayanus, S. 
castellii, S. kudriavzevii and S. kluyveri.  S. cerevisiae genes were used as inputs for the PRFdb 
(http://prfdb.umd.edu/) local BLAST database. The resulting homologous genes were queried for 
potentially significant -1 PRF signals as previously described[12].  Downstream stimulatory 
structures were predicted using the hotknots, unpack, or pknots algorithms.  Note that no 
homologs were identified in the S. castelii and S. kluyveri genomes for SPR6, in the S. kluyveri 
genome for EST2, or for TBF1 in the S. castelli genome.  Hyperlinked URLs lead to all potential 





Appendix 15: Interleukin Receptor Genes Containing -1 PRF 
Signals 
• CCR5 is the co-receptor for HIV-1, and individuals who do not express CCR5 are 
refractory to infection by the virus[262,263].  
• Expression of the IL7RA chain is critical for mounting an effective cellular 
immune response, and for maintaining long term T-cell memory (reviewed in 
[264]).  
• Interleukin-8 is a proinflammatory cytokine that is involved in chemoattraction 
and activation of neutrophils. The IL8 α-chain receptor (CXCR1) is a member of 
the G-protein-coupled receptor family that binds to IL8 with high affinity and 
transduces the signal through a G-protein activated second messenger 
system[265]. CXCR1 cleavage represents an important pathophysiologic 
mechanism in Cystic Fibrosis and other neutrophilic airway diseases[266], and 
expression of the CXCR1-Ha allele was found to protect patients against rapid 
progression to AIDS[267].  While CXCR1 only binds IL8, the IL8 β-chain receptor 
(CXCR2) also binds GRO and NAP-2[268].  Gene knockout studies in mice 
revealed a profound increase in the neutrophil and B-cell populations 
accompanied by lymphadenopathy and splenomegaly, suggesting that this 
receptor is the major mediator of neutrophil migration to sites of 
inflammation[269].  
• Interleukin-27 triggers expansion of antigen-specific naive CD4-positive T cells 
and promotes polarization towards a Th1 phenotype, which is critical for cell-
mediated immunity.  The interleukin 27 receptor α-chain (IL27R) is widely 
expressed in the immune system, and IL27R deficient mice were less able to 
control bacterial and parasite infections[270–272].  The hyper-susceptibility of 
IL27R knockout mice to experimental autoimmune encephalomyelitis suggested 
that this receptor may regulate production of proinflammatory cytokines and 
antagonize T cell-mediated immune hyperactivity[271,273].   
• The interleukin-2 γ-chain receptor (IL2RG) is shared among receptors for 
numerous interleukins involved in T-cell memory generation (IL2, IL4, IL7, IL15 
and IL21), and defects in its expression can result in Severe Combined Immune 
Deficiency syndrome (SCID)[264].  
• Interleukin-22 is structurally related to IL10[274], and the IL22 receptor α-1 chain 
(IL22R1) complexes with the IL10 receptor β-chain to serve as a common 
receptor chain for both IL10 and IL22[275].   IL22R1 expression is restricted to 
skin and respiratory and digestive tissues[276]; skin from patients with psoriasis 
or atopic dermatitis expressed high levels of IL22 and β-defensins, and it has 
been proposed that IL22 directly promotes the innate, nonspecific immunity of 
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